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Abstract 
Hypertension is a global health condition that has been increasing in prevalence 
around the world on an annual basis. Antihypertensive medications are the first line in 
managing high blood pressure. Hypertensive patients have reported different levels of 
adherence to antihypertensive medications, ranging from optimal to poor. Different 
factors have been found to contribute to antihypertensive medications adherence. 
Identifying factors related to poor adherence to medications is a fundamental step for 
suggesting future improvements that tailor specific interventions to improve medications 
adherence. This research project aimed to fill the gap in the literature by focusing on 
identifying the status of antihypertensive medication adherence and the associated factors 
to this adherence.  
In Saudi Arabia, the research attention toward hypertensive patients practice has 
focused on identifying the prevalence of hypertensive patients at regional and country 
levels. There have been few attempts to identify hypertensive patients practice with 
antihypertensive medications however these attempts have been limited due to the 
research design and methods of assessment of adherence.  
This study followed a cross-sectional design using a survey method and was 
conducted in Jeddah city in Saudi Arabia.  Since this study was conducted on Arabic 
speaking population, it was necessary to translate the research instrument.  
The second phase in this research project was the main study that was conducted 
in King Fahad General Hospital with 308 hypertensive patients. The collected data in the 
main study were analysed in two stages: validating the research instrument and 
conducting statistical analysis to achieve the research objectives. The first stage 
considered conducting a Principal Component Analysis (PCA) in order to validate the 
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research instrument which confirmed six factors loading in this instrument that is 
represented the following scales in the instrument; the perceived knowledge of 
hypertension and antihypertensive medications, Hill-Bone Compliance scale of 
medication adherence, BMQ-Specific, BMQ-Necessity, PDRQ-9 and the perceived 
quality of healthcare scale. This followed by an assessment for the internal consistency 
of the instrument. The results of internal consistency assessment reported a Cronbach 
alpha scores ranged from acceptable (Belief about Medication Questionnaire-Specific 
scale =.60) to excellent (Patient-Doctor Relationship Questionnaire-9=.91) for the 
included scales in this instrument.  
In terms of achieving the research objectives, the second stage of the analysis 
involved, univariate, bivariate and multivariate analysis. As the first objective aimed to 
identify the status of antihypertensive medication adherence, the results of analysing the 
Hill-Bone Compliance scale revealed that 28% of the patients were optimal adherents 
and that 72% of the patients were suboptimal adherents to antihypertensive medications. 
For the second objective of this research project that focused on identifying the 
significant factors associated with antihypertensive medication adherence, the analysis 
showed that patient’s concern about taking antihypertensive medication (p=.002), their 
belief of the necessity of taking antihypertensive medications (p=.021), and the patient-
physician relationship (p=.038) were significantly associated with adherence to 
antihypertensive medication. 
In the context of current knowledge, this is one of the very few studies in Saudi 
Arabia to identify the status of antihypertensive medication adherence and the relevant 
factors related to this adherence. The findings of this research have the potential to inform 
healthcare policies and strategies that will improve antihypertensive medication 
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adherence in the Saudi Arabian population, and contribute to the health status of this 
population.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 vi 
 
Table of Contents 
 
Chapter One: Introduction .................................................................................................................. 1 
1.1. Background of the study ......................................................................................................... 2 
1.2. Health and healthcare in the context of Saudi Arabia ............................................................. 9 
1.3. Research Gap ........................................................................................................................ 16 
1.4. Aims and objectives of the study .......................................................................................... 16 
1.5. Significance and contribution of the research ....................................................................... 17 
1.6. Organization of the thesis ..................................................................................................... 19 
Chapter Two: Literature Review ...................................................................................................... 21 
2.1. Medication adherence ........................................................................................................... 21 
2.1. Measuring medications adherence ........................................................................................ 25 
2.2. Factors affecting antihypertensive medication adherence .................................................... 41 
Chapter Three: Conceptual Framework .......................................................................................... 74 
3.1. The use of theories in medication adherence research .......................................................... 74 
Chapter Four: Methods ...................................................................................................................... 86 
4.1. Research design .................................................................................................................... 86 
4.2. Research instrument .............................................................................................................. 87 
4.3. Pilot study ........................................................................................................................... 100 
4.4. Main study .......................................................................................................................... 105 
Chapter Five: Results ....................................................................................................................... 116 
5.1. Pilot study ........................................................................................................................... 116 
5.1.1. Scales reliability .......................................................................................................... 118 
5.1.2. Instrument modification .............................................................................................. 118 
5.1.3. Descriptive analysis .................................................................................................... 119 
5.2. Main study .......................................................................................................................... 124 
5.2.1. Sample overview ......................................................................................................... 124 
5.2.2. Measures of reliability and validity............................................................................. 126 
5.2.3. Univariate analysis ...................................................................................................... 128 
5.2.4. Association between independent variables and medication adherence ..................... 134 
5.2.5. Predictors of antihypertensive medications adherence ............................................... 138 
5.3. Summary of the results ....................................................................................................... 140 
Chapter Six: Discussion and Conclusion ........................................................................................ 142 
6.1. The pilot study .................................................................................................................... 142 
 vii 
 
6.2. Status of antihypertensive medication adherence ............................................................... 146 
6.3. Predictors of antihypertensive medication adherence ......................................................... 154 
6.4. Implications for practice ..................................................................................................... 176 
6.5. Implications and recommendations for future research ...................................................... 181 
6.6. Strengths and limitations ..................................................................................................... 183 
6.7. Conclusion .......................................................................................................................... 188 
References .......................................................................................................................................... 191 
Appendices ......................................................................................................................................... 220 
Appendix A: Ethical Approvals ...................................................................................................... 221 
Appendix B: Research Instrument .................................................................................................. 221 
Appendix C: Permission to Use Copyright Protected Tool  ........................................................... 221 
Appendix D: SPSS Outcome .......................................................................................................... 242 
 
 
 
 
 
 
 
 
 
 
 
 
 
 viii 
 
 
 
 
List of Figures 
 
Figure 1: Map of Saudi Arabia (Emw, 2016). ...................................................................................... 10 
Figure 2: The Health Belief Model (Glanz et al, 2008, p.49) ............................................................... 76 
Figure 3: The Theory of Planned Behaviour (Ajzan, 1991, p.182). ..................................................... 77 
Figure 4: The Social Learning Theory (Bandura, 1977). ...................................................................... 78 
Figure 5: WHO model of medication adherence (WHO, 2003). .......................................................... 83 
Figure 6: Conceptual Framework ......................................................................................................... 85 
Figure 7: Process Followed for the Translation of the Questionnaire................................................... 99 
Figure 8: Distribution of Hill-Bone Compliance scale responses for the pilot study ......................... 120 
Figure 9: Factors loading .................................................................................................................... 127 
Figure 10: Distribution of Hill-Bone Compliance scale responses for the main study ....................... 134 
  
 ix 
 
 
 
List of Tables 
Table 1 : Self-report measures of adherence to antihypertensive medications ..................................... 33 
Table 2: Data coding for the main study ............................................................................................. 114 
Table 3: Sample sociodemographic characteristics of the pilot study ................................................ 117 
Table 4: General alpha reliability statistics for the scales included in the pilot study questionnaire .. 118 
Table 5: Descriptive statistic of Hill-Bone Compliance scale 9-items ............................................... 120 
Table 6: Health and health behaviour related data .............................................................................. 121 
Table 7: Descriptive statistic of the perceived knowledge scale items ............................................... 122 
Table 8: Descriptive statistic of the belief about medication scale items ........................................... 123 
Table 9: Descriptive statistic of the patient-doctor relationship scale items ....................................... 123 
Table 10: Descriptive statistic of the perceived quality of healthcare support items .......................... 124 
Table 11: Sample sociodemographic characteristics for the main study ............................................ 125 
Table 12: Kaiser-Meyer-Olkin measure of sampling adequacy ......................................................... 127 
Table 13: Internal consistency for the questionnaire sub-scales used in the main study .................... 128 
Table 14: Health and health behaviour related data ............................................................................ 129 
Table 15: Descriptive statistic of the perceived knowledge scale items ............................................. 130 
Table 16: Descriptive statistic of the belief about medication scale items ......................................... 131 
Table 17: Descriptive statistic of the patient-doctor relationship scale items ..................................... 131 
Table 18: Descriptive statistic of the perceived quality of healthcare support items .......................... 132 
Table 19: Descriptive statistics for all independent variables’ scales ................................................. 132 
Table 20: Descriptive statistic of Hill-Bone Compliance scale 9-items ............................................. 133 
Table 21: Bivariate results: sociodemographic and health-related factors ......................................... 135 
Table 22: Bivariate results: the perceived knowledge ........................................................................ 136 
Table 23: Bivariate results: the beliefs about medication ................................................................... 137 
Table 24: Bivariate results: the patient-doctor relationship ................................................................ 137 
Table 25: Bivariate results: the perceived quality of healthcare ......................................................... 138 
Table 26: Final multiple logistic regression model ............................................................................. 140 
 
  
 x 
 
 
List of Abbreviations 
 
 
BMQ                                Belief about Medication Questionnaire  
KAUH                              King Abdulaziz University Hospital  
KFHJ                               King Fahad General Hospital  
MOH                                Ministry of Health  
PCA                                  Principal Component Analysis  
PDRQ-9                           Patient-Doctor Relationship Questionnaire-9 
RA                                    Research Assistant  
SHMS                              Saudi Hypertension Management Society  
SPSS                                Statistical Package for the Social Sciences  
 
 
 
 
 
 
 
 
 
 
 
 
 
 xi 
 
  
QUT Verified Signature
 xii 
 
Acknowledgment 
 
 
I want to express my sincere gratitude to my supervisors. Dr. Janet Hou and 
Dr.Ignacio Correa-Veleze, this thesis would not be possible without your tremendous 
support. All the valuable feedback, insightful guidance, encouragement and motivation 
throughout this journey have contributed to this success.  
 
I extend my appreciation and thank Umm Al-Qura University in Saudi Arabia, and 
their provision of the Ministry of Higher Education Scholarship for providing me with 
the support to complete this degree.  
 
I would like to acknowledge the assistant and the continued support of my 
colleagues, Dr.Khalid Abo Alshamat and Dr. Ibrahim Mahmoud.  
 
My heartfelt appreciation also goes my parents and my sisters, who always 
supported and encouraged me during this journey with their prayers, wishes and love.  
Holding a special place in my heart is my gratitude to my wonderful husband, 
Adam Isaac, for his unconditional love and support and willingness to take this journey 
with me.  
 
  
 xiii 
 
 
1 
 
Chapter One: Introduction 
 
The availability of antihypertensive treatment has improved the quality of life for 
hypertensive patients by reducing the impact of the accompanying symptoms for 
hypertensive conditions. Additionally, antihypertensive treatments assist in preventing 
the consequences of complications that are likely to occur in those cases of non-treated 
conditions (Staessen et al., 2000). However, regardless of the wide-spread availability of 
treatment, the adherence to taking medication by individuals with hypertension has been 
reported to vary, from optimal to very poor.  
Hypertension is increasing rapidly in both developed and developing countries. It 
is estimated that hypertension accounts for more than 9.4 million deaths per year (World 
Health Organisation, 2013). Complications related to hypertension are irreversible and 
hypertension itself is one of the main causes of an increased burden on healthcare systems 
(Degli Esposti et al., 2004). 
An uncontrolled high blood pressure level or complications related to poor 
treatment adherence are a great challenge for individuals with hypertension, healthcare 
professionals and healthcare systems. This is due to the significant effort required in 
managing the resultant problems related to this poor adherence (Gatti, Jacobson, 
Gazmararian, Schmotzer, & Kripalani, 2009; Hadi & Rostami-Gooran, 2004; Hashmi et 
al., 2007). Researchers have identified various predictors that influence antihypertensive 
treatment adherence. These include both factors derived from the individual patient and 
also factors related to healthcare systems. Examples of individual patient factors include: 
socio-economic status of patient, patient knowledge, social support and beliefs. 
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Healthcare system (or provider level) factors include: provider’s communication, 
accessibility to treatment and patient education. Relatively little is known about the 
factors associated with antihypertensive medication adherence and this is particularly so 
in the context of Saudi Arabian hypertensive patients. 
1.1. Background of the study 
The management of hypertension in Saudi Arabia  
Hypertension is a significant health problem in many developed and developing 
countries. Hypertension, or in another word high blood pressure, is a cardiovascular 
condition. It is defined by the World Health Organisation (WHO) as “systolic blood 
pressure equal or greater than 140 mm Hg and diastolic blood pressure equal or more 
than 90 mm Hg”. Risk factors associated with developing hypertension are advanced age, 
advanced age and family history, in addition to modifiable factors such as increased salt 
intake, increased alcohol intake, lack of physical activity, obesity and overweight 
(American Heart Association, 2012). In the United States, the National Health and 
Nutrition Examination Survey found that the prevalence of hypertension among adults 
aged 18 years and over in 2011–2012 was 29.1% (United States Department of Health 
and Human Services, Centers for Disease Control and Prevention, 2013). The Australian 
Bureau of Statistics (2006) reported that the most common cardiovascular condition in 
Australia was hypertension, which was reported for 11% (2.1 million) of the population 
(Australian Bureau of Statistics, 2006). The WHO 2013 report found that approximately 
40% of the world’s adults were estimated to have hypertension (WHO, 2013). The WHO 
report identified that the prevalence had increased in individuals older than 25 years in 
different countries, with 50% of individuals in this age group having hypertension. 
Around the world, it was estimated that approximately 1 billion people have hypertension 
and that hypertension contributes to more than 9.4 million deaths per year (WHO, 2013). 
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Hypertension is also a common health issue in Saudi Arabia, where the prevalence 
of the condition is increasing. Recent data from a national survey that measured the blood 
pressure of 10,735 Saudis aged 15 years or older found that about 45% of participants on 
medication for hypertension had their blood pressure controlled. According to this 
survey, the prevalence of hypertension and borderline hypertension in Saudi Arabia was 
very high with 27.2% of respondents found with high blood pressure (El Bcheraoui et 
al., 2014). Moreover, control of hypertension was poor (El Bcheraoui et al., 2014). The 
Global Burden of Disease Study in 2010 (University of Washington, Institute of Health 
Metrics & Evaluation, 2013) ranked hypertensive heart disease as the 13th most common 
cause of premature mortality in Saudi Arabia. In 2010, hypertensive heart disease was 
the cause of 2.37% of total deaths and 0.73% of total disability adjusted life years 
(DALYs) in Saudi Arabia (compared to 1.66% of total deaths and 0.62% of total DALYs 
worldwide) (University of Washington, Institute of Health Metrics & Evaluation, 2013). 
The development of a sustainable, systematic healthcare system in Saudi Arabia is 
designed to benefit all the country citizens, including prevention of common health issues 
and disease-related complications, and to ensure public wellbeing is the focus of the 
Saudi healthcare service. The government in Saudi Arabia is intent upon creating 
mechanisms to improve and implement comprehensive health service programmes 
through the Ministry of Health (MOH), as well as other related health organizations. 
Accordingly, the MOH has adopted a number of programmes and health policies 
designed to prevent, detect, evaluate and treat non-communicable diseases, one of which 
is hypertension.  
An important role in turning clinical practice guidelines and programmes into 
action, a unified protocol for early hypertension diagnosis, and the appropriate 
management of this health issue and its complications is fulfilled by the Saudi 
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Hypertension Management Society (SHMS) (Saudi Hypertension Management Society, 
2011). SHMS also assists with the development of national awareness and educational 
programmes aimed at healthcare professionals and the general public for primary 
prevention of hypertension. The MOH collaborates with SHMS, as well as other 
interested groups to develop an evidence-based knowledge database and research that are 
specific for heritage and culture related issues in Saudi. Such issues include the 
relationship between health conditions such as hypertension and fasting during Ramadan 
and the Hajj. The SHMS protocol, developed according to locally adopted regulations 
and rules in order to assess and control high blood pressure issues, is based upon local 
circumstances as well as scientific evidence. Rules and regulations that are developed are 
distributed throughout Saudi Arabia, together with the participation and support of 
organisations and existing programmes. It is the intention of the Ministry of Health to 
integrate guidelines throughout the country for the national clinical practice of 
hypertension, as a means of continually improving the prevention, detection and control 
of hypertension (SHMS, 2011). 
 
Medication adherence in hypertension  
Medication adherence in antihypertensive conditions is defined as taking 
medications adequately and frequently to maintain the optimum control of blood 
pressure. Achieving optimum results from using antihypertensive medications is 
manifested by the absence of symptoms such as dizziness, headache and sweatness, 
normal blood pressure reading (120/80 mm Hg) (World Health Organisation, 2014) and 
in the long term, fewer chances of contributing complications.  
The major challenge that patients with hypertension encountered was that 
hypertension was often an asymptomatic condition and, therefore, consistent adherence 
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to and compliance with treatment regimens based on reported symptoms was problematic 
(Almas, Godil, Lalani, Samani, & Khan, 2012). Individuals with hypertension sometimes 
reported some or none of the following overt symptoms: dizziness, blurred vision, nausea 
and headache (Saudi Hypertension Management Society, 2011, p. 30). This became a 
challenge in controlling hypertension since patients withheld or discontinued treatment 
in the absence of overt symptoms and restarted treatment when such symptoms arose 
(Hashmi et al., 2007). It was also challenging in the medical practice since physicians 
were more motivated to treat symptomatic conditions rather than asymptomatic 
conditions (Degli Esposti et al., 2004). 
The complexity of the hypertension treatment regime was another challenging 
concern. Daily frequent dosing of hypertension medication or the need to take other drugs 
in addition to the hypertension medications contributed to the complexity of this 
treatment regimen. Not all individuals with hypertension were treated with mono-
therapy, since two-thirds of the cases require two or more types of antihypertensive 
agents in order to best control the condition (American Heart Association, 2012; 
Australian Bureau of Statistics, 2006). Additionally, individuals with hypertension often 
had comorbidities, such as diabetes or hyperlipidaemia, which contributed to the 
complexity of their treatment regimen because these medical conditions necessitated the 
use of additional drugs (McDonald, Pezzin, Peng, & Feldman, 2009). However, 
following a complex treatment regimen was not always cited as being a challenge for 
patients because some studies reported that some patients with a complex treatment 
regimen were compliant because they understood and experienced the seriousness and 
the severity of their disease more than patients who were on a lighter regimen (Hashmi 
et al., 2007).  
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The adherence cut-off level has been described as 80% for patients with 
hypertension. However, estimating this level varies among researchers and clinicians 
based on the method used for assessment. It has been identified that consumers of no less 
than 80% of their high blood pressure medications had maintained control of their blood 
pressure levels  (Herttua, Tabak, Martikainen, Vahtera, & Kivimaki, 2013). The presence 
of complications related to poor adherence to antihypertensive medications occurred in 
hypertensive patients who consumed less than 80% of their antihypertensive medications 
(Herttua et al., 2013; Jagadeesh, Balakumar & Maung-U, 2015; Khan et al., 2010).  
The major concern for clinicians and individuals of the poor medication 
adherence group in hypertensive patients is the contributing unpleasant complications. 
This extends to incurring another concern for the health system that will require dealing 
with the cost of treating the complications. The effect of the treatment adherence level 
on the incidence of cardiovascular events has been measured to produce valuable 
evidence. In Italy, 18,806 newly diagnosed patients with hypertension without 
cardiovascular diseases were included in a general practice registry and were observed 
for 4.6 years (Degli Esposti et al., 2004). This Italian general practice registry included 
comprehensive information on hospital admissions, laboratory results, cardiovascular 
events and mortality, and drug prescriptions. The patients were classified according to 
their adherence level: high, intermediate, and low. The findings showed that 51% of 
patients had a low adherence level, and only 8% were in the high-adherence group. These 
results were not consistent because the adherence level varied among patients during the 
study. At the end of the study, there were 49% low-adherent patients and 19% high-
adherent patients. The important finding of the study showed (after the appropriate risk 
adjustment) that  patients who had high risk for cardiovascular events were less adherents 
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to their antihypertensive medications [hazard ratio, 0.62; 95% confidence interval (CI), 
0.40–0.96] (Degli Esposti et al., 2004). 
Moreover, poor adherence to antihypertensive medication was linked to a high risk 
of hospitalisation and increased healthcare costs. A longitudinal study that included 
59,647 patients diagnosed with essential hypertension was reassembled from Med-Echo 
and Régie de l’Assurance Maladie du Québec databases (Dragomir et al., 2010). Subjects 
included were aged 45–85 years and newly treated with antihypertensive therapy but 
showed no cardiovascular symptoms. The participants were observed for three years. 
Within the 3-year follow-up period, those low-adherent patients were more likely to 
present with cerebrovascular disease (OR, 1.13; 95% CI, 1.03–1.25), coronary disease 
(OR, 1.07; 95% CI, 1.00–1.13), and chronic heart failure (OR, 1.42; 95% CI, 1.27–1.58). 
The low adherence to antihypertensive treatments among hospitalised patients was 
associated with increased costs by approximately US$3,574 (95% CI, US$2,897–$4,249) 
per person within the 3-year period (Dragomir et al., 2010). 
Therefore, adherence to antihypertensive pharmacotherapy showed a reduction in 
symptoms of hypertension (Staessen et al., 2000), prevented complications that could 
lead to morbidity and mortality, and decreased the cost of treating complications 
(whether this financial burden was on hypertensive patients or on the healthcare system). 
Accordingly, it is vital to assess patients’ adherence to antihypertensive medications and 
identify the factors that could facilitate or hinder medication taking practice. This 
assessment will facilitate early attention to poor medication adherence issues and 
therefore guide proper interventions that are customised to the specific barrier.  
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Reasons for non-adherence in hypertension patients  
There are several attempts to investigate reasons influencing non-adherence in 
hypertensive patients. Reasons or factors as identified in the literature tended to be 
examined from three main perspectives: demographic; knowledge, comprehension and 
information giving; and finally patient behaviour (Kaufman & Birks, 2009).  
- Demographic reasons for non-adherence  
The epidemiological perspective tended to focus on examining the impact of the 
socio-demographic factors including gender, age and education status. The focus on these 
factors limits the possible explanations for medication non-adherence because it 
produces large possible results that have contradictory explanations when compared with 
previous studies. For example, some studies showed that education status is a significant 
predictor for antihypertensive medication adherence (Wu et al., 2012; Zyoud et al., 
2013), while other studies contradict this finding (Nunes, de Silva, Bernardino, Oliveira, 
& Neto, 2015). Generally, this approach claimed to present a less useful explanation for 
healthcare providers and researchers in order to improve or suggest interventions for 
improving medications adherence practice for hypertensive patients (Kaufman & Birks, 
2009).  
- Knowledge, comprehension and information giving  
This approach assumes that the lack of received information and knowledge are 
the main reasons for medications non-adherence (Kaufman & Birks, 2009). However, 
assuming that medication non-adherence is based exclusively on lack of knowledge fails 
to recognise that there are other factors which need to be considered to give a broader 
picture about the problem of non-adherence such as patient’s beliefs (Magadza, Radloff, 
& Srinivas, 2009).  
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- Patient behaviour  
This approach focusses on aspects of patient behaviour that could explain 
medication non-adherence. Some of the aspects of patient behaviour that could influence 
patient adherence practice are motivation, self-efficacy and belief (Kaufman & Birks, 
2009). These aspects are best to be studied when guided with a theoretical approach such 
as the belief model (Horne, Weinman, & Hankins, 1999). 
1.2.  Health and healthcare in the context of Saudi Arabia   
 
This section provides an overview of the economy, healthcare structure, culture 
and religion of Saudi Arabia and the influence of these factors on health and healthcare. 
It also includes information about the healthcare services in Jeddah city.  
The Kingdom of Saudi Arabia is situated in the Middle East and lies between the 
Red Sea and the Arabian Gulf (Figure 1). The country comprises an area of 200 million 
square kilometres and is one of the largest countries in the Middle East area (Central 
Department of Statistics and Information of Saudi Arabia, 2015). The country consists 
of thirteen regions that include Riyadh, Qassim, Ha’il, Madinah, Makkah, Tabuk, Bahah, 
Asir, Najran, Jawf, Jizan, Northern Borders and Eastern Province. This study was 
undertaken in Makkah region in Jeddah city, a city situated on the western coast by the 
Red Sea in Saudi Arabia. The latest estimated population of Jeddah city is 4,082,184, 
representing 14% of the total population in Saudi Arabia (Central Department of 
Statistics and Information of Saudi Arabia, 2015).  
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Figure 1: Map of Saudi Arabia (Emw, 2016). 
 
The estimated population of Saudi Arabia for the year 2014 was 30,770,375 
according to the reported information by the Central Department of Statistics and 
Information about Saudi Arabia, which is based upon the 2014 census. Saudi citizens 
comprise the majority of the total population, with 20,702,536 citizens and 10,067,839 
residents. Population to gender classification indicates that the male population was 
10,398,993, and the female population was 10,303,543 (Central Department of Statistics 
and Information of Saudi Arabia, 2015). 
Saudi Arabia was classified at high level in the Human Development Index (0.75) 
in 2010; therefore the country has a ranking of 55 out of 194 other countries. Increases 
in national income are expected to have a positive influence on its services, which include 
the healthcare services (Centers for Disease Control and Prevention, 2013). The 
country’s sound economy and well-established industrial base has led to an increase in 
income for the Saudi population, leading to an income of US$24,726 per capita in 2008, 
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when compared with previous years (G. Brown, 2005). The economic levels for families 
in Saudi Arabia are variable, and range between the ultra-rich, to the middle class, to very 
poor; most of the population being classified as middle class. High-rise buildings are the 
preferred choice for the middle class in most towns, whilst low-rise family housing seen 
with connecting houses, often described as duplexes in the United States of America, 
house the very poor. Family and close friends are the most important social grouping in 
the community (Brown, 2005). Average monthly income that is considered the middle-
class income for the Saudi citizen or a non-Saudi citizen is 5,000–10,000SR 
(US$1332.32–US$2664.64) (Central Department of Statistics and Information of Saudi 
Arabia, 2015).For its citizens and residents, the governmental health sector provides 
health services free of charge. 
The Ministry of Health (MOH) in Saudi Arabia manages three tiers of healthcare 
services that include the primary, the secondary and the tertiary levels. The primary 
health services are the first tier, which involves monitoring of the healthcare centres. The 
second tier involves general “public” hospitals and the third tier involves tertiary services 
that focus on central or specialised levels of care. The focus of these services is on grass-
root involvement regarding provision of healthcare, the main motivation being to provide 
suitable healthcare for all citizens and residents (Jannadi, Alshammari, Khan, & Hussain, 
2008). The MOH operates 2,037 primary healthcare centres, 244 secondary healthcare 
centres and 56 tertiary care centres all throughout Saudi Arabia (Jannadi et al., 2008). 
For chronic conditions management, primary healthcare centres are able to 
provide a comprehensive management care plan for patients that include diagnosis, 
monitoring and treatment adjustments. As the relevant facilities for tertiary advanced 
conditions are not an integral part of primary care in cases requiring some medical or 
surgical procedures and  treatment of complications, the general practitioner refers the 
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case to the secondary or tertiary healthcare facilities (Almalki, Fitzgerald & Clark, 
2011a). In this sense, primary healthcare facilities in Saudi Arabia have some drawbacks 
with the services provided for chronic illnesses including hypertension. These 
shortcomings relate to a lack of the supportive resources required for essential care (Al-
Khaldi & Al-Sharif, 2005) and issues with hard-copy (non-digital) medical records 
(Hasanain, Vallmuur & Clark, 2015). Consequently, the number of reported cases of 
diabetes, cardiovascular diseases, obesity, and high blood pressure among the people of 
Saudi Arabia has been increasing, despite the increased availability of primary healthcare 
services, which leads to access to other healthcare facilities. Such cases are sent to the 
secondary healthcare centres and tertiary healthcare service levels offered through the 
MOH (Almalki, Fitzgerald & Clark, 2011a).  
The current study with its two stages i.e. pilot and main studies, was conducted 
in tertiary health care facilities, due to the previously explained drawbacks of the primary 
healthcare facilities. Secondary and tertiary hospitals are equipped with advanced 
services and experienced medical practitioners.  Mostly patients with chronic conditions 
are referred to these hospitals to receive additional care that requires life-style 
modifications (i.e. smoking cessation, diet and exercise), plus blood and radiological 
investigations.  
- Healthcare services in the city of Jeddah 
Jeddah has both private and public health facilities. The Health Statistics Annual 
Book from the Ministry of Health in Saudi Arabia (2015, p. 38 & 50) stated that in Jeddah 
the primary facilities include 108 health centres and eight general hospitals, which are 
government owned and operated. The services are provided by the Ministry of Health 
authorities and the National Guard. Private health facilities include 29 hospitals. These 
hospitals with bed capacity of 2,836; and 151 clinics providing services at various 
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locations within Jeddah city (Kingdom of Saudi Arabia, Ministry of Health, 2015). In 
order to research the status of antihypertensive medication adherence and predictors 
affecting this practice, this research was conducted in the two major governmental 
hospitals in Jeddah city: King Abdulaziz University Hospital and King Fahad General 
Hospital. Some of the factors considered in selecting these hospitals included the type of 
the provided services and the accessibility to health demand data. In addition, all the 
services provided at these hospitals are quite similar to the remaining hospitals of Jeddah 
city. 
The present study was conducted in two locations, the pilot study in King 
Abdulaziz University and the main study in King Fahad General Hospital in Jeddah city. 
King Abdulaziz University Hospital is an educational governmental hospital in Jeddah. 
The hospital has a capacity of 845 beds, plus 157 beds dedicated for specialised and 
general clinics and critical care units. The hospital is involved in patients’ departments 
for different specialities including medical, surgical, gynaecology, labour and delivery, 
critical care, operation room, emergency, haematology and oncology, and paediatric. 
This is in addition to the outpatient department that includes different clinics. Services 
are provided free of charge for Saudi citizens (KAUH, 2016). King Fahad General 
Hospital (KFHJ) by comparison, is considered a major medical landmark and 
governmental hospital in Jeddah city. It is considered the main referral centre for 
emergency and traffic accident cases in Jeddah and surrounding areas since it has a 
clinical capacity that reaches 600 beds and a surgical cadre from different specialities 
that have the capability to deal with these cases. The hospital includes the following 
departments: Heart Centre, ear-nose-throat (ENT) Centre, Jeddah Kidney Centre (JKC), 
Dental Centre, Medical Rehabilitation Centre and Prince Sultan Bin Abdul Aziz Centre 
for Advanced Laparoscopic Surgeries (KFHJ, 2016). 
14 
 
Despite the substantial influence of the Saudi Arabia economy on the healthcare 
system, the Arabic culture and Islamic religion are significant factors that shape health 
and healthcare. 
- Saudi Arabia culture and religion: Influence on health and healthcare 
The major aspect which shapes the Saudi culture is certainly the religion Islam. 
As a major principle of the Islamic faith, predestination is strongly believed by the people 
and so occurrence of any disease is attributed as Allah’s will. They believe that a disease 
is not a punishment, instead it is a way of compensation for one’s wrong doings. In Saudi 
Arabia, the belief regarding predestination does not really stop the Saudis from obtaining 
medical treatment or using the easily accessible preventive services like childhood 
immunisation programs (Halligan, 2006). It is stated by the Prophet Mohammad that, 
“no fatigue, no disease, nor sorrow, nor sadness, nor hurt, nor distress befalls a Muslim, 
even if it were the prick he receives from a thorn, but Allah expiates some of his sins for 
that” (Harford & Aljawi, 2013). 
The social orientation of Saudi Arabia is nurtured by the Islamic religion beliefs. 
This is showing at community and family levels. In spite of the representation of Islamic 
religion values and the influence of the Arab traditions in the Saudi Arabia community, 
gender-segregation is a main feature. This is applied in different organisations, 
governmental or private, such as schools, universities, hospitals, banking, companies and 
restaurants (Mobaraki & Söderfeldt, 2010). With a focus on medical treatment, hospitals 
in Saudi Arabia are designed to include two sections for each department one for female 
patients and other for male patients, and this is obvious in in-patient departments and 
nursing rooms. This rule is not rigid since it is common for different gender to provide 
treatment in case of the unavailability of the healthcare provider from the same gender, 
for instance, female patients can seek treatment from male physicians. Although, there 
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are a few issues encountered in this practice such as communication and relationship with 
the different gender healthcare provider existed, the Saudi community still work with the 
respect of its conservative culture. Dealing with these issues, for example, the lack of a 
same-gender physician for women has emphasised for male physicians to practice their 
role in accordance to Saudi culture etiquette and for female patients to be more assertive 
and proactive in explaining their health condition (Al-Doghaither, 2004).  
The above issue addresses the culture and religion view from gender perspective, 
however, this must always be seen in the broader context of the family.  
With regard to the religion and Arab tradition at the family level, most Saudi 
families live in traditional, extended-family households (Halligan, 2006). Saudi families 
have close ties to their members from first or second degree relatives. According to the 
Islamic teachings, elder members have special admiration, respect and position in the 
family for their wisdom and life experience. This special family care extends to ill 
members in the family (Al-Shahri, 2002). For an ill member or relative, the family 
provides the care and support for this member as a respect for the prophet Mohammed 
words that “Muslims, in their mutual love, mercy and compassion, are like one body, if 
one organ complained, the rest of the body develops a fever” (Al-Shahri, 2002). 
Therefore, Saudi Muslim families shows the care of their member under the lights of the 
Islamic values and teachings.  
With all the above provided information about how the economy, healthcare 
system, culture and religion in Saudi Arabia are supportive toward health and healthcare, 
hypertension is still a major issue facing significant number of the population every year.  
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1.3. Research Gap  
 
Research focussing on the factors affecting the practices of hypertensive patients 
regarding their antihypertensive medication use in Saudi Arabia is limited. Existing 
studies have aimed to investigate medication compliance and knowledge of hypertension 
(Al-Sowielem & Elzubier, 1998), treatment practices and hypertension control (Saeed et 
al., 2011) or compliance with treatment for hypertensive patients (Mohamoud, 2012). 
The significant findings included a lack of patient knowledge about hypertension (Al-
Sowielem & Elzubier, 1998), that patients’ practices in response to hypertension 
management needed to change (Al-Hamdan, Saeed, Kutbi, Choudhry, & Nooh, 2010), 
and a low awareness of hypertension condition, poor treatment and control (Saeed et al., 
2011). Although the significant strength of these studies was that they used large samples 
and identified some facets of hypertensive patients’ medication practice, to the current 
time there is no study in Saudi Arabia which has attempted to identify the associated 
factors with antihypertensive medication adherence among hypertensive patients. 
Therefore, this research project aimed to contribute to the hypertension research field by 
highlighting the factors associated with antihypertensive medication adherence for 
hypertensive patients in Saudi Arabia.  
1.4. Aims and objectives of the study  
The purpose of this research was firstly to assess the status of antihypertensive 
medications adherence among hypertensive patients and then to identify the factors 
associated with this adherence behaviour in Saudi Arabia. For this purpose, the research 
developed and translated a number of scales to Arabic language that can be used for 
future clinical and research purposes for the Arabic speaking population. The findings 
highlighted by this research can be used to improve the future pharmacological 
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management of hypertensive patients in Saudi Arabia. This may be achieved by 
informing healthcare providers and decision makers of the most appropriate directions 
for their efforts and the most effective ways to allocate the available financial resources 
towards improving the health outcomes of hypertensive patients in Saudi Arabia. 
The current study has the following objectives: 
1- Translate and validate existing scales to assess the status of antihypertensive 
medication adherence and the associated factors among a Saudi Arabian population. 
2- Identify the status of antihypertensive medications adherence in hypertensive 
patients in Jeddah city, Saudi Arabia. 
3- Identify predictors of antihypertensive medication adherence in the study 
population. 
1.5. Significance and contribution of the research 
In developed countries, an enormous effort has been made to investigate 
hypertensive patients’ adherence to their antihypertensive medications and the factors 
associated with their adherence or non-adherence to medication regimes. This is in order 
to improve clinical outcomes, reduce the risk factors, complications and the costs 
associated with treating poorly managed high blood pressure. However, in Saudi Arabia, 
despite the alarming increase of the prevalence of hypertension, research conducted in 
this area is not sufficient to identify the status of antihypertensive medications adherence 
among hypertensive patients and the associated adherence factors. Identifying the status 
of antihypertensive medications adherence is a vital step for assessing hypertensive 
patient’s pharmacological management, early detection of medications adherence issues 
and preventing further complications related to poor adherence.  
Understanding the factors associated with antihypertensive medications 
adherence from the growing literature that documented the three major domains, namely, 
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individual-related, provider-related and healthcare–system related factors requires an 
understanding of the significance of these factors in relation to antihypertensive 
medications adherence in global studies. However, it does not necessarily mean that these 
factors are applicable to all populations such as hypertensive patients in Saudi Arabia. 
This is due to the differences of demographic profile, cultural context and the healthcare 
system for the selected hypertensive patients’ population from Saudi Arabia. Therefore, 
conducting this research in Saudi Arabia may lead to a different understanding. 
Accordingly, identifying these factors will guide the development of suitable 
interventions that may assist to change hypertensive patients’ medication-taking 
behaviour. This study is the first research investigating these three domains of factors 
associated with antihypertensive medication adherence in hypertensive population in 
Saudi Arabia.  
This research was based on a quantitative approach that incorporated applying a 
cross-sectional study design using a survey method. A research instrument was 
developed and translated and used to elicit answers to research questions. The instrument 
used will contribute to assessing the medication adherence practices and the influential 
predictors for this practice for hypertensive patients in Arabic speaking populations and 
therefore identify areas which require improvements. It could be used as a supportive 
tool to assess the pharmacological management for hypertensive patients and therefore 
assist in developing appropriate interventions.  
From another perspective, the research seeks to contribute to theory building 
through identifying the situation of hypertensive patients with regard to their adherence 
to medication taking regimes as well as highlighting the significant, relevant related 
factors to this medication taking practice. Based on the synthesis of the findings of this 
19 
 
research, this work proposes an example for the need to improve hypertensive patients’ 
medication adherence practice in Saudi Arabia.  
This study will add to the body of international literature on medication adherence 
by investigating this important issue in an under-researched population. Since there is a 
paucity of research about treatment adherence behaviour for hypertensive patients in 
Saudi Arabia, this study determined the predictors associated with antihypertensive 
medication adherence. The findings of this research have the potential to inform 
healthcare policies and strategies that will improve antihypertensive medication 
adherence in the Saudi Arabian population, and contribute to the positive health status of 
this population. Although the idea of this research was applied to hypertensive patients, 
it can influence and direct future research for any other chronic illness where the role of 
medication adherence to long-term medications is significant.  
1.6. Organization of the thesis 
This research project is presented in the following research chapters: 
Chapter one: Introduction. In this chapter a brief introduction to antihypertensive 
medications adherence, healthcare system and hypertension management in Saudi 
Arabia. This is followed by stating the purpose of this study, the significance and the 
contribution of the research and finally the aims of this study.  
Chapter two: Literature review. This chapter included three parts. The first part 
provides an overview of the terminologies used in medication adherence behaviour. The 
second part includes a review of the measurement used to assess medications adherence 
and then provides information about the self-report measures used to assess medication 
adherence in hypertensive research. Finally, a review for the factors associated with 
antihypertensive medications is included to illustrate these factors and to construct the 
elements for the conceptual framework.  
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Chapter three: Conceptual framework. In this chapter, a general overview about 
theories used in medication adherence research is provided. It also includes information 
about intentional and unintentional medication adherence followed by illustrating the 
conceptual framework that guided this study.  
Chapter four: Method. This chapter presents the methodological approach for 
conducting this research project, showing the instrument developed to collect data for 
this study and information about the two stages involved in this research project, the pilot 
and the main study.  
Chapter five: Results. This chapter presents the results of this research project 
provided for the two studies conducted: the pilot study and the main study. It also 
highlights the results that answers the aims of this research project. 
Chapter six: Discussion and conclusion. In this chapter, a discussion of the 
research findings is provided, research strengths and limitations, implications for clinical 
practice and recommendations for future practice.   
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Chapter Two: Literature Review 
 
This chapter gives firstly an overview about different terminologies used to 
describe medication-taking behaviour and categorises patients’ medication adherence 
into optimal and suboptimal. A literature review and evaluation of measurements for 
assessing antihypertensive medication adherence are included, followed by a review of 
the research related to the associated factors with antihypertensive medication adherence.  
2.1. Medication adherence 
As this work has factors affecting antihypertensive medication behaviour as its 
main focus, terminology regarding this behaviour needs to be clarified. 
Terminologies commonly used in medication-taking behaviour 
Based on the available literature, a number of different terminologies have been 
used to describe how patients follow a pharmacological therapeutic regimen. The 
common terms used in the literature are compliance, concordance and adherence. Until 
recently, the most used term to describe medication taking behaviour in the 
pharmaceutical and medical literature was compliance. Compliance is defined as ‘the 
extent to which the patient’s behaviour matches the prescriber’s recommendations’ 
(Haynes, McDonald, Garg, & Montague, 2002). However, this term has been criticised 
because it implies that a patient follows a therapeutic plan passively without questioning 
their physician’s orders. In reality, it is not based on patient competence, but on an 
agreement between the healthcare provider and the patient, that the patient will follow a 
suggested treatment plan (Osterberg & Blaschke, 2005). 
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Another term used to describe patients following a treatment plan, is concordance 
(Lowry, Dudley, Oddone, & Bosworth, 2005). The concept of concordance is based on 
the meaning of the therapeutic communication between patient and prescriber, which in 
turn is based on involving the patient and respecting their views and decisions. This term 
is incorrectly used as a synonym for adherence, although it differently conceptualises the 
therapeutic communication process. The World Health Organization (WHO) adopted the 
term ‘adherence’, which is defined as ‘the extent to which the patient follows medical 
instructions’ (WHO, 2003). In terms of chronic diseases such as hypertension, there is a 
variety of non-pharmacological interventions that require adherence in order to better 
control the blood pressure condition. These include a healthy diet, an exercise program 
and restricting smoking and alcohol consumption. This has led the WHO to employ a 
holistic meaning of adherence to cover all behaviour of patients with chronic conditions 
including adherence to pharmacological and non-pharmacological interventions. Thus, 
the latest definition of adherence, adopted by the WHO has been chosen for this study. 
In this context, adherence is ‘the extent to which a person’s behaviour-taking medication, 
following a diet, and/or executing lifestyle change corresponds with agreed 
recommendations from a healthcare provider’ (WHO, 2003).  
Categorisation of medication adherence  
There is no agreement about definitive categories to define patients with different 
status of medications adherence. Different categorisations have been used arbitrarily in 
the literature concerned about assessing medications adherence.  
The following categories have been adopted in different studies to describe 
whether or not a person adheres to their treatment: high and low (Holt et al., 2013; 
Matsumura et al., 2013), good and poor (Gabrielle et al., 2013; Hyre et al., 2007), perfect 
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and imperfect (Song et al., 2011), and optimal and suboptimal (Yue, Bin, Weilin, & 
Aifang, 2015).  
The classification into two different categories should be based on the underlying 
meaning of these terminologies as well as on the method applied to measure medication 
adherence. With regard to the meaning, is defined ‘perfect’ as ‘precisely accurate, exact, 
absolute, complete’ (Stevenson, 2010); and on the contrary, ‘imperfect’ or ‘non-perfect’ 
as having a fault, or incomplete action (Stevenson, 2010). Describing the medication 
adherence as “perfect” means that patients precisely adhere to the medication, which 
could include taking medication at a specific time, in an accurate dose and with no 
evidence of a single missing dose, which is challenging for any patient, in particular those 
with chronic conditions (Song et al., 2011). In addition, determining whether or not a 
patient has been ‘perfect’ in following medication instructions, is complex to detect in 
patients’ self-reporting or via electronic monitoring (i.e. blood pressure reading) (T. M. 
Nguyen, La Caze, & Cottrell, 2013); however, it is possible to detect the accuracy of 
medication adherence with the use of the Medication Events Monitoring System 
(MEMS®) that is a medication bottle that contains a microelectronic chip which registers 
information about every bottle opening such as the date and time. The MEMS® provides 
a detailed profile of the patient’s adherence behaviour. (Cramer, Mattson, Prevey, 
Scheyer, & Ouellette, 1989). Therefore, the use of “perfect” or “imperfect” terms to 
describe medications adherence is questionable depending on the method used.  
Other categories such as ‘good’ and ‘bad/poor’ and ‘high’ and ‘low’ in terms of 
medication adherence, have been used to describe hypertensive patients who were above 
or below the cut-off point of adhering to antihypertensive medications (Hyre et al., 2007; 
Lee et al., 2013). It is important to note that it is inaccurate practice to identify a threshold 
of antihypertensive medication adherence based on self-reported measures of adherence 
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(T. M. Nguyen, et al., 2013). Self-report measures of medication adherence report 
individuals’ perceived responses about their adherence behaviour. Identifying a threshold 
to classify patients below and above the cut-off point of medications adherence reflects 
an actual behaviour rather than a perceived reported behaviour. In terms of 
antihypertensive medications, identifying the threshold that classifies patients falling 
below or above the cut-off point of adherence is measured by assessing the 
pharmacokinetic effect of the medication via measuring the serum concentration levels 
of the drug in the body (Morrison, Stauffer, & Kaufman, 2015). Therefore, the use of 
‘high/good’ and ‘low/poor’ limits to define antihypertensive medications adherence for 
data collected from self-report measures, is arguable for this reason.  
However, using terms such as ‘good’ and ‘bad/poor’ and ‘high’ and ‘low’ focusses 
on behaviour rather than outcomes and therefore ignores the fact that desired outcomes 
could be achieved, despite poor adherence. In this sense, the terms “optimal” and 
“suboptimal” are recommended as more appropriate terms. To illustrate, in the case of 
antihypertensive medications, the optimum control of high blood pressure for patients 
with hypertension can be achieved by taking the prescribed medications 100–80% of the 
time. This is also similar to the case of developing complications related to insufficient 
treatment. When a cut-off value of 80% of antihypertensive medications adherence was 
considered in conducting empirical studies, it was shown that the risk of developing 
cardiovascular complications increases sharply in patients who had antihypertensive 
medications adherence below 80%, which therefore were considered suboptimal (Herttua 
et al., 2013; Jagadeesh, Balakumar & Maung-U, 2015; Khan et al., 2010). Accordingly, 
labelling categories of medication adherence as optimal or suboptimal: were applied in 
this research project. This is because use of ‘optimal’ and ‘suboptimal’ can involve the 
meaning of satisfactory outcome however differentiates medication taking behaviour 
25 
 
(Ho, Bryson, & Rumsfeld, 2009). Therefore this can be seen as an appropriate description 
for patients’ behaviour in medication taking. In medication taking, patients are likely to 
miss a dose or a few during their treatment; despite this, they still gain a satisfactory 
outcome of the treatment, which is shown in blood pressure control for individuals’ 
taking antihypertensive medications which represented as an suboptimal adherence (Ho 
et al., 2009).  
In addition, in the case of using self-report measures to assess medications 
adherence as was done in the studies in this research project, identifying patients with 
different levels of adherence is according to the suggested cut off-point of the used scale. 
This is because the arbitrary nature of the provided cut-offs for most self-report measures 
for medication adherence needs to be carefully considered (T. M. Nguyen et al., 2013). 
Identifying patients on the lower range of the scale scores does not distinguish between 
types such as low adherence and sporadic adherence, in other words, patients at different 
phases of medication-taking behaviour. Therefore the use of ‘suboptimal’ is preferred to 
describe patients who report low scores and ‘optimal’ for patients who report high scores 
on the adherence scale (T. M. Nguyen et al., 2013).  
The term “suboptimal’ covers those who are sporadic, low and non-adherent, while 
‘optimal’ covers those who take their medications as prescribed. However, the 80% cut-
off point that is defined as suboptimal cannot be applied to self-report measures as these 
have their own cut off-point.  
2.1. Measuring medications adherence 
The ultimate goal of medication adherence is to achieve improvements in an 
individuals’ health condition and positive clinical outcomes. Assisting medication 
adherence is a valuable step in identifying the possibility of approaching positive 
medications outcomes. With the widely available measures of medication adherence used 
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in research, there is no gold standard measure for medication adherence, due to the 
diverse contexts of researchers’ frameworks when choosing one measure over another. 
The literature search identified two types of categorisations of medication adherence 
measurements.  
Measures of medication adherence were categorised as direct and indirect measures 
in some studies (Hawkshead & Krousel-Wood, 2007). A direct method of measuring 
medication adherence includes the biological essay that detects the metabolites or 
markers for medication concentration in a body fluid such as blood or urine (Hawkshead 
& Krousel-Wood, 2007). The other category is the indirect method that involves self-
reporting questionnaires, diaries, patient interview, pharmacy records, pill count, 
prescription claims, clinical outcomes and electronic monitoring (Hawkshead & Krousel-
Wood, 2007). 
A different categorisation for medication adherence measures involves the 
classification of objective and subjective measures (Hawkshead & Krousel-Wood, 2007). 
The objective measures of medication adherence involve clinical outcomes, dose count, 
pharmacy records, Medication Events Monitoring System (MEMS®) and drug 
concentration. Physician or family reports, patient interview and self-report adherence 
scales have been classified as subjective measures of medication adherence. There is no 
difference between the two categories of the mentioned measures in terms of the achieved 
outcomes. This is since both categories have been classified according to the method of 
collecting information whether the method is direct or indirect, or objective or subjective. 
This study adopted the first classification of medication adherence measures: direct and 
indirect. 
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Direct measures of medication adherence 
Assessing medications adherence using direct measures, claimed to produce 
accurate results (Hawkshead & Krousel-Wood, 2007; Prado Jr, Kupek, & Mion Jr, 2007). 
Regular blood and/or urine tests require recording the baseline readings for the 
haematological serum level of the drug concentration and the urine parameters for the 
drug clearance (Pullar, Kumar, & Feely, 1989). There are several markers that have been 
used to assess medication adherence, including bromide, phenobarbitone, digoxin and 
isoniazid, or its metabolites, isonicotinic acid and acetylisoniazid (Pullar et al., 1989). 
Bromide has been used as a marker in randomised clinical trials to assess adherence to 
antihypertensive medications, and it reports the actual drug intake (Braam, van Uum, 
Lenders, & Thien, 2008). Bromide is easily absorbed through the gut and if it is used in 
small doses. Bromide is distributed in the extracellular space and leads to no innocuous 
effect. The half-life of bromide is long, about 12 days (Uum, Braam, Russel, Swinkels, 
& Thien, 2006). Due to the previously mentioned characteristics, bromide is an 
appropriate marker to detect medication adherence in many chronic conditions. 
However, the use of this method as a measure for medication adherence reported some 
significant drawbacks. There are some issues related to the nature of the drug marker 
used and it’s pharmacokinetic in the human body. For example, in the case of renal 
insufficiency, bromide is exerted through the kidneys; therefore patients with renal 
insufficiency might experience higher results of serum bromide concentrations (Uum, et 
al., 2006). Another issue is that the level of bromide concentrations is influenced by body 
weight (Uum, et al., 2006). Therefore the reported results of medications level in the 
blood test in previously mentioned cases may be inaccurate.  
The use of drug markers is an expensive and impractical approach for measuring 
medication adherence in the clinical setting. In research settings, the use of drug makers 
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in studies focussing on medication adherence is intrusive, since multiple blood samplings 
are necessary to lead to the research outcome. In addition, the direct measure of 
medication adherence does not provide information about intentional and unintentional 
reasons for medication non-adherence (Hawkshead & Krousel-Wood, 2007). 
Indirect measures of medication adherence  
Indirect measures for medication adherence involves physician estimates, pill 
count, pharmacy refill records, blood pressure reading, the Medication Events 
Monitoring System (MEMS®) and self-report measures. 
Physician estimates of patients medication adherence behaviour is a method that is 
based on a pill count method and is one of the earliest measures used to assess medication 
adherence. Studies have shown that this method not accurate and therefore it is rarely 
used by researchers (Roter et al., 1998). This method is often erroneous because some 
patients do not bring the bottles that have some remaining pills that indicates their poor 
adherence to medications or discard the remaining pills before their hospital visit to show 
that they were adherent to the prescribed medications (Claxton, Cramer, & Pierce, 2001; 
Lee et al., 2007). Recent studies of pill counts reported useful information when 
conducted in patients’ homes and without emphasising the purpose of assessment 
beforehand (Svarstad et al., 1999). Pill counts could be difficult to interpret. This is 
because patients might combine some pills from different containers into one medication 
container. Moreover, home visits were not always possible (Gilbert, Evans, Haynes & 
Tugwell, 1980). In addition, clinic based pill counts been criticised by researchers. This 
is because many patients did not return their pill containers with them when come to the 
clinic for another visit, plus when compared to more objective methods, returned 
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medication containers appeared to overestimate medication adherence (Claxton et al., 
2001; Lee et al., 2007). 
Estimating medication adherence over a period of time in large populations could 
be obtained from pharmacy refill records, which are relatively inexpensive, unobtrusive 
and objective, (Sclar, Skaer, Robison, Legg, & Nemec, 1994). However, retrieving data 
from pharmacies’ refill records provides information as a gross measure of adherence for 
large populations in the long term such as that used in the PHARMO system in the 
Netherlands by pharmacoepidemiology researchers (Leufkens & Urquhart, 2007). 
Therefore the use of this method will not provide data for measuring short-term 
medication adherence in individual patients. The local pharmacy refill record of one 
healthcare organisation is also a disputable measure of medication adherence because 
some patients might seek other pharmacies to refill their medications. In the absence of 
an e-health database system (as is the case in Saudi Arabia) that enables integrating the 
information across organisations to track every dispensing of a drug to patients, 
(Altuwaijri, 2008), the accuracy of the collected information about medication 
adherences using the pharmacy refill records is therefore disputed.  
Blood pressure readings and other physiological measures are other indirect 
methods that were used by researchers for assessing non-adherence (Craig, 1985; Gilbert, 
Evans, Haynes, & Tugwell, 1980). These measures were not always feasible or reliable 
and they reflected medication adherence within one or two days before taking blood 
pressure readings. When using these measures, the likelihood of receiving inaccurate 
information was significantly high. This is because patients would often increase their 
medication intake within a few days prior returning to the clinic; as such, these methods 
are faulty for measuring medication adherence (Urquhart, 1994). An effective use of 
these measures would be with frequent follow up of patients for a considerable period to 
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identify the actual effect of antihypertensive medication adherence on blood pressure 
control, which is the case in cohort studies (De La Sierra et al., 2011; Farmer et al., 1990). 
However, in some public hospitals such as is the case in Saudi Arabia appointments 
provided by primary health care clinics or hospitals may take weeks or months; therefore 
it is challenging to track patients in a cohort study. Therefore, it is hard to maintain 
frequent follow up with hypertensive patients.  
The MEMS®, which was developed by Aprex Corporation Fremont, California 
(Cramer et al., 1989), considers a sophisticated method for assessing medication 
adherence. MEMS® dispenses medication into a small bottle that has a microprocessor 
in the lid. The microprocessor lid counts the number of every opening and records the 
dates and times. Each container opening presumes an event where dosage has been 
consumed, although there is no assurance that the dose been actually consumed by the 
patient. However, misleading information can be found if the patient tried to open and 
close the container at the same time every day as their prescribed intervals in order to 
falsify the pattern of their medication adherence. The accuracy of MEMS® in measuring 
medications adherence has been shown in various studies as more reliable than other 
methods (Bovet, Burnier, Madeleine, Waeber, & Paccaud, 2002; Grigoryan, Pavlik, & 
Hyman, 2012). For this reason, it is widely regarded as method of comparison for other 
medication adherences measures. Although MEMS® showed its effectiveness, it has 
other practical issues (i.e. the inaccurate use of the container by patients) and high costs. 
This is as patients could open the container many times during the day without taking the 
medications just to inflate their adherence rate, which has showed an obstacle for the 
widespread application of this measure in routine clinical practice and large studies 
(Lyimo, 2012).  
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Different studies have widely adopted flexible and practical methods such as self-
report measures to assess medications adherence. Self-report measures, were used in this 
research to collect patients’ perceived response about their medications adherence 
behaviour. 
Self-report measures of adherence 
The motive for using self-reporting measures in research is due to their low cost 
and simple application. An advantage of using this type of measure is that it has the 
potential to identify the exact reasons for patients’ non-adherence and why the individual 
is exhibiting this behaviour (Hawkshead & Krousel-Wood, 2007). The review for the 
literature on self-report measures of adherence was conducted using various databases, 
including MEDLINE [via ebsot], PubMed, and CINHAL. Keywords were used to refine 
the search, medication adherence, scale, antihypertensive and factors. Synonyms 
included: medication compliance, questionnaire, high blood pressure medications and 
determinants/predictors, respectively. The search considered articles from 2000 till 2015, 
for up to date information. Qualitative studies, review papers, letters and magazines were 
excluded.  
The following medication adherence scales (Table 1) have been used to collect 
information regarding different aspects of adherence such as medication-taking 
behaviour (Smith, Hankins, Hodson, & George, 2010; Weinman & Horne, 2002; Willey 
et al., 2000), barriers to and determinants of adherence (Choo et al., 1999; Fodor et al., 
2005; Horne, Weinman, & Hankins, 1999; M. T. Kim, Hill, Bone, & Levine, 2000; 
Morisky, Ang, Krousel-Wood, & Ward, 2008; Svarstad, et al., 1999) and beliefs 
associated with adherence (Horne, Weinman, & Hankins, 1999; Ogedegbe, Mancuso, 
Allegrante, & Charlson, 2003; Risser, Jacobson, & Kripalani, 2007; Wetzels et al., 2006). 
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The following overview of these scales provides information about authors, the original 
development, scale constructs, items and validation of these scales.  
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Table 1 : Self-report measures of adherence to antihypertensive medications  
 
 
Scale  
 
Author/s (year); 
Country 
 
Original development 
(Sample size and 
setting) 
 
Scale Construct  
 
Items 
 
Validation and 
Comparison measure of 
adherence 
 
Group 1: Medication-Taking Behaviour 
  
Adherence Self-
Report 
Questionnaire 
(ASRQ) 
Schroeder, Fahey, 
Hay, Montgomery 
and Peters (2006), 
United Kingdom 
245 with uncontrolled 
hypertension, general 
practice 
Medication adherence 6 items 
(Likert scale, 
perfect= level 1- 
low = level 6) 
Internal consistency, 
sensitivity, specificity and 
criterion validity were not 
reported. 
Validated against MEMS® 
(Test for trend: p <0.05). 
Medication 
adherence Report 
Scale – 5 (MARS-
5) 
Horne and 
Weinman (2002), 
United Kingdom 
128 patients from GP 
clinics 
Medication adherence 5 items (Likert 
scale, 1=always- 
5=never). 
Sensitivity 0.85, specificity 
0.97. 
Criterion validity was not 
significant 
[ pharmacy record] 
Stages of Change 
for Adherence 
(SOCA) 
Willey el al., 
(2000), United 
States of America 
731 patients with 
hypertension, primary 
clinics 
Medication adherence 2 items (four 
Multiple choice 
responses).  
Internal consistency, 
sensitivity and specificity 
were not reported. 
Criterion validity was 
significant. 
[MEMS® and MAS scale] 
 
Group 2: Barriers and Determinants of Adherence  
 
Brief Medication 
Questionnaire  
Svarstad, 
Chewning, Sleath 
and Claesson 
20 patients using 
Medication Events 
Monitoring System 
(MEMS®), Pharmacies 
1-Regimen scale for potential 
non-adherence 
2-Belief screen 
1-five items (open 
ended questions) 
Internal consistency was 
not reported for the scale. 
Sensitivity = 0.80, 
specificity =1.0. The 
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(1999), United 
States of America 
3-Recall screen to measure 
potential problems 
2-2 items (scores of 
one or more belief 
barrier range =0-2) 
3-2 items (scores 0-
2 for responses 
“very, somewhat, 
not at all’) 
criterion validity was 
significant. 
[MEMS®] 
Choo et al. 5-item 
Questionnaire  
Choo et al., (1999), 
United States of 
America 
286 hypertensive 
patients, Primary Health 
Care 
Forgetfulness. Intentional 
variance from treatment 
recommendation 
5 items (multiple 
choice responses) 
Internal consistency, 
sensitivity and specificity 
were not reported.  
Criterion validity was 
significant. 
[*MEMS®] 
Fodor et al. 
Adherence 
Questionnaire  
Fodor et al., (2005), 
Central Europe 
(German, 
Hungarian and 
Slovakia) 
359 hypertensive 
patients, Work-site  
Medication adherence  Dichotomous 
(yes/no), open 
responses 
Internal consistency, 
sensitivity and specificity 
were not reported.  
Criterion validity was 
significant. 
[Clinical outcome “*BP 
control”] 
Hill-Bone 
Compliance scale- 
14 
Kim, Hill, Bone, 
Levine (2000), 
United States of 
America 
Study 1= 139 
hypertensive patients. 
Study 2= 341 
hypertensive patients, 
Primary Health Care 
Medication adherence, 
appointment keeping and salt 
intake. 
14 items (4 points 
scale, 1 = none of 
the time- 4= all of 
the time) 
Internal consistency 
Cronbach’s alpha = .84. 
Sensitivity, specificity and 
criterion validity were not 
reported. 
[Clinical outcome “BP 
control”] 
Morisky 
Medication 
adherence Scale 
(MMAS) 
Morisky, Ang, 
Krousel-Wood and 
Wood (2008), 
United States of 
America 
1367 hypertensive 
patients, Hypertension 
Clinics 
Medication adherence 8 items with yes/no 
response 
Internal consistency = 0.83, 
sensitivity = 0.93, 
specificity =0.53, criterion 
validity was significant. 
[Clinical outcome “BP 
control”] 
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Reported 
Adherence to 
Medicine (RAM) 
scale 
Horne, Weinman 
and Hankins 
(1999), United 
States of America 
524 hypertensive 
patients, Primary Health 
Clinics 
Medication adherence  4 items (5 Likert 
scale response) 
Internal consistency 
Cronbach’s alpha = .72. 
Sensitivity, specificity and 
criterion validity were not 
reported. 
[comparison measure of 
adherence was not 
available] 
 
Group 3: Belief Associated with Adherence  
 
Maastricht Urecht 
adherence in 
Hypertension 
(MUAH) 
Wetzels, Nelemans, 
Wijk, Broers, 
Schouten and Prins 
(2006), The 
Netherlands 
255 
Hypertensive patients, 
GP clinics 
(positive attitude towards 
health care and medications, 
lack of discipline, aversion 
towards medications, active 
coping with health problems) 
40 items  
( 7 points Likert 
scale ranging from 
1= totally disagree 
to 7= totally agree) 
Internal consistency =0.74, 
sensitivity and specificity 
were not reported. The 
criterion validity was 
significant. 
[MEMS®, pharmacy 
record, Brief Medication 
Questionnaire]  
Beliefs about 
Medicines 
Questionnaire 
(BMQ-General) 
and (BMQ-
Necessity ) 
Horne, Weinman 
and Hankins 
(1999), United 
States of America 
524 patients with 
chronic illness, Primary 
Health clinics 
Necessity, concern, overuse, 
harm 
18 items ( 5 points 
scale, 1= very 
often, 5= never) 
Internal consistency 
(Cronbach’s alpha) for the 
BMQ scales and test-retest 
correlation indicated that 
the scales within accepted 
limits.  
Internal consistency = .70, 
sensitivity and specificity 
were not reported. The 
criterion validity was 
significant. 
[RAM scale] 
Self-efficacy for 
Appropriate 
Medication Use 
scale (SEAMS) 
Risser, Jacobson 
and Kripalani 
(2007), United 
States of America 
436 patients with 
coronary heart diseases 
and comorbid 
Self-efficacy (1= taking the 
medications under difficult 
circumstances, 2= taking the 
13 items 
(3 Likert scale) 
1= not confident, 
2= somewhat 
Internal consistency 
Cronbach’s alpha = .89. 
Sensitivity and specificity 
were not reported. 
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 conditions, primary 
health clinics 
medications under uncertain 
or changing circumstances) 
confident, 3= very 
confident  
Criterion validity was 
significant. 
[*MAQ] 
Medication 
Adherence Self-
Efficacy scale 
(MASES) 
Ogedegbe, 
Mancuso, 
Allegrante and 
Charlson (2003), 
United States of 
America 
Open-ended interviews 
with 106 patients. 72 
patients for the item 
analyses phase, Primary 
clinics from urban 
practice 
Self-efficacy  26 items. 
1 = not at all sure, 
2= somewhat sure, 
3= very sure 
Internal consistency 
Cronbach’s alpha = .95. 
Sensitivity and specificity 
were not reported. 
Criterion validity was not 
significant. 
 [Clinical outcome “BP 
control”] 
 
*MEMS® = Medication Events Monitoring System 
*BP=Blood pressure 
*MAQ= The Medication Adherence Questionnaire
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Evaluation of medication adherence measures used in hypertension studies 
In order to evaluate the self-report measure to be used in a research project 
focussing on assessing medications adherence, Garfield and colleagues (2011) suggested 
a method for evaluating the properties of the measure. According to their suggested 
method of evaluation, the self-report measure needs to have achieved the following 
criteria: optimal pragmatic, psychometric and theoretical properties (Garfield, Clifford, 
Eliasson, Barber, & Willson, 2011). The evaluation of the medication adherence scale 
that was used in hypertensive research was guided by these criteria. 
1) Pragmatic properties 
The pragmatic properties means that the measure of medication adherence has 
low cost, is not intrusive, and is brief, which makes it easy to use as a repeated measure 
for reporting adherence behaviour over time. This property is applicable to most of the 
self-report measures of medication adherence used in hypertension studies. However, 
some of the scales used to measure medication adherence for hypertensive patients 
included large numbers of items such as the Maastricht Utrecht adherence in 
Hypertension (MUAH) (Wetzels et al., 2006), that has 40 items, and the Medication 
Adherence Self-Efficacy scale (MASES) (Ogedegbe et al., 2003), that involves 26 items. 
Therefore, it could be argued that these scales are long and time consuming for 
respondents if they are included in combination with other measures and items in a 
survey.  
One of the pragmatic properties of the self-report measures is that the measure’s 
contents should be easily administered in different ways: self-administration, face to face 
interview and telephone interview. For example, the Hill-Bone Compliance scale has 
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been administered via these various methods. The Hill-Bone Compliance scale was 
administered by the researcher using a self-administration method in different studies to 
assess antihypertensive medication adherence (Krousel-Wood, Muntner, Jannu, 
DeSalvo, & Re, 2005). Also, it was used in face to face interviews (Song et al., 2011) 
and telephone interviews (Han, Song, Song, & Kim, 2013; G. C. Nguyen et al., 2008). 
With these different methods of application, no difficulties were reported regarding the 
administration of the scale. 
The pragmatic properties encompass the logic and semantics of the measure. This 
is examined in the wording of the scale items and responses. Responding to the scale 
items and choosing the appropriate response should not be linguistically challenging for 
the respondent. For example in the Choo et al. (1999) 5-item scale, the fifth question 
asked the participants the following: “Most people forget to take their medicine 
occasionally, how often does this happen to you?” (Choo, et al., 1999). Responses for 
these items were “never, almost never, more than almost never”. These responses lack 
clarity and are ambiguous, especially if they are translated into another language such as 
Arabic.  
Some open question responses may be taxing on the memory and therefore time 
consuming for participants. For instance, in the Brief Medication Questionnaire 
(Svarstad, et al., 1999), the first questions ask participants to provide information 
regarding the medication they use. This information includes the name, dose and side 
effects of the medication. For patients who have low literacy levels, these types of 
questions about their medical conditions could be challenging for those who cannot recall 
the names of medications (Backes & Kuo, 2012).  
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2) Psychometric properties 
The psychometric property of the scale involves assessing the validity and the 
reliability of the instrument. One of the issues preventing the use of any scale is the lack 
of cross-cultural studies that could adapt these scales to different cultural contexts (Polit 
& Beck, 2008). Most of the scientific questionnaires and scales designed to measure 
antihypertensive medication adherence have been developed in English speaking locales 
(Fodor et al., 2005; Zeller, Schroeder, & Peters, 2007). To measure the same construct in 
a different cultural setting, it is important to choose a scale that shows high validity and 
reliability when it was adopted into a different cultural context. This is because the 
process of cross-cultural adaptation attempts to show the equivalency between original 
source and target, based on content (Beaton, Bombardier, Guillemin, & Ferraz, 2000). 
Some of the scales were not translated into different cultural contexts and were only 
applied once such as Choo et al. 5-item questionnaire and Fodor et al Adherence 
Questionnaire (Choo, et al., 1999; Fodor, et al., 2005; Wetzels et al., 2006); therefore, it 
is difficult to assume their adaptability into the Arabic speaking context. 
Some of the scales such as the Hill-Bone Compliance scale (Kim, Hill, Bone, & 
Levine, 2000), and the Morisky Medication Adherence scale (MMAS) (Morisky et al., 
2008) have been widely applied in different linguistic contexts and have shown no 
serious shortcomings in their application. There were different validation studies that 
have been conducted in different cultural contexts to assess the psychometric properties 
of these scales. For the Hill-Bone Compliance scale, there were studies that validated the 
scale in the English language context (Kim, Hill, Bone, & Levine, 2000; Krousel-Wood 
et al., 2005), in Asian languages such as Korean (Song et al., 2011), and in Turkish 
(Karademir, Koseoglu, Vatansever, & van den Akker, 2009), Persian (Dehghan, Nayeri, 
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& Iranmanesh, 2015), and African languages such as Xhosa (Lambert et al., 2002), with 
the translated versions of the scale showing acceptable levels of validity and reliability.  
The psychometric property criterion was met similarly for the MMAS which has 
also been translated in different cross-cultural contexts (Chan & Hassali, 2014; Fabbrini 
et al., 2013; Moharamzad et al., 2015). The MMAS was an appealing option to be used 
in this study; however, the Hill-Bone Compliance scale has been chosen over MMAS 
because of its four Likert scale option, which provides a broader range of responses 
regarding medication adherence. It is worth mentioning that the dichotomised (yes/no) 
response option of MMAS (Morisky et al., 2008) gives respondents very limited response 
options. 
3) Theoretical properties 
The theoretical properties reflect the theoretical base of the self-report measure. 
In order to measure adherence, it is important to identify causes of non-adherence. Causes 
of non-adherence were classified into intentional and unintentional causes, thus the self-
report measure should be able to distinguish between these causes in order to suggest 
future intervention. The chosen scale in this study, the Hill-Bone Compliance scale, 
constructs measures for both intentional and unintentional causes of medication non-
adherence (Dehghan et al., 2015; Karademir, et al., 2009).  
Issues with other medication adherence measures that prevented their use in this 
study, are that some scales such as the Medication Adherence Self-Efficacy scale 
(MASES) (Ogedegbe, Mancuso, Allegrante, & Charlson, 2003) and the Self-efficacy for 
Appropriate Medication Use scale (SEAMS) (Risser, Jacobson, & Kripalani, 2007) were 
used to measure specific constructs, such as self-efficacy, which was not in the scope of 
this study. An additional issue regarding scales construct is that the constructs of some 
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of the previously mentioned scales were not designed to be an optimal tools for 
measuring medication adherence. For example, the Adherence Self-Report 
Questionnaire (ASRQ) (Schroeder et al., 2006) should be used in combination with 
MEMS® to monitor antihypertensive medication adherence rather than used alone to 
assess individual’s medication adherence perceived behaviour (Zeller et al., 2007).  
To conclude, the Hill-Bone Compliance scale is consistent with the pragmatic, 
psychometric and theoretical properties of the self-report measures.  
2.2. Factors affecting antihypertensive medication adherence 
A strong focus is placed on understanding the variety of factors that may 
influence antihypertensive medication adherence. This is due to the reported high 
prevalence of hypertension complications related to improper antihypertensive 
medication adherence (Degli Esposti et al., 2004). The factors identified are allied to 
specific patient characteristics, health-related, medication-related, healthcare provider 
and health system factors. All these different factors were tested simultaneously in 
various studies to assess their influence on antihypertensive medication adherence; the 
results of the various studies conducted in this field showed similarities to inconsistent 
findings found across different studies that were conducted in different contexts. Various 
studies have attempted to determine the influence of a single factor such as smoking 
status (Zeller et al., 2007) or gender differences (Holt et al., 2013), however, the issue of 
non-adherence is multifactorial. Thus, exploring multiple factors is essential to draw any 
clear conclusions. The review of the literature related to factors affecting 
antihypertensive medication adherence is provided under the umbrella of three main 
dimensions of factors affecting medications adherence; these include individual related 
factors, healthcare provider factors and healthcare system factors.  
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1- Individual-related factors  
The individual related factors include all the factors that are specific to individual 
patients and their health. Factors specific to patient include socio-demographics, 
knowledge, beliefs and factors related to their health issues such as the years of diagnosis 
with hypertension, presence of comorbidities, smoking and use of medication aid 
reminders.  
- Sociodemographic characteristics 
Sociodemographic patient characteristics were commonly investigated and the 
results differed between studies. The studies that explored factors affecting 
antihypertensive medication adherence and sociodemographic factors were considered 
in this literature review. These factors included the patient’s age, gender, marital status, 
income, employment and level of education.  
 Age 
Hypertension occurs at any age if the patient has the underlying risk factors that 
contribute to the presence of high blood pressure. However, the main risk factor which 
contributes to the presence of primary hypertension is aging; this is in addition to other 
risk factors such as family history, ethnicity and unhealthy lifestyle. Secondary 
hypertension, which is another type of hypertension that occurs as a result of primary 
health issues such as renal insufficiency also occurs at any age. Knowing that 
hypertension occurs at any age encouraged researchers to consider the factor of age when 
assessing factors related to antihypertensive medication adherence. This was because 
looking at the matter of antihypertensive medication adherence from various age groups 
resulted in diverse adherence behaviours.  
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Age is an influencing factor in medication adherence. Although different studies 
have reported inconsistent findings about the significance of this factor in relation to 
antihypertensive medication adherence, the variation of adherence behaviours amongst 
hypertensive patients from different age groups were evident.  
The increase in age reported an inverse association with adherence behaviour. An 
observational cross-sectional study that involved 1,000 hypertensive patients in Greece 
reported better antihypertensive medication adherence among patients younger than 60 
years old. The study used a pre-coded questionnaire to assess adherence behaviour 
among three age groups: hypertensive patients aged less than 40 years, between 40 to 60 
years and above 60 years. Antihypertensive medication adherence was better among 
patients aged 40 to 60 years old, (22.3% of 589 patients were adherents) compared to 
those aged 60 years old (3.8% of 395 patients were adherents) (Yiannakopoulou, 
Papadopulos, Cokkinos, & Mountokalakis, 2005).  
Another study that assessed antihypertensive medication adherence in Turkey 
among 750 hypertensive patients from different age groups found a gradual decrease in 
antihypertensive medication adherence with aging. Antihypertensive medication 
adherence was assessed by asking patients to report on dichotomised response (yes, no) 
if they were taking medications as prescribed. Poor antihypertensive medication 
adherence was found in 51.9% of 160 hypertensive patients under the age of 49 and it 
increased among other age groups as the age range increased (age ranges 50–59, 60–
69,70–79) to report 75.8% poor adherence in 33 patients aged older than 80 years 
(Karakurt & Kaşikçi, 2012). 
Aging contributes to a decline in the psychomotor abilities. In addition, patients’ 
health condition is impacted during aging. For example, there are some health issues such 
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as vision and cognitive impairments (dementia or Alzheimer’s Disease) that are more 
common in aged individuals. Consequently, the decrease in self-reliance related to these 
issues explained the reason of decreased antihypertensive medication taking in aged 
individuals (Hashmi et al., 2007; Karakurt & Kaşikçi, 2012).  
The results differed if patient’s self-reliance was enhanced. The studies that were 
conducted in a different cultural context where social support for aged patients was 
available reported opposite results. In this specific cultural context, family members take 
the responsibility for the medication routine of their older family members. In Pakistan, 
a cross-sectional study reported results from a sample of 460 hypertensive patients. The 
sample consisted of 199 male patients (mean age 54 ± 10 years) and 239 females (mean 
age 50 ± 11 years) with 20% of total cases being younger than 40 and 19% of cases being 
older than 60 years. Antihypertensive medication adherence increased with age 
(p < 0.05). Less medication adherence was observed in patients younger than 40 years 
old compared to those who were older than 70 years who reported the highest mean 
adherence rate (mean adherence = 91 ± 14%) (Hashmi et al., 2007). This finding was 
similar to another study conducted in Malaysia which a similar same social support 
structure (Hassan et al., 2006).  
 Gender 
Gender was a predictive factor that influenced patient’s adherence behaviour. 
Personal factors such as the demographic variance, for example, educational background 
and income level, should be taken into account when focussing on the difference in 
medication adherence behaviour between genders.  
The demographic differences between men and women contributed to different 
results regarding antihypertensive medication adherence in different studies (Braverman 
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& Dedier, 2009; Li, Wallhagen, & Froelicher, 2008). A cross-sectional study of 144 
Chinese immigrants in the United States of America (75 women and 69 men) that 
explored the relationship between sociodemographic and cultural-related factors in 
relation to antihypertensive medication adherence found that women tended to report 
higher adherence than men (Li et al., 2008). Antihypertensive medication adherence in 
male patients and female patients was 69% and 75% respectively, however gender was 
not reported as a significant predictor of adherence in this study (p >0.05).  
Another study reported different findings. A sample of 21 male and 49 female 
hypertensive patients drawn from a larger randomised control trial was analysed to assess 
the relationship of antihypertensive medication adherence and sociodemographic, plus 
clinical and cognitive characteristics in the United States of America. The study reported 
that different levels of education was a significant predictor of antihypertensive 
medication adherence among African-American men and women. The results reported 
that men with lower levels of education were more adherent to their medications than 
those with higher levels of education (91% vs. 72%, respectively; F [1, 47]54.244; 
p < 0.05). The opposite result was observed for women: those with less than high school 
education were less adherent to their medications (61%) than women with greater formal 
education (74%) (Braverman & Dedier, 2009).  
The literature search revealed other factors that contributed to the differentiation 
of medication adherence behaviour between genders such as illness representation. 
Different genders coped differently with their illness and that contributed to 
differentiation in their health behaviour. Coping with illness was a result of illness 
representation. Some of the illness representation constructs that were reported as 
differences between men and women regarding medication adherence involved personal 
control (personal controllability) and illness identity (i.e. symptoms experienced 
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associated with illness). A longitudinal study of 118 hypertensive patients (74 male 
participants, 44 female participants) in Taiwan that used the Medication Adherence 
Inventory (MAI) scale to assess antihypertensive medication adherence evaluated the 
association between gender and antihypertensive medication adherence. The reported 
results found gender difference was a significant factor in adherence (p<0.05) and that 
adherence to antihypertensive medication was higher among men (mean = 62.10, 
SD = 4.77). On the other hand, medication adherence was lower among women 
(mean = 60.52, SD = 6.06) (S. L. Chen, Lee, Liang, & Liao, 2014). The findings reported 
that constructs of illness perception were associated with different medication adherence 
between genders. Men showed a belief in higher personal control and fewer symptoms 
which was a significant predictor that contributed to their medication adherence 
compared to women. 
Thus, when looking into differences in medication adherence behaviour between 
genders, a holistic overview on other factors that differentiate health behaviours between 
genders needs to be considered. 
 Marital status  
The involvement of a domestic relationship with a partner contributed positively 
to health management. It was therefore important to consider the role of marital status in 
antihypertensive medication adherence. This was because it was considered a measure 
of a social network that acted as a supportive factor for patients during illness 
management (Sperber, Sandelowski, & Voils, 2013). A cross-sectional study of 636 
hypertensive patients from two primary care clinics at Duke University Medical Centre 
in the United States of America, that investigated emotional well-being for unmarried 
hypertensive individuals in regard to their antihypertensive medication adherence found 
that being married (50.47% of participants) was associated with a higher likelihood of 
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antihypertensive medication adherence (OR = 0.166, p < 0.05) (Trivedi, Ayotte, 
Edelman, & Bosworth, 2008).  
This was similar to another study conducted with 1,326 patients with coronary 
artery disease undergoing cardiac catheterisation in the United States of America. The 
study examined the adherence to cardiovascular medications for 12 months after hospital 
discharge. Unmarried individuals accounted for 30% of the sample and reported lower 
cardiovascular medication adherence for 24.7% of these participants. The multivariable 
predictors showed that being married contributed to better adherence among the study 
sample (Kulkarni, Alexander, Lytle, Heiss, & Peterson, 2006).  
To elaborate on the previous findings, spousal support in medication adherence 
was found to have provided practical support such as reminding the patient to take their 
medications (Trivedi et al., 2008). In the absence of marital support, patients with chronic 
illness reported poor management of their health conditions as well as increased 
complications related to this poor management of their illness, such as the presence of 
cardiac events in heart failure patients (Wu et al., 2012).  
 Income 
Economic status was associated with medication adherence for patients with 
chronic illness as well as hypertension. This relationship was linked to the ability to 
afford the medications. Antihypertensive medications vary in price from affordable to 
expensive (Després et al., 2014; Goldman, Joyce, & Zheng, 2007). The role of patient 
economic status in relation to medication adherence was not limited to the ability to 
afford the medications; it extended to the enhancement of medication adherence via the 
monetary pathway or via education or knowledge pathways, since individuals with 
higher income had better education and therefore, better knowledge about medication 
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adherence (Awwad et al., 2015; Shehadeh-Sheeny, Eilat-Tsanani, Bishara, & Baron-
Epel, 2013). Therefore, it is reasoned that patients with high income contribute better to 
their own illness management including medication adherence. 
Patients with low-income had poor health management because of the struggle 
they faced to seek healthcare services or afford treatment. Low-income status was an 
issue associated with poor adherence for minorities in communities that did not receive 
effective health support as was the case for low-income African Americans in the United 
States of America (Ibrahim, 2003; Shaw & Bosworth, 2012), and in patients in urbanised 
communities in rural Eastern Uganda (Bagonza, Rutebemberwa, & Bazeyo, 2015).  
Several other studies considered the role of the individual’s economic status in 
relation to antihypertensive medication adherence, however, and the results shown were 
not significant for this factor (Bader, Koprulu, Hassan, Ali, & Elnour, 2015; Zyoud, Al-
Jabi, Sweileh, & Morisky, 2013). The nature of the healthcare support provided for 
hypertensive medications was potentially the reason for these contrary results.  
In countries where the health system was supportive, the need to personally afford 
the medications was less because medications were provided with no cost for patients. 
For example, in Saudi Arabia, the healthcare system supports the pharmacological 
management of patients. Medications are provided at no cost for patients in government 
hospitals and in primary healthcare clinics (Alkhawajah & Eferakeya, 1992). However, 
the antihypertensive medication adherence behaviour in relation to the availability of free 
medications has not been identified in any previous studies. 
 Employment  
Employment status was a predictive factor for antihypertensive medication 
adherence. A study conducted with 241 older Korean hypertensive patients showed that 
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being employed was linked to a higher probability of antihypertensive medication 
adherence (OR = 4.09, p <0.05) compared to retired or unemployed patients. The 
reported rate of poor antihypertensive medication adherence in the study was 41%. 
The association with employment status and antihypertensive medication 
adherence was argued from two sides. First was the availability of personal financial 
support that supported access to medical services and treatments; second was the 
availability of a daily job routine that enhanced the patient’s cognitive and functional 
status and therefore aided having a medication adherence routine (Park, Kim, Jang, & 
Koh, 2013). 
However, it was argued that illness management and medication adherence was 
impacted in employed patients due to a busy lifestyle where adhering to medication 
routines might not fit in. A study that identified the role of employment in illness 
management and malaria medication adherence for 440 patients in an outpatient setting 
in Nigeria has reported a negative association between employment and medication 
adherence (Okuboyejo, Mbarika & Omoregbe 2014). A significant explanation for 
similar findings was that malaria medications required some time off work where the 
patient was required to continuously visit the clinic to receive injections and undergo 
rehabilitation therapy. 
When considering employment status as a factor, there was significance in 
identifying antihypertensive medication adherence in a context where employed and 
unemployed patients received the benefits of a free healthcare system and did not 
experience the stress of needing financial support to fund their treatment. Another matter 
of significance when considering employment status as a factor in antihypertensive 
medication adherence was knowing that antihypertensive medications are easy-to-use 
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oral tablets that require no preparation that might disturb work routines or cause any fear 
of stigmatisation at work such as in the case of injections (Okuboyejo, 2014; Sweeney & 
Vanable, 2014), therefore, it was valuable to identify if hypertensive employed patients 
were adhering to their medications. 
 Education status 
The scientific literature has repeatedly reported a strong association between 
poorer health outcomes and lower levels of education. Individual education status 
showed significant positive association to antihypertensive medication adherence (Wu et 
al., 2012; Zyoud et al., 2013).  
Research conducted on a sample of 410 hypertensive patients in Palestine 
assessed socio-demographic factors in relation to antihypertensive medication adherence 
using the Morisky Medication Adherence Scale (MMAS). This research reported 
significant association between the patient’s level of education and medication 
adherence. The results showed that increases in MMAS scores (scale scores ranged from 
0 to 8) for medication adherence was associated with the increase in education level. 
Education levels were identified in the study as: no formal education, primary, secondary 
and university. The MMAS median score of the non-formally educated patients (9.8%) 
adherence score was 6.8 compared to 7.8 for hypertensive patients with a university 
degree (26.9%), therefore, the reported patients level of education was a significant 
predictor for the differences of the adherence score (p <0.05) (Zyoud et al., 2013).  
Another study examined the relationship between health literacy and medication 
refill adherence for 1,549 patients with chronic illness in the Unites States. Cumulative 
Medication Gap (CMG) was used as a measure of medication refill adherence; low 
adherence was defined as CGM ≥ 20%. The patients’ level of education in this study was 
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identified as the following: grade school or less, some high school, high school and more 
than high school. The results showed 929 (60%) of the patients demonstrated adequate 
adherence (CGM < 20%) and that the patients’ level of education was a significant 
positive predictor (p <0.05) in medication refill adherence. This was determined by the 
reporting of the minimum rate of adequate adherence among patients with grade school 
or less education (15.6%, n = 145) and the maximum medication refill among patients 
with more than high school (31.9%, n = 296) (Gazmararian et al., 2006). Health literacy 
was a potential pathway between health outcomes and level of education (van der Heide 
et al., 2013). 
Poor health literacy about medications improved via educational interventions 
provided by healthcare providers (van der Heide et al., 2013). Patients who had any form 
of medication education reported more adherence to antihypertensive medication (Bader 
et al., 2015), however in the absence of medication education, the patients’ level of 
education was a helpful factor. Educated patients were potentially advantaged by their 
educational status to seek further health information about their health conditions 
compared to those who were uneducated. It was found that less educated patients’ health 
condition management could be impacted because of the absence of this factor.  
- Knowledge 
Evaluating patient’s knowledge about their illness was a significant step in 
understanding how the individual patients were managing their illness. Hypertensive 
patients worldwide have reported low levels of knowledge and awareness about 
hypertension as a chronic health condition and its treatment. This has contributed to poor 
hypertension control and therefore the presence of cardiovascular complications. Several 
studies have focussed on identifying reasons of uncontrolled hypertension based on 
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evaluating patient’s knowledge about hypertension and antihypertensive medications. 
Areas of knowledge that are poorly understood by hypertensive patients include causes 
of hypertension, symptoms, risk factors, prevention, target blood pressure, 
complications, onset and dietary management. Research on antihypertensive medication 
adherence has showed lack of knowledge among hypertensive patients about required 
duration of antihypertensive medication treatment, long term side effects and the 
importance of antihypertensive medications to control blood pressure and prevent 
complications.  
In North Carolina in the United States of America, an attempt was made to assess 
530 primary care hypertensive patients’ current knowledge about various aspects of high 
blood pressure. A questionnaire of six items assessed specific knowledge about 
hypertension that was related to the importance of high blood pressure in someone’s life 
as follows: importance in their life –‘high blood pressure is not life threatening’; 
prevention – ‘there is nothing you can do to prevent high blood pressure’; screening – 
‘most of the time people with high blood pressure don’t feel it’; aspects of treatment – 
‘taking medications will cure high blood pressure’; control – ‘blood pressure is high 
when recorded as over 140 over 90 mm Hg or higher’; and lifestyle – ‘Americans eat 
more salt and sodium than they need’. The data was analysed based on the following 
responses: ‘true’, ‘false’ and ‘not sure’ (responses of ‘not sure’ were treated as ‘false’). 
The data of this study showed that 44% answered all items correctly, 34% answered one 
item incorrectly, and 22.3% answered two items incorrectly. Among the questionnaire 
items, the item most often answered incorrectly was related to whether hypertension 
causes symptoms (26.2%), nothing can be done to prevent hypertension (22%), and if 
antihypertensive medications will treat hypertension (19% ) (Viera, Cohen, Mitchell, & 
Sloane, 2008). Knowledge of hypertension symptoms was also found to be an issue with 
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hypertensive patients in another study that was conducted in Sudan with 242 hypertensive 
patients (Osman, Suleiman, & Elzubair, 2007). Only 38.8% of the participants showed 
high scores for knowledge of the symptoms of hypertension mentioned in the survey. 
Another study conducted in the United States of America that surveyed 1,762 
hypertensive patients assessed specific aspects related to diastolic/systolic blood 
pressure. The tested domains included: knowledge of hypertension terminologies, 
knowledge of hypertension (i.e. as a factor that increased risk for developing other 
diseases), perceived importance of systolic blood pressure (SBP) and diastolic blood 
pressure (DBP) as important risk factors for developing other diseases, knowledge of 
target blood pressure, ability to recall SBP and DBP values from a recent clinic visit and 
correct labelling of high blood pressure values. The major finding of this study was that 
a high percentage of participants were unable to identify the target of SBP and DBP 
according to the reported target on the report of the Joint National Committee on 
Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC VI). For 
example, 71.7% were unable to identify the target for SBP and 61% for DBP (Alexander, 
Gordon, Davis, & Chen, 2003). Similar results were reported in another study where 826 
hypertensive patients from a primary health care setting in Michigan in the United States 
of America struggled to report the optimal level of SBP and DBP (Oliveria, Chen, 
McCarthy, Davis, & Hill, 2005). 
Studies showed inadequate knowledge about hypertension and antihypertensive 
medications among patients with uncontrolled hypertension and patient’s poor to 
moderate therapeutic adherence. A cross-sectional study was conducted on 447 
hypertensive patients from three hospitals in Karachi, Pakistan, using a survey method to 
assess knowledge about hypertension among 323 controlled and 124 uncontrolled 
hypertensive patients. The questionnaire used 15 items. The minimum reported score for 
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the scale was 15 and the maximum score was 38. The results showed significant 
difference between controlled and uncontrolled hypertensive patients, for example, the 
mean (SD) of the knowledge composite score were 21.85 (4.74) and 18.67 (4.70) 
respectively. For the uncontrolled hypertensive patients, the following areas of 
knowledge reported lower responses: knowing that hypertension is unavoidable with age 
(6.1%), knowing the importance of blood pressure (SBP, DPB) (3.2%) and knowing that 
hypertension is asymptomatic (2.6%) (Almas, Godil, Lalani, Samani, & Khan, 2012). 
This result was similar to a study conducted on 254 hypertensive patients in Nigeria, 
since only 11.4% of patients knew that hypertension was often asymptomatic (Osman et 
al., 2007).  
The association between patient’s knowledge of hypertension management and 
antihypertensive medication adherence was evaluated on 385 hypertensive patients using 
a survey method for patients visiting the outpatient departments in two public hospitals 
in Quetta city, Pakistan (Saleem, Hassali, Shafie, Awad, & Bashir, 2011). Medication 
adherence was assessed using the Drug Attitude Inventory 10 (DAI-10) that included 10 
items requiring ‘yes’ and ‘no’ responses. The knowledge was assessed using the 
Hypertension Fact Questionnaire (HFQ) that included 15 questions used to assess the 
patients’ knowledge about hypertension, causes of hypertension, treatment and 
management. The scoring of HFQ ranged from 0 (no knowledge) to 15 (good 
knowledge). The study showed that there were no patients who reported good adherence, 
and patients were either poor adherents to antihypertensive medications (64.7%) or 
moderate adherents (35.3%). Out of the total sample, only three patients (0.8%) showed 
having an adequate general knowledge about hypertension. Poor knowledge was reported 
according to response to questions relating to onset and management of hypertension, 
and dietary control of hypertension.  
55 
 
Knowing various aspects about the hypertension condition was integral to 
medication adherence since it contributed to the therapeutic management of illness. 
Knowing the target level for blood pressure was part of the goal setting that a patient 
might consider during the medication regimen. Hypertensive patients who reported 
knowing their target blood pressure showed optimal adherence to antihypertensive 
medications (Karaeren et al., 2009). Areas which showed a lack of knowledge about 
antihypertensive medications are the following: reasons for the duration of taking 
antihypertensive medications and the importance of antihypertensive medications (Kim 
et al., 2007). 
Antihypertensive medication adherence should be maintained even in the absence 
of symptoms. This is because high blood pressure is usually a life-long condition that has 
a continuing effect on the internal vascular system and organs’ condition if it is poorly 
treated. Patients have the misconception that antihypertensive medications are used 
sporadically in response to everyday symptoms which may be attributed to high blood 
pressure (Karaeren et al., 2009). This misconception is due to the lack of knowledge 
about the use of antihypertensive medications or the excessive concern about long term 
adverse effects or dependence (Horne, Clatworthy, Polmear, & Weinman, 2001). A 
cross-sectional study on 254 hypertensive patients in Nigeria assessed knowledge of 
hypertension and awareness of hypertension treatments. The answers of the structured 
questionnaire that involved nine items about knowledge of hypertension and 
antihypertensive treatment showed a lack of knowledge among the participants in many 
dimensions relating to antihypertensive medications. The results showed that 58.3% 
patients believed that antihypertensive drugs should be used only when symptoms were 
present and that 6.3% believed that medications should be used for a period of two weeks 
to five years, but not for their whole life. Only one-third of the participants knew that 
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antihypertensive medications are long-term medications (35.4%) (Oluranti Familoni, 
Abayomi Ogun, & Olutoyin Aina, 2004).  
The need for continuing adherence to antihypertensive medications was a 
significant factor with hypertensive patients in Saudi Arabia. Hypertensive patients 
tended to perceive that antihypertensive medications were for short term use and could 
be stopped once the outcome was achieved. A cross-sectional study that interviewed 347 
patients from primary health care centres in Tabuk city assessed the antihypertensive 
medications rate using a pill counting method and the associated factors with this 
adherence. According to this study adherent patients were 47% of the total sample while 
53% were non-adherent. Patient knowledge about the need for adherence to 
antihypertensive medications was a significant predictor of adherence (p <0.05). Among 
adherent patients in this study, 58.5% knew the need for adherence to antihypertensive 
medications (Khalil & Elzubier, 1997). Another cross-sectional study using a survey 
method in Saudi Arabia agreed with the previous findings. This study which recruited 
190 hypertensive patients attending primary health care centres in Al-Khobar city 
assessed hypertensive patients’ knowledge and misconception about hypertension. 
According to the study, 43.7% of patients thought that antihypertensive medications 
could be stopped once blood pressure control had been achieved (Al-Sowielem & 
Elzubier, 1998).  
The patient’s background knowledge and information about medications affected 
their belief (Magadza, Radloff, & Srinivas, 2009). Significantly, healthcare providers 
should play an active role in explaining the antihypertensive medication actions on high 
blood pressure as a health condition including the consequences of long term use or poor 
use of these medications. 
57 
 
- Beliefs 
The accumulated evidence suggested that patients’ beliefs had a significant and 
major role in influencing medication adherence. Beliefs about medication use were 
classified into general beliefs and specific beliefs. General beliefs about medication use 
involved harm and overuse. Beliefs about harm included the belief that medications were 
harmful, poisons, addictive, and should not be taken continuously. Overuse refers to the 
belief that medications were overused (overprescribed) by physicians (Horne, Weinman, 
& Hankins, 1999). The specific beliefs refer to those beliefs that influence patients’ 
evaluations of the prescribed medication(s) including, the perception of the personal need 
for treatment (belief of necessity), and the concern regarding the medications’ long term 
use (belief of concern) (Horne et al., 2013; Horne et al., 2001). The belief of the necessity 
of taking medications reflected the patients’ understanding of their illness and the 
importance of the medications for treating their illness. This therefore influenced their 
motivations to take the medication(s). On the other hand, patient’s concerns about 
medication arose from misconceptions of what they believed they knew or had 
experienced with regard to the medications. For example, patients had concerns about 
the presence of side effects due to the long term use of medications (Magadza et al., 2009; 
Saleem et al., 2015). A recent systematic review and meta-analysis of ninety-four studies 
asserted that specific belief concepts including the concepts of necessity and concern, 
was a sufficient conceptual framework to understand patients’ perspectives on prescribed 
medications (Horne et al., 2013).  
A study that investigated these two components of medication belief was 
conducted on a sample of 324 patients with chronic illness sourced from teaching and 
general hospitals in London and Brighton in the United Kingdom (Horne & Weinman, 
1999). This cross-sectional study aimed to assess the relationship between medication 
58 
 
adherence and the beliefs about medications. Medication adherence was assessed using 
four items with five scale responses that had scores ranging from 4 to 20, where the 
higher score reported higher levels of medication adherence. Patients’ belief was assessed 
by using The Beliefs about Medicine Questionnaire (BMQ) that has ten items to assess 
the belief about necessity of the prescribed medications for controlling the illness and the 
concern about potential consequences from using the medications. The scale is a five 
scale response that has scores ranging from 5 to 25, where the highest score represents 
the highest concern or necessity level. The results showed that 89% of the sample 
reported high necessity of their medications while 36% of the sample reported their 
concerns about potential adverse effects of medications. The findings of this study 
reported that patients’ belief about their medications (necessity and concern) was the 
strongest predictor for medication adherence, accounting for 19% of the variance in 
reported medication adherence.  
Another cross-sectional study was conducted on a sample of 242 hypertensive 
patients from a secondary care hypertension and shared scheme in the United Kingdom 
and assessed the role of medications belief on antihypertensive medication adherence 
(Ross, Walker, & MacLeod, 2004). Medication adherence was assessed using the 
Morisky Medication Adherence Scale (MMAS) and medication belief assessed using the 
Belief about Medicines Questionnaire (BMQ). The BMQ used in this study had 18 
questions that included the following domains: 10 questions were related to specific 
attitudes (necessity and concern) and the other 8 questions were about general attitude to 
medicines (including harm and overuse). Responses were registered on a 5–point Likert 
scale and the higher score indicated stronger beliefs. The results indicated that patients 
who reported high necessity to antihypertensive medications were more likely to be 
adherent (OR 3.2, p<0.05) and that patients who reported concerns about potential 
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adverse effects were less likely to be adherent (OR 0.6, p<0.05). The results reported no 
significant relationship between the aspects of harm and overuse of medications in 
relation to antihypertensive medication adherence. Beliefs about medicines in this study 
was affected by education level since patients with lower levels of education were more 
likely to believe that medications were necessary (X2 = 7.154, p<0.05). 
Several studies have investigated the role of medications belief (necessity and 
concern) in affecting antihypertensive medication adherence focussing on the major 
elements of belief, necessity and concern (AlHewiti, 2014; Fernandez-Arias et al., 2014; 
Rajpura & Nayak, 2014; Ruppar et al., 2012). Findings of these studies supported 
patients’ beliefs about the strong necessity of taking the medications which contributed 
substantially to positive medication adherence. On the contrary, those patients with 
increased levels of concern about using medications contributed to poor adherence.  
The belief–specific concepts (necessity and concern) were investigated in Saudi 
Arabia to assess the relationship of belief about medicines in relation to long-term 
medication adherence for patients with chronic illness (AlHewiti, 2014). The study was 
conducted on 408 patients with different chronic conditions. Medication adherence was 
assessed using the 8–item Morisky Medication Adherence Scale (MMAS–8) and the 
belief about medications assessed using the BMQ. Among other factors that were 
assessed in this study, specific belief about medications use was found to be a significant 
predictor for medications adherence and explained 27.7% of the variance in adherence 
for patients with chronic illness.  
In the Middle East, a randomised control trial that recruited 136 hypertensive 
patients from three government hospitals in Jordan assessed hypertensive patients’ 
beliefs regarding their antihypertensive medications adherence using the General Belief 
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about Medication Questionnaire (BMQ) that focussed on the “harm” (harm, overuse and 
sensitivity) and “benefit” aspects of the belief of medications. In the study, the results 
revealed that the BMQ General Harm scores were negatively correlated with adherence 
(GH: −0.73, p <0.05, GO: −0.31, p < 0.05 and GS: −0.46, p <0.05) and the BMQ General 
Benefit score was positively correlated with medication adherence (p < 0.001), that 
represented an increase in positive beliefs and a reduction in negative beliefs about 
medication improving adherence (Alhalaiqa, Deane, Nawafleh, Clark, & Gray, 2012). 
There were some other studies conducted in the Middle East that focussed on the role of 
belief in medication adherence, however it considered a different methodological 
approach (a qualitative interview) (Saleem, Hassali, Shafie, & Atif, 2012) or all chronic 
diseases (Sweileh et al., 2014). There is a paucity of research assessing hypertensive 
patients’ beliefs in Saudi Arabia. 
Improving patients’ belief about their chronic illness medications, including for 
hypertension, was the core effort of educational intervention studies (Horne et al., 2013). 
The outcome of these intervention studies agreed that enriching the patient’s information 
about the illness and the prescribed medications resulted in patients viewing the 
medications as a necessity, while the lack of information provided about the illness and 
medications resulted in patients concerned about using the medications. 
- Health and health behaviour-related factors 
The health-behaviour related factors include those factors that are related to individual 
patient’s health and health behaviours. Some of these factors include the years of 
diagnosis with hypertension, the presence of other health conditions in addition to 
hypertension, smoking status, and the use of medication reminder aids. 
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 Duration of hypertension  
The experience that hypertensive patients encounter when dealing with 
antihypertensive medications during their treatment differs according to the years of 
diagnosis with hypertension. During the initial stages of hypertension treatment, 
healthcare providers usually provide close and continued monitoring of the patient’s 
condition to evaluate the effectiveness of the prescribed medications and the need to 
adjust the treatment regime, which could include changing the medication, adding further 
medications or changing the medication dosage (Mazzaglia et al., 2009; Valcárcel, 
Jiménez, Arístegui, & Gil, 2003). Thus, medication adherence has been found to differ 
between newly diagnosed patients and patients with longstanding diagnoses and 
treatment regimes.  
Although studies that considered investigating the effect of years of hypertension 
diagnosis between new and long-term hypertensive patients in relation to 
antihypertensive medication adherence reported no significant association (Hsu, Mao, & 
Wey, 2010; Zyoud et al., 2013), antihypertensive medication adherence rates reportedly 
fall in newly diagnosed patients (Baggarly, Kemp, Wang, & Magoun, 2014; Friedman, 
McAlister, Yun, Campbell, & Tu, 2010). Therefore, looking into antihypertensive 
medication adherence behaviour by considering the duration of hypertension diagnosis 
is of substantive importance.  
There were different reasons which contributed to different antihypertensive 
medication taking behaviour among new and long-term patients. For newly diagnosed 
patients, the lack of knowledge about antihypertensive medications was relevant since 
some hypertensive patients held the mistaken belief that taking the medications is only 
necessary when experiencing the symptoms of high blood pressure (Oluranti Familoni et 
al., 2004). Hypertension is a long-term condition; therefore it is required to maintain 
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continued medication taking behaviour to achieve an appropriate control of the patient’s 
blood pressure. Adapting to this long-term treatment regime was challenging for newly 
diagnosed individuals with chronic health conditions, for example some medications 
produced unpleasant side effects such as frequent urination experienced with diuretics 
(Mazzaglia et al., 2009). On the other hand, hypertensive patients diagnosed with 
hypertension for a long time developed different medication taking behaviour. 
Consequently, it is important to consider the effect of years of diagnosis of hypertension 
in relation to antihypertensive medication adherence.  
 The presence of comorbidities  
The presence of comorbid health conditions should be taken into account when 
considering medication adherence behaviour. Hypertension is a chronic health condition 
that could be diagnosed alone or with another health condition such as diabetes, 
hyperlipidaemia or renal insufficiency. Patients diagnosed with comorbidities are 
overwhelmed with poly-medications to control their illness. Therefore, the medication 
adherence behaviour for patients with comorbidities may be different than the behaviour 
of other patients diagnosed with hypertension only. Studies have reported various results 
regarding the influence of comorbidities on antihypertensive medication adherence 
(Hashmi et al., 2007; Khanam et al., 2014; Park et al., 2013). 
A population based study of 29,960 patients diagnosed with hypertension in 
Bangladesh noted that patients with cardiovascular morbidities were less likely to report 
poor adherence to antihypertensive medications (OR = 0.79, 95% CI = 0.64–0.97). A 
study that was conducted in the Middle East focussed on factors affecting 
antihypertensive medications adherence among 250 hypertensive patients. This cross-
sectional study that interviewed patients from outpatient clinics in United Arab Emirates 
recorded the presence of comorbidities as a not significant factor to antihypertensive 
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medications adherence (p >0.05) (Bader et al., 2015). Other studies also have found that 
comorbidities are not a significant factor in relation to antihypertensive medication 
adherence (Hashmi et al., 2007; Park et al., 2013).  
Other studies however have found that patients with comorbidities have better 
adherence compared to patients diagnosed with hypertension only (An & Nichol, 2013). 
Underlying factors that support medication taking behaviour among patients with 
comorbidities could be the reason of the variation in the published results. Habit 
formation was found to be the factor that influenced medication adherence among 
patients with comorbidities (Reach, 2005). This could be clear in the case of a patient 
who had been diagnosed with comorbid condition(s) before the diagnosis with 
hypertension, therefore adhering to antihypertensive medications was better for this 
patient because of the habitual actions that had been developed during the use of previous 
medications for a comorbid health condition. Medications adherence in chronic 
conditions may have explained the prior development of habits that a patient initiated 
and maintained during the treatment regimen (Reach, 2005).  
A study that was conducted in two government hospitals in Taif city in Saudi 
Arabia assessed various aspects of adherence for hypertensive patients including diet, 
exercise and medications among hypertensive patients and the associated factors to 
adherence. The cross-sectional study included 144 male hypertensive patients who were 
surveyed. The results of the study found that the presence of comorbidities was a 
significant factor in the commitment to a healthy diet (OR = 0.2, CI = 0.07–0.7, p <0.05), 
regular exercise (OR = 4.7, CI =1.2–18.8, p <0.05) and antihypertensive medications 
(OR = 3.8, CI = 1.6–9.4, p <0.05) (Elbur, 2015).  
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On the contrary, a qualitative study that included six focus groups of HIV patients 
with diabetes or hypertension that was conducted in Maryland clinics in the United States 
of America among 35 patients reported a decrease in antihypertensive medication 
adherence for patients with hypertension and comorbidities, the main explanation being 
the patient feeling overwhelmed with multiple medications and therefore experiencing 
concern regarding the presence of side effects related to taking multiple medications 
(Monroe, Rowe, Moore, & Chander, 2013).  
The role of knowledge and awareness of health conditions is another underlying 
factor that should be considered when explaining medications adherence for patients with 
comorbidities (Ghembaza, Senoussaoui, Tani, & Meguenni, 2014). 
 Smoking 
Studies that have focussed on identifying determinants of antihypertensive 
medication adherence considered smoking status as a factor. Results varied from 
showing smoking as a significant predictor of antihypertensive medication adherence to 
having no significant effect. An open large-scale multicentre study in France was 
conducted on 2,173 hypertensive adult patients to evaluate predictive factors on 
antihypertensive medication adherence (Vaur et al., 1999). Medications adherence was 
assessed by using the electronic pill boxes (MEMS) that helped in identifying missed 
doses, delayed doses and correct doses periods. The results showed that smoking is a 
significant factor of poor antihypertensive medication adherence (OR = 1.65, 95% 
CI = (1.29–2.11), (p <0.05). According to this population trial, young hypertensive 
patients who lived in large urban areas and smoker showed poor adherence to 
antihypertensive medications. Another studies investigated the association of smoking 
status as a single predictor in relation to antihypertensive medication adherence. This 
result is in line with a study conducted in Saudi Arabia. This community-based cross-
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sectional study that included 900 hypertensive patients aimed to determine the adherence 
to the therapeutic plan for hypertensive patients attending the primary health care centres 
in Almadina city in Saudi Arabia. Patients’ adherence to the therapeutic plan was 
assessed from their attendance at the clinic, periodic medical check-ups and blood 
pressure measurements. The study showed that 760 of the patients were considered as 
poor adherents and 140 patients were considered fair to good adherents. The results 
recorded a statically significant finding of smoking status between the poor and the fair 
to good groups (p <0.05) for non-smokers, active smokers and passive smokers 
(Mahmoud, 2012).  
A study conducted in Bristol, United Kingdom on 331 hypertensive patients 
showed the opposite results (Zeller et al., 2007). Antihypertensive medication adherence 
was measured using the MEMS® for a five week period. Smoking status showed that 
15.1% regularly smoked cigarettes, 39.7% were former smokers and 45.2% had never 
smoked cigarettes. The results showed that the difference between the means of 
antihypertensive medication adherence in patients who had never smoked and current 
smokers was 5.9% (95% C = 1.3%–13.1%), and in patients who had never smoked and 
former smokers, it was 2.5% (95% CI = 2.5%–7.4%). The study reported that smoking 
status was not a significant predictor of antihypertensive medication adherence in the 
study population. Zeller et al., (2007) asserted that the effect of smoking status on 
medications adherence differed depending on the population of study and that it is not 
comparable to draw a conclusion based on comparison with other studies of patients from 
different backgrounds.  
 The use of reminder aids 
The use of medication reminder aids reduced the risk of forgetfulness and therefore 
assisted in medications adherence. Studies that assessed the role of the use of medication 
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reminders found an improvement of medication adherence among patients who used 
medication reminders to remind them to take their daily dosages of medications.  
A meta-analysis of eleven published randomised control trials that were conducted 
between 1999 and 2009 evaluated the use of reminder interventions in assisting 
medication adherence (Fenerty, West, Davis, Kaplan, & Feldman, 2012). To assess 
medications adherence, the meta-analysis measured the number of the taken medication 
doses compared to the number prescribed within a set period of time. The results showed 
that eight of the reviewed studies reported statistically significant increases of medication 
adherence for at least one interventional group compared to the control group. The 
increase of medication adherence in the meta-analysis for the intervention groups 
compared to the control groups was 66.61% versus 54.71% (95% CI for mean = 0.8% to 
22.4%).  
The majority of studies that considered the factor of medication reminders in 
medication adherence were designed to include medications reminder aids in the 
interventional studies to draw conclusions about the impact of the use of medication 
reminder aids on medications adherence behaviour (Gaziano, Bertram, Tollman, & 
Hofman, 2014; Kamal et al., 2015; Sarkar, Sivashankar, & Seshadri, 2015). It is valuable 
to identify whether hypertensive patients use medication reminder aids to remind them 
with their daily medication routine and how this affects their medication adherence 
behaviour. 
2- Physician-patient relationship 
Several factors of the physician–patient relationship contribute to patient health 
outcomes including medications adherence. Two important factors include 
communication and continuity of care. Physician–patient communication processes 
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involve verbal and nonverbal communication, task-oriented behaviour (effective 
questioning and transmission of information), psychosocial behaviour (expressing 
empathy and concern), partnership and participation during encounter. A meta-analysis 
of 106 correlational studies and 21 experimental interventions about physician–patient 
communication in relation to treatment adherence found that physician communication 
was positively correlated to medication adherence (Zolnierek & Dimatteo, 2009). 
According to this meta-analysis, the risk of treatment non-adherence among patients who 
were treated by physicians who communicate poorly was 19% (Zolnierek & Dimatteo, 
2009).  
Several studies in this field have highlighted the role of the physician–patient 
communication on medications adherence. A cross-sectional study of 439 hypertensive 
African-American patients assessed patient’s perception of the quality of their 
physicians’ communication in addition to the extent of patients’ involvement in the 
treatment decisions in relation to participant’s medications adherence. The provider’s 
communication was assessed using an eleven–item scale, nine items using a 4–Likert 
scale and two items with a yes/no response. Medications adherence was assessed using 
the 4–item Morisky scale. The results showed that 51% of the participants rated their 
provider communication as not collaborative and that 55% of the patients were non-
adherents. Collaborative communication was a significant predictor to medication 
adherence in this study (B = -0.11, p <0.05). Patients who rated their interactions as 
collaborative communication with their physicians showed better adherence to their 
medications (Schoenthaler et al., 2009). 
Another study of 58 providers and 869 patients in seven primary healthcare clinics 
in the United States of America assessed the effects of communication skills intervention 
provided for physicians in the primary healthcare clinics on improving hypertensive 
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patients’ health outcomes was conducted in a randomised controlled trial. The trial 
involved two educational training sessions for physicians on the use of a patient-centred 
counselling approach and communicating with hypertensive patients toward improving 
their antihypertensive medications management (Manze et al., 2015). The follow up with 
379 hypertensive patients involved assessing the effects of whether patients received 
discussions about hypertension-related issues from physicians, medications adherence 
and blood pressure readings. The random effect least square regression reported no 
significant differences in the change in provider counselling [parameter estimate (PE): 
0.83, CI 95%: -0.13, 1.79] and patient medication adherence [PE: -0.26, 95% CI: -.79, 
0.27]. Thus, the results concluded that extensive and in depth interventions that enhance 
physician communication skills are required to contribute to improving hypertensive 
patients’ medication adherence. 
Physician–patient communication aspects that needed to be considered in terms of 
antihypertensive medications adherence involves: providing collaborative 
communication where patient’s needs were addressed and hypertension management 
practice issues were evaluated; assessing patients’ information and reducing the chance 
of receiving conflicting information about medications; and also adapting patient-centred 
communication to patients with hypertension where issues about their illness and 
medications were discussed openly (Stavropoulou, 2008). The effective relationship 
between physician and patient is not limited to aspects of providing good quality 
communication that target patient’s needs, but it extends to include a continuity of care 
where this information is shared in an ongoing relationship. A significant component of 
the physician–patient relationship in terms of medication adherence for patients with 
chronic illness is the continuity of care.  
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A longitudinal study that included 7 years of follow up examined the relationship 
between medication adherence and the continuity of care. Information related to a total 
of 11,299 type 2 diabetes adult patients were retrieved from the national health insurance 
dataset in Taiwan (C.-C. Chen, Tseng, & Cheng, 2013). Level of medication adherence 
was assessed by calculating ‘the ratio of the number of days medications’ were supplied 
divided by ‘the total number of days in each study year’. The independent variable in the 
study considered the continuity of care index that calculated the ‘number of different 
physicians seen’ and ‘the number of visits to every physician in each year during the 
study period’. The study outcome showed that patients who scored a high to intermediate 
level of continuity of care had been more adherent to their medications than those who 
had a low continuity of care score (OR = 3.37, 95% CI = 3.15–3.60 and OR = 1.84 , 95% 
CI = 1.74–1.94, respectively). 
Another study has confirmed this finding. The study focussed on examining the 
relationship between the refill adherence to medications and number of prescribers for 
several cardiometabolic conditions that included: hypertension, dyslipidaemia and heart 
failure. The study considered a retrospective cohort data that were drawn from single 
Veterans Administration Medical Centre in the South-eastern United States of America 
between 2008 and 2010 for 7,933 patients (Hansen et al., 2015). Level of medication 
refill adherence was measured using the ‘multiple-interval gap measure’ which used 
information from pharmacy fill and refill dates, in addition to quantities and daily doses 
in order to estimate the percentage of days in each year. The number of prescribers was 
measured by counting the number of prescribers who wrote a prescription for a 
filled/refilled medication. The results showed that antihypertensive refill adherence was 
lower in patients who were seeing ≥ 4 prescribers (odds ratio [OR] = 0.69; 95% 
CI = 0.59–0.80). Anti-dyslipidaemia medications refill adherence was lower in patients 
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who were seeing 3 prescribers (OR = 0.80; 95% CI = 0.70–0.92) or ≥ 4 prescribers 
(OR = 0.77; 95% CI = 0.64–0.91). Medications refill adherence might be improved by 
minimising the number of prescribers who are involved in patients’ health management. 
The continuity of medications management is best accomplished by considering the 
presence of single pharmacist or prescriber to maintain the continuity of care.  
It is challenging to assess the continuity of care for Saudi hypertensive patients 
attending the outpatient department in tertiary hospitals. Patients commonly experience 
long time between appointments (weeks or months), which increases the chance that the 
physician could not be available for the next appointment (Youssef, 2014). Another 
reason for not seeing the same physician again is that most general hospitals in Saudi 
Arabia support medical education (Al-Mohaimeed et al., 2014). Medical students or 
medical fellows (house officers/ residents) training takes place in governmental hospitals 
in Saudi Arabia, including the outpatient departments in these hospitals. Therefore, 
chances for seeing the same treating physician are low.  
Continuity of care contributes to better interpersonal relationships and better 
information sharing between the physician and the patient, and this leads to better goal 
alignment and improvement of medication adherence (Hansen et al., 2015; Stavropoulou, 
2008). However, this is also achieved by developing an appropriate relationship between 
the patient and the physician if psychotherapeutic aspects of understanding and agreeing 
about the medical symptoms, patient satisfaction with the provided quality of care, and 
agreement about the treatment received are involved (Van der Feltz-Cornelis, Van 
Oppen, Van Marwijk, De Beurs, & Van Dyck, 2004). Therefore, to understand the 
association of the physician-patient relationship with medication adherence, it is 
important to focus on the evaluation of the healthcare provider as an effective 
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professional who is able to assist the patient and provide an effective psychotherapeutic 
intervention.  
3- Healthcare-system related factors 
Healthcare system support to hypertensive patients has a significant role in 
enhancing adherence to antihypertensive medications. The World Health Organisation 
has identified that shortcomings and complexity with healthcare systems contributes to 
barriers to optimal medication adherence (WHO, 2003). The specifically related support 
to hypertensive patients in relation to their adherence behaviour considers elements of 
providing supportive information regarding the prescribed medications and the easy 
accessibility to medications. 
Successful hypertension management relies on comprehensive continuity of care 
aligned with health education. The main focus of providing educational support or 
information resources is to help hypertensive patients to adhere to medical advice on 
medications and highlight the importance of periodic health examinations and screening 
(Al-Khaldi & Al-Sharif, 2005). The educational resources should include education 
sessions and education materials such as booklets and pamphlets. Studies found that 
conducting educational interventions that provide patients with information regarding 
their health condition and medications contributed to increased antihypertensive 
medication adherence, whether this support was given by providing educational sessions 
or materials (Beune et al., 2014; Gross, Anderson, Busby, Frith, & Panco, 2013; 
Hacihasanoğlu & Gözüm, 2011). However, there has been no specific study which 
explored the association with the quality of the provided education resources with 
antihypertensive medication adherence in Saudi Arabia. 
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In Saudi Arabia, general and private hospitals are resourced with education and 
information materials compared to the local primary healthcare clinics, however, the 
quality of these resources in governmental hospitals have not been investigated in relation 
to hypertensive patients. With regard to primary healthcare clinics, patient education and 
health education materials are neglected aspects and require special attention from the 
Saudi health system. The study that was conducted to evaluate the availability of health 
education materials in primary health care settings in Aseer region (South) in Saudi 
Arabia reported the inadequacy of the essential resources such as booklets, pamphlets 
and videotapes to conduct health education (Al-Khaldi & Al-Sharif, 2005).  
The high out-of-pocket costs that are spent in form of payments or insurance for 
medications create financial burden for patients with chronic illness. In the United States 
of America , the Medicare Current Beneficiaries Survey for Medicare beneficiaries from 
1999 to 2000 found that Medicare spending for inpatient hospitalisation was significantly 
reduced by the use of prescription medicines. It was estimated that for each additional 
prescription medication filled, the hospital cost was decreased by $104, approximately 5 
per cent of the mean total Medicare payments in 2000 for the study participants’ inpatient 
hospital services (Stuart, Doshi, & Terza, 2009). In hypertension, affording the cost of 
antihypertensive medications was a challenge for all privately and publicly insured 
patients (Després et al., 2014; Goldman et al., 2007; Pesa et al., 2012). In Saudi Arabia, 
healthcare services provided by governmental hospitals are free-of-charge (Almalki, 
Fitzgerald, & Clark, 2011a; Walston, Al-Harbi, & Al-Omar, 2008). Patients’ access to 
medical services and treatments is available with no cost to patients who visit 
governmental hospitals in Saudi Arabia. Hypertensive patients are not excluded from the 
benefit of the services provided that include filling/refilling their medications for free. 
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Thus, the hypertensive patient’s medication adherence behaviour needs to be identified 
in relation to this available type of support. 
In summary, in order to identify the status of antihypertensive medication 
adherence in this research project, it was crucial to firstly work on defining the 
terminology that was used to categorise patients’ adherence to antihypertensive 
medications to optimal and suboptimal groups. This was followed by reviewing and 
evaluating measures that have been used to assemble information about medication 
adherence. The Hill-Bone Compliance scale was used for meeting the suggested criteria 
of evaluating the self-report measures. Reviewing studies concerned about factors 
associated with antihypertensive medications adherence was a significant step to 
identifying the gap in the literature and informing the study design. The outcome of this 
review was to identify three main domains of factors associated with antihypertensive 
medications adherence that included individual related factors, healthcare provider 
factors and healthcare system factors.  
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Chapter Three: Conceptual Framework 
 
Different models and theories have been developed and applied to identify factors 
affecting medication adherence. Selecting the appropriate model or theory is based on its 
components and their best fit to different units of practice. This chapter provides an 
overview on the theories used  in medication adherence research, and intentional and 
unintentional medication non-adherence. This is followed by the conceptual framework 
that guided this study.  
3.1. The use of theories in medication adherence research  
To gain a deeper knowledge about the factors associated with medication non-
adherence, researchers have employed branches of cognitive theories. Some of the social 
cognition models used to investigate medication non-adherence have included the Health 
Belief Model (HBM) (Bandura, 1977) the Theory of Planned Behaviour (TPB) (Ajzen 
& Fishbein, 1980) and the Social Learning Theory (SLT) (Lerner, 1990). 
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The HBM has been widely used in medication adherence studies (Kamran et al., 
2014; Peltzer, 2005; Venkatachalam et al., 2015). The underlying assumption of the 
HBM is that patients are able to make suitable decisions about their health (Bandura, 
1977). The model suggests that actions taken by patients are governed by a belief of 
susceptibility to having an ill-health condition; the presence of serious consequences due 
to the occurrence of the illness; the availability of courses of actions to avoid the 
condition; and an understanding that the advantages of taking the actions outweigh the 
costs. This model contains several cognitive constructs that predict why people take 
actions to control their illness (Figure 2). These constructs include perceived 
susceptibility, severity, threat, self-efficacy, benefits and barriers (Horne, 1997). 
The main criticisms of the HBM include: the relationships between model 
constructs have not been investigated thoroughly; and that that no definition has been 
built for the individual construct nor any clear rules of the relationship between these 
constructs were formulated. Another major weakness is that the HBM did not include the 
positive effects of negative behaviour and social influences (Munro, Lewin, Swart, & 
Volmink, 2007). A recently published meta-analysis signposted that the HBM model is 
able to predict 10% of variance in patient’s behaviour at best. The studies included in the 
analysis were heterogeneous and were not able to support conclusions to validate the 
model (Harrison, Mullen, & Green, 1992). In terms of applying the model for studies 
concerning long-term medications adherence, it has been recommended that further 
studies to assess the validity of this model be undertaken (Munro et al., 2007). 
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Figure 2: The Health Belief Model (Glanz et al, 2008, p.49) 
 
The TPB assumes that motives to perform certain behaviour involve the intention 
to perform the behaviour and the perceived behavioural control (Bane, Hughe, & 
McElnay, 2006). The intention to perform a behaviour or not is determined by the 
person’s attitude toward the behaviour. The individual’s intention to perform certain 
behaviour is the best predictor and immediate determinant of that behaviour (Figure 3). 
This is based on whether the attitude reflects a positive or negative evaluation of the 
behaviour of interest. This is in addition to the subjective norm which includes the 
person’s perception of the surrounding pressure from society or significant others, and 
by the perceived behavioural control which means perceiving that performing the 
behaviour of interest is within someone’s control (Bane, Hughe, & McElnay, 2006; 
Peters & Templin, 2010).  
Despite this, the application of this model in medication adherence research has 
revealed variance in intention and behaviour. Not all of the components of this theory 
have operated as expected. Different studies have used various measurements to describe 
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how each component of this model was operationalised, using different quantitative 
measures (Bane, Hughe, & McElnay, 2006; Peters & Templin, 2010) or structured 
qualitative interviews (Lewis, Askie, Randleman, & Shelton-Dunston, 2010). It is argued 
that measurement items that were used in questionnaires to assess this model were not 
appropriately worded to assess each component, since they were designed to specifically 
answer the research questions under study (Horne, 1997). Therefore, it is challenging to 
describe the application of this model to medication adherence. 
 
 
 
 
 
 
 
 
 
 
Figure 3: The Theory of Planned Behaviour (Ajzan, 1991, p.182). 
 
According to the results presented from a meta-analysis study examining this 
theory, the theory explains less than 50% of variance in intention and approximately 25% 
of variance in behaviour in intention alone (McEachan, Conner, Taylor, & Lawton, 
2011). These results suggest that the support for this theory is limited. This is in addition 
to another major weakness of using this theory in medication adherence studies, since 
the theory omits the fact that patient’s behaviours are not always under volitional control 
and it results because of the impacts of past behaviour on current behaviour such as the 
role of habit in adhering to medications (Munro et al., 2007).  
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The SLT, developed by Bandura, assists in understanding the driving forces of 
human behaviour (Bandura, 1977). The main concept of the theory is that human 
functioning is directed by continuous interaction between the following three elements: 
behaviour, personal factors and the external environment (Figure 4). The regulation and 
motivation for personal behaviour is based on the individual’s standards and on his or 
her evaluation of the reactions that the actions have been made. The important 
determinations of an individual’s behaviour are personal factors, self-efficacy 
expectations and outcome expectations. Social Learning Theory is the best and most 
useful of the models of interventional studies conducted to improve medications 
adherence (Bartlett, Lukk, Butz, Lampros-Klein, & Rand, 2002; Okuboyejo, Mbarika, & 
Omoregbe, 2014; Simoni, Frick, & Huang, 2006). This is when the intervention 
specifically targeted known obstacles of medication adherence, enhanced self-efficacy 
for patients regarding their medication adherence behaviour and problem-solving 
opportunities and strategies. 
 
 
 
 
Figure 4: The Social Learning Theory (Bandura, 1977). 
 
The previous theories serve interpersonal, environmental and social constructs of 
factors affecting medication non-adherence. However, the key limitations of adherence 
research within social cognition models are that there has been little consistency across 
studies and the proportion of variance in adherence behaviours predicted by social 
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cognition models has generally been small. Additionally, it is argued that health 
behaviour does not arise from static “one off” decisions, as implied by the social 
cognition model, but rather that decisions are made in stages. Moreover, the 
representations of these constructs differ across several illnesses and cultural groups 
(Horne & Weinman 1999).  
Although different theories have attempted to identify factors associated with 
medication adherence, concepts of these theories miss important factors that are not 
involved in their scope, and which play a significant role in medication adherence, 
specifically antihypertensive medication adherence (Horne, 1997). Different studies that 
have been conducted in hypertension research have identified several variables 
associated with the issue of medication non-adherence. To demonstrate which factor is 
perceived as the most important cause of adherence, researchers have categorised these 
factors into dimensions. To investigate factors that account for patients’ medication 
taking behaviour, the seminal research suggests two broad categories of medication non-
adherence: intentional and unintentional (Lehane & McCarthy, 2007b; Lowry et al., 
2005; Wroe, 2002). Accordingly, factors related to non-adherence fall into these 
categories. To understand the operation of the conceptual framework of this research 
project, it is valuable to provide an understanding of these two categories. 
Intentional medication non-adherence  
Intentional non-adherence occurs when the patient actively decides to deviate 
from the prescribed treatment plan (Lehane & McCarthy, 2007a, 2007b). This involves 
a rational decision-making process, when the patient weighs the benefits of the prescribed 
medications against the uncertainty of the benefits of the medications (Horne et al., 
2013). The concept of intentional medication non-adherence is best understood in terms 
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of the belief factors that influence the start and continuation of the prescribed medications 
(Horne et al., 2013; Lehane & McCarthy, 2007b). 
The applied theories in medication adherence studies have failed to uncover 
common major themes contributing to patients’ belief about medication adherence in 
chronic illness, such as views about the general nature of medicines (healing and harm); 
negative views about medications (addiction or overuse, long-term danger, medicine as 
poison); and doctors overuse of medicines (Horne, 1997; Horne & Weinman, 1999). The 
great body of work that has combined these themes has concluded that concepts of belief 
related to chronic-illness medication are general belief concepts (harm and overuse), and 
specific beliefs (necessity and concern) (Horne & Weinman, 1999).  
 Useful themes to identify the general belief concept about medication involve 
the belief in the capacity of medicines to cause harm and in the overuse of medicines by 
doctors. The belief in medications as harmful emphasises that medicines are poisonous 
and addictive, and should not be used long-term. The overuse concept emphasises the 
perception that medicines are overused and overprescribed by physicians (Horne, 1997; 
Horne, Weinman, & Hankins, 1999). Horne, Graupner and colleagues (2004) in later 
work noted that these general perceptions about medicines arise from past experiences 
of the individual patient or others in addition to their beliefs about the nature of 
medications (Horne et al., 2004). Therefore, patients’ beliefs about medicines in general 
should be differentiated from their beliefs about specific medications prescribed for a 
specific illness.  
The specific concepts of belief about prescribed medicines involve the perception 
of the necessity of these medicines and the concern about using these specific medicines 
for one’s illness (Horne, 1997; Horne, Weinman, & Hankins, 1999). These concepts have 
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been emphasised in the empirical literature that focussed on assessing the role of belief 
in medication adherence for a specific illnesses such as asthma (Weinman & Horne, 
2002) and hypertension (Alhalaiqa et al., 2012). Understanding patients’ specific beliefs 
about prescribed medications answers questions about how patients’ beliefs about 
medications affect their adherence (Horne et al., 2013).  
Unintentional medication Non- adherence  
The unintentional dimension of non-adherence is defined as the passive 
behaviour of not adhering to medications and is not associated with individuals’ beliefs 
or cognitive factors (Lowry et al., 2005; Wroe, 2002). Unintentional medication non-
adherence is associated with patients’ characteristics, in contrast to their intentions, 
which are associated with the rational decision-making process (belief) (Lowry et al., 
2005). Different factors have been researched in this area, including elements related to 
personal factors such as sociodemographics and knowledge (Awwad et al., 2015); 
healthcare-system related factors such as comorbidities (Williams, Manias, Cross, & 
Crawford, 2015); or others that influence patients’ adherence behaviour, such as the 
provider’s communication and healthcare support (Iihara et al., 2014). The detailed 
literature review provided in the previous chapter highlighted several factors of the 
unintentional medication non-adherence domain and their association with 
antihypertensive medication adherence. 
Although patients exhibit both intentional and unintentional facets of medication 
adherence, researchers are increasingly investigating a unilateral approach to medication 
adherence (Haynes, McDonald, Garg, & Montague, 2002). Acknowledging both 
dimensions of medication adherence is encouraged by clinicians in order to understand 
the problem of non-adherence (Lehane & McCarthy, 2007a, 2007b). In order to identify 
82 
 
the factors associated with antihypertensive medication adherence among hypertensive 
patients in the study population, the current study was guided by both categorisations of 
medication adherence, intentional and unintentional. The employed intentional 
medication non-adherence concept involves the specific belief aspects i.e. necessity and 
concern. In contrast, the unintentional medication non-adherence concept has employed 
the following elements: individual related factors, provider related factors and 
healthcare-system factors. 
The intentional and unintentional medication non-adherence categorisation 
provided an understanding of classifying factors related to medication non-adherence 
under their categories. The World Health Organization Report of 2003 conceptualised 
factors related to medications adherence in the following domains: patient-related 
factors, socioeconomic, health condition-related factors, therapy-related factors and 
healthcare system related factors (Figure 5) (WHO, 2003, p. 11). The retrieved related 
factors to antihypertensive medications from the literature have highlighted several 
aspects such as patient’s knowledge, beliefs and provider-patients relationship.  
Accordingly, to summarise the previously highlighted factors in the literature 
review of this research project, the conceptual framework of this study conceptualised 
these factors in three main domains, under the guidance of the provided concepts by the 
WHO five dimensions model of adherence (Figure 5). 
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Figure 5: WHO model of medication adherence (WHO, 2003). 
Factors affecting antihypertensive medications adherence, as drawn from the 
empirical literature, were underpinned by the WHO five dimensions model of adherence. 
As mentioned above, this model identified the following domains: patient-related factors, 
socio-economic factors, therapy-related factor, condition-related factors and health 
system factors. The empirical literature review in the current study has identified several 
factors that can be combined under three domains. This study proposes a conceptual 
framework consisting of three domains, namely, individual-related factors, provider-
related factors and healthcare-system related factors (see Figure 6). The individual-
related factors include the socio-demographic characteristics of the patient, the patient’s 
knowledge about hypertension and its medications, the belief of the patient regarding 
concerns about and the necessity of taking antihypertensive medications, and health-
related predictors, that is, years of diagnosis with hypertension, comorbidities, smoking 
and the use of medication reminder aids. Secondly, provider-related factors refer to both 
the communication and the relationship between the healthcare provider and the patient. 
The third factor in this framework addresses healthcare system-related predictors, 
focusses firstly on the quality of the educational resources provided and then on hospital 
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support in the provision of free medications (as opposed to that which must be purchased 
through community pharmacies).  
To conclude, the overview of different theories and models underpinning 
medication adherence studies in conjugation with the literature review formed the 
conceptual framework that guided the application of this research project.  
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Figure 6: Conceptual Framework. 
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Chapter Four: Methods 
 
 A cross-sectional study consisting of three stages was used in this research project. 
The first stage involved designing and translating the research instrument to measure 
antihypertensive medication adherence. The second stage involved conducting a pilot 
study to test the validity and reliability of this translated questionnaire. The last stage was 
the main study, which assessed the status of antihypertensive medication adherence and 
its predictive factors. 
4.1. Research design  
The purpose of this study was to investigate the status of adherence to medication 
among hypertensive patients attending the outpatients departments in a tertiary hospital 
in the city of Jeddah, and to identify the factors associated with their adherence. To 
achieve these objectives, the study adopted a cross-sectional research design, using the 
self-reporting survey method for data collection. The self-reporting method was seen as 
convenient for collecting data from patients whose time at the hospital was limited. This 
study used a subjective measure of antihypertensive medication adherence which was 
commonly used in cross-sectional studies that aimed to identify the status of 
antihypertensive medications adherence (Hashmi et al., 2007; Hsu et al., 2010; Hyre et 
al., 2007; Karakurt & Kaşikçi, 2012). 
87 
 
4.2. Research instrument  
The scales used in this study included the Hill-Bone Compliance scale to measure 
medications adherence (Kim et al., 2000), Patient-Doctor Relationship Questionnaire 
(PDRQ-9) (Van der Feltz-Cornelis et al., 2004), and Belief about Medication 
Questionnaire (BMQ-Specific) (Horne et al., 1999). Permission to use these various 
scales was obtained from the original authors. Other items included patients’ perceived 
knowledge about hypertension and antihypertensive medications adherence (Almas et 
al., 2012; Kim et al., 2007; Viera et al., 2008) and the perceived quality of the particular 
healthcare systems (Almalki et al., 2011a; Beune et al., 2014; Hacihasanoğlu & Gözüm, 
2011). In addition, the research instrument collected patient information relevant to 
socio-demographics and health status related factors. A copy of the full research 
instrument is included in Appendix B. 
Sociodemographic, health and health behaviour- related data  
Data collected in this section included gender (male, female), age (18–30, >30–45, 
>45years and older), marital status (single, married, divorced, widowed), education status 
(no formal schooling, less than primary school, primary school, secondary school, high 
school, college/university, postgraduate degree), employment status (government 
employee, non-government employee, self-employed, non-paid employed, student, 
housewife, retired, unable to work), income (< 5,000, 5,000–10,000, > 10,000 SR). This 
section also included open questions in the pilot study that required patients to provide 
information about the medications used for hypertension, such as names of medications 
used, dosage, and reasons for using antihypertensive medications, as well as any side 
effects experienced. 
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Perceived knowledge of hypertension and antihypertensive medications 
Participants’ perceived knowledge about hypertension and antihypertensive 
medications were measured in two dimensions with seven items. The first dimension 
aimed to measure their perceived knowledge of the following: high blood pressure as a 
chronic health condition, what a normal level of high blood pressure was, symptoms of 
high blood pressure, complications of high blood pressure, and dealing with a high blood 
pressure condition. The second dimension intended to measure patients’ perceived 
knowledge about antihypertensive medication: the benefits and the side effects of 
antihypertensive medication. Three of the seven items were adopted from a cross-
sectional study conducted in Turkey about the effect of the content of knowledge in 
medication adherence for hypertensive patients (Karaeren et al., 2009). These items were 
as follows: “I know the target level of normal blood pressure”, “I know the complications 
of untreated high blood pressure” and “I know the side effects of the antihypertensive 
medications I use”.  
The other four items in the knowledge aspect included patients’ perceived 
knowledge about high blood pressure as a medical condition (Viera et al., 2008), signs 
of high blood pressure (Viera et al., 2008), dealing with a high blood pressure condition 
(Almas et al., 2012) and antihypertensive medications benefits (Kim et al., 2007). 
Participants were asked to provide their answers using five Likert-scale response items. 
The response categories were: strongly disagree = 1, disagree = 2, uncertain = 3, agree 
= 4, and strongly agree = 5. Scores ranged from 7 (minimum) to 35 (maximum). 
Recording high score for this scale reflected a higher perceived knowledge of 
hypertension and antihypertensive medications. 
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Belief about medication questionnaire (BMQ-Specific) 
The Belief about Medication Questionnaire (BMQ-Specific) was used in this study 
to test participants’ beliefs about the use of antihypertensive medication (Horne et al., 
1999). There were two subscales applied in the BMQ-Specific questionnaire with a total 
of eleven items, the necessity and the concern subscales. The necessity subscale included 
five items that assessed patients’ belief about the necessity of taking antihypertensive 
medications. These items were as follows: “Without my medications I would be very 
sick”, “My life would be impossible without my medications”, “My health at the present 
depends on my medicines”, “My health in the future will depend on my medications” 
and “My medicines protect me from becoming worse”. A Likert Scale with five points 
was used to assess each item, 1 = strongly disagree, 2 = disagree, 3 = uncertain, 4 = agree, 
and 5 = strongly agree. The necessity subscale scores ranged from 5 (minimum) to 25 
(maximum). Recording a higher score on this subscale reflected the higher necessity of 
taking medications. 
The concern subscale that includes six items was used to assess patients’ concerns 
about taking antihypertensive medications such as the worry of becoming dependent on 
medicines, long-term effect of medicines and the presence of unpleasant side effects. The 
concern subscale scores ranged from 6 (minimum) to 30 (maximum). Recording a higher 
score on this subscale indicated a higher concern that patients had about taking 
medications.  
The original purpose of developing the BMQ-Specific scale was to assess the 
commonly held beliefs about medication use, and it was validated on a sample of 524 
patients in the United Kingdom (Horne et al., 1999). These patients, who took 
medications for different chronic illnesses such as asthma, diabetes and mental disorders, 
were recruited from hospital clinics, general medical clinics and renal in-patients. The 
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results of the exploratory factor structure and the verified confirmatory factor analysis 
showed an acceptable degree of stability and therefore suggested that the tested factors 
represent the underpinning dimensions of the scale, necessity and concern (Horne et al., 
1999). Although some personal beliefs reflect cultural differences, the cross-cultural 
adaptation of the scale in different contexts showed an acceptable degree of reliability 
and validity (Komninos, Micheli, Roumeliotaki, & Horne, 2012; Salgado et al., 2013; 
Sjölander et al., 2013).  
The translated Greek version of the BMQ-Specific scale was tested on a sample of 
150 patients recruited from primary healthcare settings on the island of Crete, Greece 
(Komninos et al., 2012). The inclusion criteria for this study included patients taking 
long-term medications for one or more chronic illnesses. The internal reliability 
assessment using the Cronbach’s alpha test demonstrated the following results: .85 for 
the specific-necessity subscale and .76 for the specific-concern subscale. The results of 
the study indicated adequate internal reliability for the translated Greek version of the 
BMQ-Specific scale and recommended its use on the Greek-speaking population 
(Komninos et al., 2012).  
Another study that translated the BMQ-Specific scale in a different population 
group reported similar results. The study was conducted in Portugal (Guarda city and 
Covilhã city) on 300 patients visiting public hospitals and outpatient clinics using a 
translated Portuguese version of the BMQ-Specific scale (Salgado et al., 2013). The 
construct validity analysis using the principal component analysis showed 44.4% of the 
total variance explained for two components. The recorded internal reliability measures 
of the BMQ-Specific subscales were .75 Cronbach’s alpha for the specific-necessity 
subscale and .66 for the specific-concern subscale. The study recommended the use of 
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the Portuguese version of the BMQ-Specific scale to assess patients’ beliefs in taking 
medications in the Portuguese-speaking patient population (Salgado et al., 2013).  
Similarly, the Swedish translated BMQ-Specific scale that was tested on 989 
patients recommended the use of the Swedish-translated version of the BMQ-Specific 
scale in the Swedish-speaking patient population (Sjölander et al., 2013). The recorded 
Cronbach’s alphas of the Swedish BMQ-Specific were .82 for the specific-necessity 
subscale and .81 for the specific-concern subscale (Sjölander et al., 2013). 
The results of the internal reliability and the validity of the BMQ-Specific were 
satisfactory in different studies that translated the scale into different languages. 
Therefore this supported the use of this scale in the current study. In addition, regarding 
the need to test the elements of the conceptual framework that focus on the necessity of 
and concern with using antihypertensive medications, the BMQ-Specific was used to 
achieve the third aim of the current study, which focuses on identifying the significant 
factors of antihypertensive medication adherence among hypertensive patients in Saudi 
Arabia.  
Patient – doctor relationship questionnaire-9 (PDRQ-9) 
Patients’ relationship with their physicians was measured by the Patient – Doctor 
Relationship Questionnaire-9 (PDRQ-9), which was developed in primary healthcare 
settings and evaluated by Van der Feltz-Cornelis and colleagues in terms of its validity, 
initial reliability and factor structure (Van der Feltz-Cornelis et al., 2004). The study 
reported from a sample of 165 patients from an epilepsy clinic and from a primary 
healthcare clinic in the Netherlands. The factorial structure of the original questionnaire 
development demonstrated two constructs, relationship with the doctor and the medical 
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symptoms of the patients. The test and retest reliability of the scale were internally 
consistent recording a Cronbach’s alpha of .94 (Van der Feltz-Cornelis et al., 2004). 
In Spain, there was also a study to validate the findings of the original study that 
developed the PDRQ-9 in the Netherlands. The results of the Spanish study confirmed 
that there was a single relationship factor, and that there was internal consistency of the 
PDRQ-9 scale items (Cronbach’s alpha =.95) (Martín-Fernández et al., 2010). The scale 
contained 9 items that assessed patients’ relationships and communication with their 
healthcare providers. Responses to the PDRQ-9 items used a five-point Likert scale, 
where 1 = not at all appropriate, 2 = somewhat appropriate, 3 = appropriate, 4 = mostly 
appropriate, and 5 = totally appropriate. The scale scores ranged from 9 (minimum) to 
45 (maximum). Higher scores in the PDRQ-9 indicated a good doctor-patient 
relationship.  
The cultural adaptation of PDRQ-9 scale for studies conducted in different 
linguistic backgrounds recommended the use of the scale for different populations. The 
translated German version of the PDRQ-9 scale was tested for its appropriateness to 
assess German patients’ perceived therapeutic alliance (Zenger, Schaefert, van der Feltz-
Cornelis, Brähler, & Häuser, 2014). The German translated PDRQ-9 scale was tested in 
a cross-sectional population based study in Germany among 2,275 patients recruited 
from primary and psychotherapy clinics. The factorial structure analysis for the German 
PDRQ-9 items showed that all the scale items were positively correlated. The recorded 
Cronbach’s alpha for the scale items was .95 which indicated an excellent internal 
reliability and possible future usefulness in a population of German speaking patients 
(Zenger et al., 2014).  
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Similarly, the scale was translated in a study conducted in Turkey to assess factors 
influencing adherence to hypoglycaemic medications. The translated Turkish PDRQ-9 
was tested on 360 diabetic patients attending the outpatient department at one of the 
public hospitals in Turkey. The analysis of the translated Turkish PDRQ-9 showed 
Cronbach’s alpha coefficient ranging from .73 to .97 for individual scale items indicating 
an adequate internal consistency. Based on the findings of this study, the Turkish PDRQ-
9 was recommended to be used in future research in Turkey (Serap & Bayram, 2015).  
Therefore, for the above mentioned qualities of the translated PDRQ-9 scales, this 
scale was used in this study. The physician-patient relationship is claimed to be a factor 
that influences antihypertensive medication adherence. Assessing this relationship would 
identify whether this factor is associated with antihypertensive medication adherence for 
hypertensive patients in Saudi Arabia.  
Healthcare-system related factors 
A 6-item scale that aimed to assess the perceived quality of healthcare support was 
adapted from previous research about receiving health education sessions (Al-Khaldi & 
Al-Sharif,  2005; Almalki et al., 2011a; Beune et al., 2014; Gross et al., 2013). 
The perceived quality of healthcare support covered the following themes: 
receiving health education sessions (Beune et al., 2014; Gross et al., 2013), information 
brochures about hypertension (Al-Khaldi & Al-Sharif,  2005) and the availability of 
antihypertensive medications from the governmental hospital pharmacy (Almalki et al., 
2011a). Some items required patients to provide their responses to the following 
statements, “I am supported with patient’s education sessions”, “I am supported with 
education resources/materials about high blood pressure” and “It is easy to refill my high 
blood pressure medications from the hospital pharmacy”. The response categories to the 
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perceived quality of healthcare support scale items were, 1= strongly disagree, 2 = 
disagree, 3 = uncertain, 4 = agree and 5 = strongly agree. The scale scores ranged from 
6 (minimum) to 30 (maximum). Recording high score on this scale indicated a perception 
of higher quality of healthcare support.  
Hill-Bone compliance scale for medication adherence  
The Hill-Bone Compliance scale is a self-report measure designed to assess 
medications adherence behaviour among hypertensive patients (Kim et al., 2000). It 
contains 14 items that focused on three behavioural domains of high blood pressure 
treatment adherence: medication adherence behaviour (9 items), appointment keeping (3 
items) and salt intake (2 items).  
The psychometric testing developed for the Hill-Bone Compliance scale was 
assessed in two separate studies. The first study comprised a sample of 139 African-
American male hypertensive patients in inner-city Baltimore U.S. while the second study 
was conducted with a sample of 341 hypertensive patients, with both male and female 
respondents, drawn from a community based clinical trial for hypertensive patients 
residing in the inner-city of Baltimore (Kim et al., 2000). The psychometric analysis of 
the scale for both studies comprised three steps. Step one included the frequency 
distribution of each item in the scale; step two focused on the reliability of the instrument; 
and step three involved the assessment of the predictive validity of the instrument. The 
results of the psychometric analysis showed that missing responses for the scale items 
were minimal. This indicated the appropriateness of the scale for patients with low 
literacy as the scale items were easily understood by patients from educationally 
disadvantaged backgrounds who also had hypertension. The reliability tests showed a 
Cronbach’s alpha of .74 and .84 for these two studies respectively. The factor analyses 
supported the theoretical concept of the study by predicting three factors for the Hill-
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Bone Compliance scale, which is consistent with a factor loading above 0.40 for most of 
the scale items in both studies. The significant difference of high scores of 
antihypertensive medication adherence associated with controlled blood pressure at the 
baseline and the follow up for both studies’ samples supported the predictive validity of 
the Hill-Bone Compliance scale. The study recommended the use of the Hill-Bone 
Compliance scale to assess high blood pressure treatment for hypertensive patients for 
researchers and clinicians (Kim et al., 2000). 
This scale has been translated and adopted in various studies. In a cross-sectional 
study conducted among 200 hypertensive patients in one of the primary healthcare 
settings in Turkey, a Turkish translated version of the Hill-Bone Compliance scale was 
used to assess antihypertensive medications adherence (Karademir et al., 2009). Results 
assessing the translated scale internal consistency showed a Cronbach’s alpha of .83 for 
medication adherence items, and 0.72 for the whole scale including the salt intake and 
the appointment keeping items. This study concluded that the translated Turkish Hill-
Bone Compliance scale had good construct validity and internal consistency and 
recommended it for future research use among the Turkish-speaking population 
(Karademir et al., 2009).  
The Hill-Bone Compliance scale was also translated to Korean and then modified 
(Song et al., 2011). The translated Korean Hill-Bone Compliance scale included only the 
nine items from the medication adherence domain that measures adherence behaviour. 
The Korean version of the Hill-Bone Compliance scale excluded the appointment 
keeping and salt intake items because they did not meet the objectives of their study that 
focused on assessing medications adherence behaviour. This translated scale was tested 
on 525 hypertensive patients in Korea. The exploratory factor analysis of the scale 
revealed the one factor solution (medication adherence domain) as the best way to 
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characterise the data. This was showed by recording 35.4% of the explained variance of 
the medication adherence items and factors loadings above 0.40 for most of the nine 
items in the scale. The internal reliability of the whole scale items recorded a Cronbach’s 
alpha of .77. The study outcome showed that the Korean version was valid to be used for 
the Korean-speaking population (Song et al., 2011).  
During the instrument development, 9 items were included in the questionnaire 
draft, because they specifically related to antihypertensive medication adherence 
behaviour. As in the study conducted in Korea by Song et al (Song et al., 2011), the three 
items that related to non-pharmacological adherence (salt intake) and the other two items 
that related to appointment keeping were excluded from the questionnaire, because they 
did not meet the objectives of this research project (Song et al., 2011). Some of the items 
included in this scale were: “How often do you forget to take your hypertension 
medicines?”, “How often do you decide not to take your hypertension medicines?” and 
“How often do you miss taking your hypertension pills when you feel sick?” 
Responses were given in a four point Likert scale: all of the time = 4, most of the 
time = 3, some of the time = 2 and none of the time = 1. The final scale adopted the nine 
items which were related to medication adherence behaviour with scores ranged from 9 
(minimum) to 36 (maximum) with a higher score reflecting poor adherence to 
antihypertensive medication. 
Translation process 
Prior to the translation process, four expert healthcare professionals, three from 
King Abdulaziz University Hospital and one from the Queensland University of 
Technology who work with hypertensive patients were consulted regarding the relevancy 
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of the instrument items to the aim of this study and to identify any ambiguity in the 
research instrument items.  
Back translation is the widely agreed upon and widely used method of translating 
research instruments in different cross-cultural studies where the language of the target 
population for the study is different from the original language of the research instrument 
(Mason, 2005; Reichenheim & Moraes, 2007; Wang, Lee, & Fetzer, 2006). The process 
of back translation involved a forward translation from the original instrument language 
to the targeted language, which is the process that compares the meanings and concepts 
between the two languages (Brislin, 1970). The process of translating a research 
instrument is prone to errors in meaning (Wang, Lee, & Fetzer, 2006). Accordingly, 
selecting translators, employing a panel of experts and pre-testing the instruments, via a 
pilot study, were effective strategies to help minimise the chance of error and decrease 
the chance of collecting meaningless data from the main study (Gjersing, Caplehorn, & 
Clausen, 2010). Documenting the method of translating the research instrument is a 
valuable process because data obtained from the translated instrument that has been 
evaluated for equivalence are meaningful (Gjersing et al., 2010).  In this study, the 
translation process for the questionnaire followed the WHO recommendation which 
includes five steps, as described below (Figure 7):  
Step 1: Forward translation 
In the forward translation step, a translator who is bilingual and knowledgeable of 
the intended meaning of the research instrument (Streiner & Norman, 2008) is recruited. 
In this study, this step was done by a bilingual accredited translator who translated the 
English language meanings, items and concepts into Arabic forms. In this step, the 
98 
 
translator, who had no medical experience, focused only on the meanings and concepts 
of the language.  
Step 2: Expert panel 
This step involved a panel of four native Arabic speaking experts who also spoke 
English and who had previously worked on translating health research instruments 
between the two languages (English and Arabic). This team of experts had medical 
experience, which helped to ensure the accuracy of the intended medical meaning of the 
instrument. 
Step 3: Back translation  
A back translator then translated the instrument into the original language; and this 
translator was not familiar with the original instrument. This step was to confirm that the 
Arabic questionnaire was not changed through the modification process and was not 
giving a different meaning from the original English questionnaire. An accredited 
translator who had both medical knowledge and language expertise was used to approve 
the Arabic questionnaire.  
Step 4: Editing 
Finally the research instrument was edited to create final version of the 
questionnaire used in collecting data for this research. 
Step 5: Pre-testing 
The translated research instrument was tested on 110 participants (pilot study) who 
met the eligibility criteria for the study in order to provide suggestions and alternatives 
for the questionnaire and assess the understanding of the instrument contents including 
words, sentences or items that could be unfamiliar.  
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Figure 7: Process Followed for the Translation of the Questionnaire.  
Forward Translation
Bilingual acredited translator with no medical background and with 
experience in translating from English-to-Arabic and vise versa. 
Expert Panel
Two bilingual experts with medical background. Have an experience 
with translating a health research instrument from English-to-Arabic and 
vise versa. 
Back Translation
Translating the Arabic version of  the questionnaire into Arabic to assure 
the accuracy of the translated meanings and concepts.
Editing
Adjusting the instrument and approving the final version of the 
questionnaire. 
Pre-testing
A pilot study that included particpants who meet the eligibility criteria 
but who are not eligible for the main study. This pilot also included 
health care staff so they could provide suggestions and alternatives for 
the instrument.
100 
 
4.3. Pilot study  
 A pilot study was conducted to test the validity and the reliability of the 
developed research instrument.  
Participants 
Participants for this pilot study were recruited from King Abdulaziz University 
Hospital (KAUH) in Jeddah city, Saudi Arabia. In the current study, adult patients (aged 
18 and above), with a diagnosis of hypertension (>6 months), taking antihypertensive 
medications, and speaking Arabic language, were included. With regard to the diagnosis, 
it was important to include patients who had been diagnosed with hypertension for more 
than six months. It has been reported that hypertensive patients in their first six months 
after being diagnosed with hypertension have not adjusted to the antihypertensive 
medication therapy and have not attained an optimal or satisfactory level of blood 
pressure control (Mazzaglia et al., 2009; Valcárcel et al., 2003). Patients with severe 
physical disabilities were excluded because it was difficult to differentiate between those 
who were able to manage their own medication and those who would require assistance. 
In-patients, whose medications were managed by the staff nurses in the hospital, were 
also excluded. 
Sample size and sampling  
The purpose of the pilot study was to test the translated questionnaire and to assess 
the feasibility of the main study. Crocker and Algina (1986) suggested that a study 
sample ranging between 100 to 200 participants was sufficient for initial scale 
development for a study proposed to provide preliminary data (Crocker & Algina, 1986; 
Johanson & Brooks, 2010). For this pilot study, to check the validity of the translated 
instrument and to initially estimate the level of adherence among the research 
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participants, a minimum of 100 participants were chosen and an additional 20% were 
added to allow for incomplete questionnaires. Therefore, the estimated potential size for 
the pilot study was 120 participants. Recruitment of the participants in the pilot study 
ceased when this sample size was achieved.  
Hence a total of 120 participants for the pilot study were recruited via a 
convenience sampling from the outpatient department in KAUH. The convenience 
sampling strategy in this study was chosen for the following reasons: firstly, participants 
in this study were approached during their hospital visit to the outpatient department, 
which means that this was restricted to the working hours of this outpatient department 
(i.e. 08:30 am to 02:00 pm). Secondly, it was not known how many hypertensive patients 
would attend the clinic per day to follow up with their physicians, since some patients 
could miss their appointment by not attending or reschedule their appointment for that 
day. Thirdly, Farrokhi and Mahmoudi-Hamidabad (2012) stated that convenience 
sampling is selected for the purpose of the study when participants meet certain practical 
criteria, such as availability at a certain time, easy accessibility, or the willingness to 
volunteer. Therefore, to ensure achievement of the calculated sample size within the 
timeframe of this study, it was convenient to recruit every hypertensive patient attending 
a hospital appointment and who showed willingness to participate in this study.   
Data collection  
The primary preparation for conducting the study involved contacting the head of 
the outpatient departments in KAUH to ask him to facilitate contact with the relevant 
staff members working in those departments. Prior to the data collection, a meeting was 
held with two medical students (house officers) who both showed their willingness to 
become research assistants (RAs) for the pilot study. During the meeting with the RAs, 
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the aims and objectives of the study, the ethical issues involved, the contents of the 
questionnaire and the risk of bias during the data collection were discussed in detail.  
Since part of the RAs’ role was to assist patients who were unable to complete the 
questionnaire due to impaired vision, hearing, reading or writing abilities, special 
attention was given toward explaining the risk of interview bias and social desirability 
bias. These sorts of biases are liable to occur when the interviewers are involved in 
assisting the participant to complete the questionnaire. Interview bias is described as the 
distortion of the responses to the questionnaire wherein the interviewer influences the 
responses by revealing their own opinions (Phellas, Bloch & Seale, 2011). Therefore, 
one of the meeting outcomes was to assure that RAs could assist the participants to 
complete the questionnaire by reading the questionnaire questions and responses as they 
were written and clarifying any confusing or ambiguous items without revealing any of 
the RAs’ own personal opinion about the ideal response. According to Phellas et al 
(2011), the risk of interview bias can be avoided if the interviewers focus on elaborating 
the contents of the survey without involving their own personal view in exemplifying 
responses (Phellas et al., 2011).  
The other source of bias that could occur in this situation is the social desirability 
bias. This is described as the tendency of participants to report their answers in a manner 
that would be viewed favourably by others, such as by over-reporting good behaviour of 
adherence (Ivar, 2013). It has been reported that this bias is most apparent when the data 
collected through the survey method can easily identify the respondent (Ivar, 2013). 
Therefore, it was stressed to the RAs that they needed to explain to the participants that 
the questionnaires were anonymous and would not be coded with any personal 
information that could identify the participant who completed the survey. This is in 
addition to reassuring participants of the confidentiality of the provided responses, along 
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with the fact that their responses would not be used to judge on individual patient’s 
practice. Rather it would be used to identify areas that require improvement for 
hypertensive patients in Saudi Arabia, as the aim of this research project emphasised. 
Assuring the anonymity and confidentiality of participants’ responses minimises social 
desirability bias, since it gives an opportunity to report honest answers without being 
afraid of judgement (Ivar, 2013). Therefore, during the training the RAs were strongly 
reminded to explain to the patients that the collected data from these questionnaires were 
for a research project that aims to inform future improvements in hypertensive patients’ 
health practice based on the provided outcomes of the project, including this data. At the 
end of this meeting, all questions from the RAs were addressed by the principal 
researcher.   
A convenience sampling of patients who came to the cardiology/medicine and 
renal clinics for follow-up consultations with their physicians was collected. The pilot 
study was conducted between 4th of November 2013 and 24th of January 2014. Paper 
form surveys were given to the research assistants inside the clinics. To assure the 
anonymity of participants in the pilot study, individuals in outpatient clinics who met the 
eligibility criteria were identified by their treating physicians. They were given the option 
of participating in the survey, and those who agreed to participate were asked to provide 
consent and to complete the survey in the waiting room. The research assistants provided 
the questionnaire and verbally explained the purpose of the study. Participants completed 
the questionnaires in the waiting area where RAs were available to provide assistance. 
Completed questionnaires were handed back to the RAs. The time for completing each 
survey was 20-30 minutes. Out of the given 120 surveys, only 118 questionnaires were 
returned, and 8 of these questionnaires were incomplete as participants only completed 
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the demographic information. Therefore, 110 participants completed the pilot 
questionnaire. 
Research instrument 
The developed and translated questionnaire used to collect data in the pilot study 
is shown in Appendix B.  
Data management and analysis  
The data were analysed using SPSS v. 21 (SPSS IBM Statistics). An initial 
preparatory step in the data management involved checking the collected surveys for 
completeness, data coding and entry. During the data entry, careful attention to detail 
such as variables’ type and labelling was considered. The final step included dataset 
cleaning that considered checking any inconsistent responses for all the items. To manage 
any coding error, a frequency distribution analysis was considered from all the variables 
that included categorical and ordinal variables and if any error was found the data was 
checked with the original survey responses.  
The main analysis conducted for the collected data in the pilot study was assessing 
the internal consistency of the research instrument in order to evaluate the reliability. The 
reliability measures were taken to measure the internal consistency of the research 
instrument. This was evaluated using Cronbach’s alpha value for all scales and for sub-
scale items. Cronbach’s alpha was used as an index of the degree to which a measuring 
instrument was internally reliable. The reliability coefficients for Cronbach’s alpha are: 
excellent for .90, very good for values between .80 and .89, and adequate for values 
between .70 and .79 (Kline, 2005).  
Following the internal consistency assessment, a descriptive analysis was 
conducted for all variables. The categorical variables were presented in percentages and 
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counts and for the continuous variables the mean and standard deviation were reported, 
along with graphical representation of a boxplot for the Hill-Bone Compliance scale 
responses. The Cronbach’s alpha for the pilot study, along with descriptive statistics of 
the questionnaire items, are reported in the Results chapter. 
Ethical consideration   
Ethical approval for conducting the pilot study was obtained from the Queensland 
University of Technology Ethical Committee (QUT), Brisbane, Australia (Approval 
number UHREC1200000522) and KAUH Unit of Biomedical Ethics, Jeddah, Saudi 
Arabia (Reference No 936-12) (See Appendix A). 
4.4. Main study 
Participants 
Participants in this study were from King Fahad General Hospital (KFHJ) in Jeddah 
city, Saudi Arabia. Other governmental tertiary hospitals in Jeddah city were excluded 
because they served specific populations. For instance, King Abdulaziz Medical City 
treats national guard employees in the country, King Fahad Armed Force Hospital is for 
military employers, the Jeddah Eye Hospital treats patients with ophthalmologic 
conditions, Abdulaziz Hospital (Mahjer) treats endemic conditions, King Faisal 
Specialist Hospital is a research centre, and the Maternity and Children’s Hospital is 
primarily for expectant mothers in labour, gynaecology and paediatric treatment. 
 Similar to the pilot study, the inclusion criteria involved adult hypertensive 
patients who aged 18 years and above, speak Arabic language, diagnosed with 
hypertension for more than 6 months and take antihypertensive medications. In addition, 
it excluded in-patient and patients with severe physical disabilities.  
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Sample size and sampling 
To determine the required sample size for the main study, the sample size 
calculation assumed a confidence level of 95% and margin of error of 5%. The sample 
size was calculated according to the following formula (Lwanga & Lemeshow, 1991): 
N = 
t² x P(1−P) 
𝑚²
 
Where N is the required sample size, t is the confidence level at 95% (standard value of 
1.96), p is the estimated cut-off point of antihypertensive medications adherence for 
achieving optimum blood pressure control which is 80% (Herttua et al., 2013; Jagadeesh 
et al., 2015; Khan et al., 2010), and m is the margin of error at 5% (standard value of 
0.05).  
N = 
 1.962x .80(1−.80)
.052
 
3.8416𝑥 .16 
. 0025
 
0.6146 
. 0025
 
= 245.8 ≈246 
246 x 40% = 98.4 
N = 246 + 98 = 344 
 
The required sample for the main study was estimated to be N = 246. Taking into 
consideration contingencies such as non-response rate and recording error, the sample 
was further increased by 40% (N = 344). A total of 347 participants were recruited. 
A cut-off point of 80% for antihypertensive medication adherence was chosen to 
calculate the sample size for the main study. This number is used widely in the literature 
as the cut-off value of medication adherence for different types of medications and health 
conditions. The required percentage of medication adherence should ultimately be based 
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on what level of adherence is required to achieve an effective level of control on the 
health condition and the presence of complications. In the case of antihypertensive 
medications, the optimum control of high blood pressure for patients with hypertension 
can be achieved by taking the prescribed medications 80% of the time. This is also similar 
to the case of developing complications related to the insufficient treatment. When a cut-
off value of 80% of antihypertensive medications adherence was considered in 
conducting empirical studies, it was shown that the risk of developing cardiovascular 
complications increases sharply in patients who had antihypertensive medications 
adherence below 80% (Herttua et al., 2013; Jagadeesh et al., 2015; Khan et al., 2010). 
The decision for choosing 40% as the threshold for non-response and recording 
error rate was made for the following reasons; firstly, previous cross-sectional studies 
that were conducted in the outpatient clinics in tertiary hospitals in Saudi Arabia reported 
a response rate of between 49.2% (Mayet, 2015) and 87.47% (Khan, Al-Abdul Lateef, & 
Khan, 2012). Therefore, it was important to cover for the unreturned or uncompleted 
surveys with a response rate of 40%. Secondly, the possibility of high rate of 
uncompleted surveys related to health or personal issues. The pilot study showed that out 
of the 110 participants in the study, 50.9% were older than 45 years and 82.7% had no 
level of formal education. Patients older than 45 years old may experience other health 
conditions, such as vision problems (e.g. glaucoma), that are related to other 
comorbidities such as diabetes. In Saudi Arabia, older patients with chronic illness, 
specifically diabetes, tend to experience vision problems from their early forties; this is 
evidenced by the predicted increase in the prevalence of glaucoma from 2.65% to 2.86% 
in the next decade for the population aged 40 years old and more (Al Obeidan, Dewedar, 
& Mousa, 2011). 
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In addition to this health related issue, the lack of formal education for some 
patients and associated limited literacy was considered as a possible difficulty that could 
lead to uncompleted surveys or low response rate. Although research assistants were 
available to assist the participants with understanding and completing the surveys, the 
required time for assistance was limited and varied from one individual patient to another. 
Therefore, the research assistants would not be available all the time for all patients. 
Finally, the possibility of high rate of unreturned surveys related to the outpatient 
department workload. Outpatient departments in tertiary hospitals have a busy 
atmosphere. In all hospitals in Saudi Arabia, waiting areas are segregated by genders and 
are the common area for all patients who are attending different clinics. Therefore the 
difficulty of tracking all patients who had agreed to participate in the two separate, 
crowded waiting areas was anticipated.  
With regard to the sampling strategy, similarly to the pilot study, the convenience 
sampling strategy was applied. Because the main study was also conducted in the 
outpatient departments, the convenience sampling strategy was chosen for the following 
reasons: easy access to patients at a certain time in the clinics and achieving the sample 
size within the timeframe of this current study. 
Data collection  
The primary preparation for conducting the study involved contacting the medical 
director of the outpatient departments in KFHJ to facilitate access to the relevant staff 
members working in the clinics. Nurses in the vital signs rooms (four nursing staff, 
including two males and two females) showed their willingness to become research 
assistants (RAs) for the main study and therefore attended the training meeting with the 
principal researcher. At the meeting, the study's aim and objectives, participants’ 
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eligibility criteria, issues related to bias during the data collection and the relevant ethical 
issues were discussed in detail. The issues explained to the RAs involved addressing the 
needs of elderly participants, who had vision problems, were unable to read or write, or 
who required assistance with understanding the survey's items when completing the 
questionnaire. As in the pilot study, the risk of interview bias and social desirability bias 
were explained thoroughly and emphasised. At the end of the meeting, the RAs’ 
questions were addressed by the principal researcher.  
The main study was conducted from 25th of August 2013 to 30th of January 2014. 
The working hours for the outpatient departments in general governmental hospitals in 
Saudi Arabia, including clinics, have daytime hours from 08:30 am till 02:00 pm from 
Sunday to Thursday; therefore, participants were approached during these times. 
Participants were sampled from medical cardiology clinics and renal clinics.  
In KFHJ, after the patients confirmed their appointment at the outpatient 
department reception, they were required to go to the nursing room for vital signs 
assessment (pulse, blood pressure, body temperature, respiration rate) and then to remain 
in the waiting room until the clinic nurses called them to see the physician. For cultural 
reasons, nursing rooms are segregated by gender in most hospital settings in Saudi 
Arabia. Vital signs assessment time is around 7:30 am, and usually before physicians 
attend the clinics at 8:30 am. Patients usually attend early to avoid the busy periods and 
to see their physicians promptly.  
To recruit participants for the study, individuals coming into the nursing room were 
identified by the colour of the waiting card number they held. Patients who visit medical 
clinics for cardiology and renal treatment receive pink waiting card numbers, while 
patients visiting surgical clinics receive yellow card numbers. To confirm their eligibility 
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for this study, patients with pink waiting cards were asked whether they had been 
diagnosed with hypertension, for how long they had had the condition, and whether or 
not they took antihypertensive medications.  
To avoid the problem of gender under-representation, the questionnaire was 
distributed in equal numbers in the male nursing room and the female nursing room on 
every day of the data collection timeframe. Therefore, it was best to approach patients 
after they had their vital signs taken and before they were called to see their physicians. 
The principal researcher and the RAs identified eligible participants, explained the 
study’s aims and objectives, obtained the consent form and administered the 
questionnaire to the participants, who completed the survey while waiting. After the 
surveys were completed, these were handed back to the principal researcher and the 
research assistants. 
Research instrument 
The research instrument for the main study was a modified version of the 
questionnaire used in the pilot study. These modifications included removing the 
question regarding the medications including name, dose, reasons for use and side effects 
in addition to two items of the Hill-Bone Compliance scale (item 3 and 4). This is due to 
the reported low response rate to these questions in the pilot study and lack of the 
relevance to the aim of the study (see Appendix B).  
Data management and analysis 
The collected surveys from KFHJ were checked for completeness and prepared for 
entry into the statistical analysis SPSS program. Surveys were numbered for future 
reference before data entry. The data were entered with careful attention to different types 
of variables and correct labelling of the variables. Value labels were used to identify the 
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socio-demographic variables, health-related data and the scale responses items. Table 2 
shows the data coding for the modified research instrument. 
The last step of dataset cleaning was undertaken by checking the inconsistent 
responses for all the items. To eliminate any coding error, all the variables (categorical 
and ordinal variables) were inspected for errors by running frequency distribution before 
considering the actual analysis. For any error that was found, checking with the original 
data in the surveys was made to correct the errors.  
The data analysis process went through two main stages: first, validating the 
developed research instrument, and second, analysing the data to answer the research 
questions which included analysis of the data in the univariate, bivariate and multivariate 
forms.  
Before conducting the analysis for the collected data in the main study, it was 
essential to conduct tests for the validity and reliability of the used research instrument 
in the main study (see Chapter 5). Therefore, to test the underlying construction of the 
translated questionnaire, a principal component analysis (PCA) was conducted to test the 
correlation between the variables. The main focus of the PCA is establishing what linear 
components exist within the data and how a particular variable contributes to that 
component (Field, 2009). The Kaiser-Meyer-Olkin measure was applied in order to 
check the sampling adequacy tests. Bartlett's test of sphericity was selected so as to 
indicate whether the factor model was appropriate. To graph the eigenvalues, the scree 
plot showed the number of factors which needed to be retained.  Field (2009) stated that 
with a sample of more than 200 participants, the scree plot provides an adequately 
reliable criterion for factor selection (Field, 2009). Kaiser’s criterion, which was followed 
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for factors extraction, retained all factors with eigenvalues equal to or more than 0.60. 
Finally, the criteria of Cronbach’s alpha test was used to test internal reliability.  
A descriptive analysis was conducted for all variables. The categorical variables 
were summarised using percentages and counts. For continuous variables in this study, 
the mean and standard deviation were reported for normally distributed findings and the 
median, maximum and minimum values been reported for skewed findings. The 
maximum and minimum values were reported for the sum of scales responses in addition 
to a graphical representation of boxplot for Hill-Bone Compliance scale responses. To 
define the status of adherence, the Hill-Bone Compliance scale responses were 
dichotomised into optimal adherence and suboptimal adherence by grouping and coding 
the responses for “some of the time”, “most of the time”, and “all of the time” as 
suboptimal adherence, and “none of the time” responses as optimal adherence.  
A bivariate analysis was conducted using the Pearson’s Chi-square test to assess 
the association between the outcome measure (proportions of adherence) and 
independent variables. The bivariate analysis showed the relationship of the status of 
adherence and all the independent variables in this study, including the socio-
demographic variables, diagnosis and treatment related factors, perceived knowledge 
about hypertension and antihypertensive medication adherence, beliefs about 
medication, the physician-patient relationship and perceived quality of healthcare 
support. Consequently, the median values for these scales were used to create binary 
variables to identify the lower and upper value for every scale. For example, low 
knowledge in the knowledge scale refers to reporting low level of knowledge of 
hypertension condition and antihypertensive medications. 
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Binary logistic regression analysis using the backward stepwise likelihood-ratio 
method was used to assess the predictors of antihypertensive medication adherence, 
controlling for the socio-demographic factors (gender, age, marital status, education 
status, employment status, smoking status, income, and time since diagnosis of 
hypertension), which were fixed into the model. The final model for the binary logistic 
regression includes all the socio-demographic factors and the significant predictors of 
adherence. The alpha level of significance for all inferential statistics was set at 0.05. 
Overall model fit was estimated using the R2 statistic value.  
Ethical consideration 
The ethical approval for the main study was obtained from KFHJ (Jeddah Research 
Canter, ethics number 00163) and Queensland University of Technology Ethical 
Committee (QUT), Brisbane, Australia (Approval number variation- 
UHREC1200000522) (See Appendix A). 
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Table 2: Data coding for the main study. 
 
Variables Items Type SPSS Coding 
Socio-
demographics 
 Categorical  
Gender 2   Male (1), female (2) 
Age 3  <30(1), 30-45(2), ≥45(3) 
Marital Status 4  Single(1), married(2),divorced(3),widowed(4) 
Education Status 7  No formal schooling(1), less than primary 
school (2), primary school completed (3), 
secondary school (4), high school (5), 
college/university (6), postgraduate (7) 
Employment 
Status 
8  Government employee(1), non-government 
employee(2), self-employed(3),non-paid 
worker(volunteer) (4), student(5), housewife(6), 
retired(7),unemployed(8) 
Patient Income 3  <5000 Saudi Riyals(1), 5000-10000(2), ≥10000 
Healthcare-
System Related 
Factors 
 Categorical  
Smoking 2  Smoker(1), non-smoker(2) 
Time since 
diagnosis 
3  <1 year(1),1-3years(2), ≥3 years(3) 
Comorbidities 2  Yes(1), No(2) 
The use of other 
medications 
2  Yes(1), No(2) 
The use of 
medication aids 
5  Yes(1), No(2) 
Perceived 
Knowledge 
7 5-Likert 
Scale 
Strongly disagree(1), disagree (2), uncertain(3), 
agree(4), strongly agree(5) 
Knowledge about 
hypertension 
   
Knowledge about 
medications 
   
Belief About 
Medication 
11 5-Likert 
Scale 
Strongly disagree(1), disagree (2), uncertain(3), 
agree(4), strongly agree(5) 
Concern 6   
Necessity  5   
Patient-Doctor 
Relationship 
9 5-Likert 
Scale 
Not at all appropriate(1), somewhat 
appropriate(2), appropriate(3), mostly 
appropriate(4), totally appropriate(5) 
 
Relationship 
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The Provision of 
Healthcare 
Support 
6 5-Likert 
Scale 
Strongly disagree(1), disagree (2), uncertain(3), 
agree(4), strongly agree(5) 
Hospital support 
(medication) 
   
Outcome [Optimal Adherence-
Suboptimal Adherence] 
 
Medication 
adherence [Hill-
Bone 
Compliance 
scale] 
9 4-Likert 
Scale 
None of the time(1), some of the time(2), most 
of the time(3), all of the time(4) 
Optimal 
Adherence  
   
Suboptimal 
Adherence  
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Chapter Five: Results 
 
This chapter presents the findings of antihypertensive medications adherence status 
among hypertensive patients attending outpatient departments in one of the main tertiary 
hospitals in Jeddah city, Saudi Arabia. It also described the predictors of medication 
adherence under these domains: individual-related factors, provider-related factors, and 
healthcare-system related factors. The findings of the pilot study and the main study are 
involved in this chapter.  
5.1. Pilot study  
The pilot study took place in King Abdulaziz University Hospital (KAUH). The 
participants were recruited from the outpatient department using a convenience sampling 
method. A total of 120 questionnaires were distributed, 113 were returned with a 
response rate of 94%. Only 110 questionnaires were completed and form the basis for 
the present analysis.  
A univariate analysis approach was used to calculate the frequencies and 
percentages for the socio-demographic data collected in the pilot study. Table 3 shows 
the description of the pilot study sample demographics. Overall, the majority of 
participants in the pilot study were male (76.4%), older than 45 years of age (76.4%), 
married (69.1%), and with formal education (82.7%). Half of the participants had a 
medium-level income between 5,000 and 10,000 SR, and 51.8% were unemployed. 
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Table 3: Sample sociodemographic characteristics of the pilot study (n=110). 
Characteristics n (%) 
Gender 
Male 
Female 
 
84 (76.4)  
26 (23.6) 
Age (years) 
31 – 45 
> 45 
 
26 (23.6) 
84 (76.4) 
Marital Status 
Single 
Married 
Divorced 
Widowed 
 
 
11 (10) 
76 (69.1) 
8 (7.3) 
15 (13.6) 
Education status 
Non-formal education: 
*No formal schooling1 
Less than primary school 
Formal education: 
Primary school  
Secondary School 
High School 
College/University undergraduate 
Postgraduate degree 
 
 
19 (17.3) 
10 (9.1) 
9 (8.2) 
91 (82.7) 
9 (8.2) 
24 (21.8) 
31 (28.2) 
26 (23.6) 
1 (0.9) 
 
Employment status 
Employed: 
Government Employee 
Non-government employee 
Self-employed 
Unemployed: 
Non-paid work (Volunteer) 
Student  
Housewife 
Retired  
Unable to work 
 
 
 
53 (48.2) 
16 (14.5) 
19 (17.3) 
18 (16.4) 
57 (51.8) 
1 (0.9) 
4 (3.6) 
16 (14.5) 
21 (19.1) 
15 (13.6) 
Income (per month) 
< 5,000 SR2 
5,000 – 10,000 SR 
> 10,000 SR 
 
49 (44.5) 
55 (50) 
6 (5.5) 
          
             1 Non-formal schooling= Learnt reading and writing in Mosques/Kuttab. 2 SR = Saudi Riyal 
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5.1.1. Scales reliability  
To measure the scales’ reliability, Cronbach’s alpha was used. The test was 
conducted for all individual items of the scales measuring dependent and independent 
variables. The reference categories for Cronbach’s alpha reliability coefficients for the 
scales are: excellent for .90; very good for values between .80 and .89; and adequate for 
values between .70 and .79 (Kline, 2005). Cronbach’s alpha value of .60 to .69 is 
considered as acceptable reliability for instruments developed for research purposes 
(Field, 2009).  Table 4 shows the Cronbach alpha scores for the scales used in the pilot 
study. Values ranged from acceptable (BMQ-Specific scale =.60) to excellent (PDRQ-
9=0.91).  
Table 4: General alpha reliability statistics for the scales included in the pilot study 
questionnaire. 
 
Sub-Scales 
Number of 
items  
Cronbach’s 
Alpha 
Perceived knowledge of hypertension 
and antihypertensive medications 
Seven items .88 
Hill-Bone Compliance scale of 
medication adherence  
Nine items .76 
BMQ-Specific (Concern- Necessity) Eleven items .60 
PDRQ-9 Nine items .91 
Perceived quality of healthcare support Six items .70 
 
5.1.2. Instrument modification 
During the data entry process, the completed questionnaires from the pilot study 
revealed two issues, a very low response rate to a few specific questions, and issues 
related to internal consistency. The collected data in the pilot study showed a very low 
response rate for the questions about medication names (0%); doses (3.6%, 4 
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participants); reasons for use (0%); and side effects (0%). As a consequence, these 
questions were removed from the questionnaire in the main study. During the internal 
reliability assessment, the internal consistency for the Hill-Bone Compliance scale 
showed as acceptable level of Cronbach’s alpha if the appointment keeping items (item 
3 and 4) were removed (Appendix D). Therefore, items 3 and 4 were not included in the 
final questionnaire and the Hill-Bone Compliance scale of medication adherence 
consisted of 9 items. The excluded items were, item 3, “How often do you make the next 
appointment before you leave the doctor’s office?” (Cronbach’s alpha if this item deleted 
=.75) and item 4, “How often do you miss scheduled appointments?” (Cronbach’s alpha 
if item deleted = .62).  It is significant to note that Song et al’s (2011) study adopted the 
9 items of Hill-Bone Compliance scale that were only considering to be measuring 
medication adherence behaviour and reported acceptable levels of validity (factor 
loading above .40) and internal reliability (Cronbach’s alpha .77) after translating the 
questionnaire (Song et al., 2011).  
5.1.3. Descriptive analysis  
Descriptive statistics for the Hill-Bone Compliance scale: 
The descriptive analysis of the Hill-Bone Compliance scale for the pilot study 
provided an overview about antihypertensive medications adherence status among 
hypertensive patients. Frequencies and percentages for each item in the Hill-Bone 
Compliance scale are shown in Table 5. The distribution of Hill-Bone Compliance scale 
responses for 110 participants in the pilot study shows that most of the participants 
recorded lower scores in Hill-Bone Compliance scale, with scores ranges from 9 
(minimum) and 22 (maximum). The Hill-Bone Compliance scale scores distribution was 
positively skewed (median = 13.00, SD= 3.38) (Figure 8).   
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Table 5: Descriptive statistic of Hill-Bone Compliance scale 9-items (n=110). 
 Responses categories n (%)   
Scale item None of 
the time  
(1) 
Some of 
the time  
(2) 
Most of 
the time  
(3) 
All of 
the 
time  
(4) 
 
Mean 
 
SD 
1- How often do you forget to take 
your High Blood Pressure (HBP) 
medicine? 
59 (53.6) 45 (40.9) 6 (5.5) 0 (0) 1.51 0.60 
2- How often do you decide not to 
take your HBP medicine? 
67 (60.9) 39 (35.5) 4 (3.6)  0 (0) 1.42 0.56 
3- How often do you forget to get 
your prescription filled?  
 58 (52.7) 35 (31.8)  16(14.5) 1 (9) 1.63 0.76 
4- How often do you run out of 
HBP pills?  
41 (37.3) 48 (43.6 )  17(15.5) 4 (3.6) 1.85 0.81 
5- How often do you skip your 
HBP medicine before you go to the 
doctor?  
 64(58.2) 39 (35.5) 6 (5.5)  1(0.9) 1.49 0.64 
6- How often do you miss taking 
your HBP pills when you feel 
better?  
62 (56.4) 38 (34.5) 9 (8.2) 1 (0.9) 1.53 0.68 
7- How often do you miss taking 
your HBP pills when you feel sick? 
67 (60.9) 35 (31.8) 8 (7.3) 0 (0) 1.46 0.63 
8- How often do you take someone 
else’s HBP pills?  
88 (80) 20 (18.2)  2(1.8) 0 (0) 1.21 0.45 
9- How often do you miss taking 
your HBP pills when you are 
careless?  
78 (70.9) 27 (24.5) 5 (4.5) 0 (0) 1.33 0.56 
Adherence scale     13.48 3.38 
 
Figure 8: Distribution of Hill-Bone Compliance scale responses for the pilot study. 
 
The results of the Hill-Bone Compliance scale dichotomised score reported as the 
following, optimal adherence = 9, and suboptimal adherence > 9. The reported results of 
antihypertensive medications adherence status for participants in the pilot study showed 
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that 17 (15.4%) of the sample had optimal adherence and that 93 (84.6%) had suboptimal 
adherence. 
Descriptive statistics for the health and health behaviour related factors: 
Table 6 below shows the descriptive analysis for the health and health behaviour 
related items for 110 participants in the pilot study. The overview of the pilot study 
sample showed that the majority of participants were diagnosed with hypertension for 
more than three years (78.2%), were none smokers (74.5%) and had no comorbidities 
(86.4%). It also showed that the majority of the participants did not take any other 
medications besides other than antihypertensive medications (86.4%) and that most of 
them used medication reminder aids (73.6%).  
Table 6: Health and health behaviour related data (n=110). 
Health-Related Characteristics  n (%) 
Time since diagnosis of hypertension 
> 6 months to < 1 year 
1 to 3 years 
> 3 years 
 
12 (10.9) 
12 (10.9) 
86 (78.2) 
Smoking status 
Smoker 
Non-smoker 
 
28 (25.5) 
82 (74.5) 
Comorbidities 
Yes 
No 
 
15 (13.6) 
95 (86.4) 
Taking other medications 
Yes 
No 
 
15 (13.6) 
95 (86.4) 
Medication Reminder Aids 
Use aids 
Do not use aids 
 
81 (73.6) 
29 (26.4) 
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Descriptive statistics for the perceived knowledge of hypertension and antihypertensive 
medications scale: 
The descriptive statistics for the perceived knowledge of hypertension and 
antihypertensive medications for the pilot study has identified the mean of this scale for 
the sample as 24.09 (SD= 7.10) (with possible scores ranging from 7 to 35) (see Table 
7). The highest mean reported for the sixth item in this scale (Mean=3.68, SD=1.36) and 
the lower mean was reported for the seventh item (Mean =2.76, SD=1.43). 
Table 7: Descriptive statistic of the perceived knowledge scale items (n=110). 
 
Perceived Knowledge of hypertension and antihypertensive medications 
Items 
 
Mean 
 
SD 
 
1- Knowledge about high blood pressure 
 
3.30 
 
1.33 
2- Knowledge about normal levels of blood pressure 3.55 1.28 
3- Knowledge about signs of high blood pressure 3.63 1.15 
4- Knowledge of high blood pressure complications 3.57 1.38 
5- Knowledge of how to deal with high blood pressure 3.57 1.17 
6- Knowledge of high blood pressure treatment benefits 3.68 1.36 
7- Knowledge of blood pressure treatment side effects 2.76 1.43 
Perceived knowledge Scales 24.09 7.10 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
 
Descriptive statistics for the belief about medication questionnaire: 
The mean of belief about medications score (with possible scores ranging from 11 
to 55) for the sample was 40.38 (SD=5.17), as indicated in Table 8. The higher mean was 
reported for item 11 in this scale (Mean= 4.28, SD= 0.84) and the lower mean reported 
for the second item (Mean=2.95, SD= 1.20).  
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Table 8: Descriptive statistic of the belief about medication scale items (n=110). 
 
Belief about medication questionnaire items 
 
Mean 
 
SD 
 
1- Without treatment I am sick 
 
3.80 
 
1.10 
2- My life would be impossible without my medications 2.95 1.20 
3- My health relies on medication usage 3.24 1.21 
4- My future health relays on my medication 3.64 1.14 
5- My medications prevent my health from becoming worse 4.24 0.79 
6- I worry from taking long life treatments 3.65 0.86 
7- My medications disrupt my life 3.55 1.31 
8- My medications are a mystery to me 3.47 0.87 
9- Having to take medications worries me 3.30 1.31 
10- I worry to become reliant on treatments 4.22 0.83 
11- These medicine give me unpleasant side effects 4.28 0.84 
Belief about Medications Scales 40.38 5.17 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
 
Descriptive statistics for the patient-doctor relationship questionnaire: 
The mean of the patient-doctor relationship scale for the pilot study was 35.65 
(SD= 7.81) and had possible scores ranging from 9 to 45. As shown in Table 9. The third 
item in this scale reported a higher mean (Mean=4.50, SD=0.83) compared to the ninth 
item that reported a lower mean (Mean=2.82, SD=1.53).  
Table 9: Descriptive statistic of the patient-doctor relationship scale items (n=110). 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Not at all appropriate, (2) somewhat 
appropriate, (3) Appropriate, (4) Mostly appropriate, and (5) Totally appropriate. 
 
 
Patient-doctor relationship questionnaire items  
 
Mean 
 
SD 
 
1-My physician helps me 
 
4.04 
 
1.12 
2- My physician have time for me 3.70 1.28 
3- I trust my physician 4.50 0.83 
4- My physician understands me 4.27 0.94 
5- My physician devotes time for me 3.90 1.26 
6- I agree with my physician about my symptoms 4.00 1.12 
7- I can talk to my physician easily 4.19 1.05 
8- I am content with my physician 4.20 1.04 
9- I can reach my physician easily 2.82 1.53 
Patient-Doctor Relationship Scale 35.65 7.81 
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Descriptive statistics for the perceived quality of healthcare support: 
The mean of the perceived quality of healthcare support had possible scores scale 
ranging from 6 to 30. As shown in Table 10, the scale for the sample was 19.26 (SD= 
4.76).  The second item in this scale reported a higher mean (Mean=3.84, SD=1.08) and 
the third item reported the lower mean (Mean=2.27, SD=1.38).  
Table 10: Descriptive statistic of the perceived quality of healthcare support items (n=110). 
 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
 
5.2. Main study  
5.2.1. Sample overview  
The main study aimed to identify the status of antihypertensive medications 
adherence and the associated factors to this adherence among hypertensive patients in 
Saudi Arabia. The study took place in King Fahad General Hospital (KFHJ). Of the 347 
questionnaires that were distributed, 316 were returned, with a response rate of 91%.  
Eight of the returned questionnaires were incomplete and therefore this analysis is based 
on 308 completed questionnaires. The description of the sample socio-demographic 
characteristics is presented in Table 11. The overview of the main study sample showed 
that the majority of participants in this study were male (56.8%), older than 45 years of 
 
Perceived quality of healthcare support scale items 
 
Mean 
 
SD 
 
1- Overall Support  
 
3.83 
 
1.12 
2- Hospital support  3.84 1.08 
3- Patient education  2.27 1.38 
4- Brochures and booklets  2.47 1.53 
5- Easy refill for medications  3.78 1.29 
6- The need to buy the medications 3.05 1.40 
Perceived Quality of Healthcare Support Scale 19.26 4.76 
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age (77.6%), married (78.2%), and with no formal education (84.7%). Nearly half of the 
participants (47.4%) had low income indicated by less than 5000 SR, and 57.5% were 
unemployed. 
 
Table 11: Sample sociodemographic characteristics for the main study (n= 308). 
Descriptive Characteristics n (%) 
Gender 
Male 
Female 
 
175 (56.8)  
133 (43.2) 
Age (years) 
18 – 30 
>30 – 45 
> 45 
 
11 (3.6) 
58 (18.8) 
239 (77.6) 
Marital Status 
Single 
Married 
Divorced 
Widowed 
 
16 (5.2) 
241 (78.2) 
27 (8.8) 
24 (7.8) 
Education status 
Non-formal education:  
No formal schooling1 
Less than primary school 
Formal education: 
Primary school  
Secondary School 
High School 
College/University 
Postgraduate degree 
 
261 (84.7) 
141 (45.8) 
120 (39.0) 
47 (15.3) 
6 (1.9) 
12 (3.9) 
16 (5.2) 
11 (3.6) 
2 (0.6) 
Employment status 
Employed: 
Government Employee 
Non-government employee 
Self-employed 
Unemployed: 
Non-paid employed (Volunteer) 
Student  
Housewife 
Retired  
Unable to work 
 
131(42.5) 
68 (22.1) 
14 (4.5) 
49 (15.9) 
177 (57.5) 
79 (25.6) 
26 (8.4) 
6 (1.9) 
61 (19.8) 
5 (1.6) 
Income (per month) 
< 5,000 SR2 
5,000 – 10,000 SR 
> 10,000 SR 
 
145 (47.4) 
95 (31.0) 
66 (21.6) 
1 Non-formal schooling= Learnt reading and writing in Mosques/Kuttab. 2 SR = Saudi Riyal  
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5.2.2. Measures of reliability and validity  
For the purpose of validating the questionnaire used in the study, the construct 
validity involved two levels of measurement: Exploratory Factor Analysis (EFA) and 
Cronbach’s alpha measurement of internal consistency. Pett, Lackey & Sullivan (2003) 
suggested that the use of the Principal Component Analysis (PCA) is recommended in 
EFA to determine the underling construct of the instrument contents (Pett et al., 2003). 
Thus, first step of EFA included conducting PCA to determine the number of factors that 
need to be extracted then evaluating the internal consistency for the instrument.  
Principal Component Analysis 
A principal component analysis was conducted on 42 items with Varimax rotation. 
The Kaiser-Meyer-Olkin measure verified the sampling adequacy for the analysis, KMO 
=0.812 (Table 12). The initial analysis was run to obtain the eigenvalues for each factor 
in the data. Ten factors had eigenvalues over Kaiser’s criterion of 1 and, in combination, 
explained 69.20% of the variance. However, the scree plot showed an inflexion that 
would justify extracting six factors (Figure 9). The decision was confirmed after 
calculating the parallel analysis for the principal component analysis. The total variance 
explained showed that the six factors had larger values than the one calculated in the 
parallel analysis. The component matrix table confirmed the extraction of six factors by 
showing a good level of loading that reported 0.40 for most of the items. 
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Table 12: Kaiser-Meyer-Olkin measure of sampling adequacy. 
KMO and Bartlett's Test 
Kaiser-Meyer-Olkin Measure of Sampling 
Adequacy. 
.812 
Bartlett's Test of 
Sphericity 
Approx. Chi-Square 7661.308 
df 820 
Sig. .000 
 
Figure 9: Factors loading 
 
The six extracted factors explained 57.71% of the total variance (Appendix D). The 
rotated component matrix showed the clustered items under the same factor, suggesting 
that: factor 1 represents the physician-patient relationship; factor 2 relates to the 
perceived knowledge about hypertension and antihypertensive medications; factor 3 
represents medication adherence; factor 4 relates to their belief about medication 
(necessity); factor 5 involves their belief about medication (concern); and factor 6 relates 
the perceived quality of their healthcare support. Therefore, the total results indicated 
that the items in the instruments were justified by representing 6 factor solutions that 
support the underling theory of the questionnaire contents.  
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 Internal Consistency  
The suggested following step after conducting PCA is to assess the internal 
consistency of the instrument. The assessment of the instrument’s reliability using 
Cronbach’s alpha confirmed the findings from the factor analysis. The individual sub-
scales showed reliable measures ranging from .77 to .90 (Table 13). 
Table 13: Internal consistency for the questionnaire sub-scales used in the main study. 
 
Sub-Scales 
 Cronbach’s 
Alpha 
Perceived knowledge of hypertension and 
antihypertensive medications 
Seven items .90 
Hill-Bone Compliance scale of medication 
adherence  
Nine items .81 
BMQ-Specific (Concern- Necessity) Eleven items .80 
PDRQ-9 Nine items .89 
Perceived quality of healthcare support  Six items .77 
 
5.2.3. Univariate analysis  
The univariate analysis in this study involved a descriptive analysis of all data 
contained in the 308 surveys. This step provided a general overview of the sample 
population, and the responses from this population. An additional reason for conducting 
the univariate analysis was identifying the status of antihypertensive medications 
adherence, including the estimation of the cut-off value for the Hill-Bone Compliance 
scale. The results of the univariate analysis reported the percentages and counts for the 
categorical and ordinal data, and the mean and standard deviation for the continuous data.  
Independent variables 
The independent variables included the factors affecting antihypertensive medications 
adherence among the study population. These factors were: the socio-demographic and health-
related factors; the perceived knowledge of hypertension and antihypertensive treatment; the 
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belief about medications; the patient-doctor relationship; and the perceived quality of 
healthcare support. The socio-demographic and health-related data were collected as 
categorical responses, while the results of the other scales were collected as ordinal Likert 
scales of 5 responses, with 1 being the lowest value, and 5 being the highest value.  
The descriptive analysis of the independent variables reported the counts and 
percentages for the categorical variables, as well as the mean, and standard deviation for 
the results of the summed-scales.  
Descriptive statistics for the health and health behaviour related factors:  
The descriptive analysis of the health-related items for the 308 participants in the 
main study are summarised in Table 14.  
Table 14: Health and health behaviour related data (n=308). 
Health-Related Characteristics  n (%) 
Time since diagnosis of hypertension 
> 6 months to < 1 year 
1 to 3 years 
> 3 years 
 
22 (7.2) 
86 (27.9) 
200 (64.9) 
Smoking status 
Smoker 
Non-smoker 
 
51 (16.6) 
257 (83.4) 
Comorbidities 
Yes 
No 
 
107 (34.7) 
201 (65.3) 
Taking other medications 
Yes 
No 
 
108 (35.1) 
200 (64.9) 
Medication Reminder Aids 
Use aids 
Do not use aids 
 
132 (42.9) 
176 (57.1) 
 
The health-related characteristics for the main study sample showed that the 
majority of participants have been diagnosed with hypertensions for more than three 
years (64.9%), were non-smokers (83.4%), and have no comorbidities (65.3%). More 
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than half of the participants reported taking only antihypertensive medications (64.9%) 
and 57.1% did not use any medication reminder aids. 
Descriptive statistics for the perceived knowledge of hypertension and antihypertensive 
medications scale: 
The descriptive statistics for the perceived knowledge of hypertension and 
antihypertensive medications identified the mean of this scale (with possible scores 
ranging from 7 to 35) for the sample as 22.93 (SD= 9.35) (see Table 15).  Responses to 
the third item in this scale reported the highest mean among the other items (Mean=3.66, 
SD=1.17) while the lowset mean was reported for the seventh item (Mean=2.51, 
SD=1.44).  
Table 15: Descriptive statistic of the perceived knowledge scale items (n=308). 
 
Perceived Knowledge of hypertension and antihypertensive medications 
Items 
 
Mean 
 
SD 
 
1- Knowledge about high blood pressure  
 
3.20 
 
1.26 
2- Knowledge about normal levels of blood pressure 3.62 1.21 
3- Knowledge about signs of high blood pressure 3.66 1.17 
4- Knowledge of high blood pressure complications 3.22 1.51 
5- Knowledge of how to deal with high blood pressure 3.52 1.26 
6- Knowledge of high blood pressure treatment benefits 3.20 1.50 
7- Knowledge of blood pressure treatment side effects 2.51 1.44 
Perceived knowledge Scale 22.93 7.5 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
 
Descriptive statistics for the belief about medication questionnaire: 
The mean of belief about medications score (with possible scores ranging from 14 
to 54) for the sample was 36.4 (SD=9), as indicated in Table 16. In this scale, the fourth 
item reported the highest mean (Mean=4, SD=1.20) and the ninth item reported the 
lowset mean among other scale items (Mean=2.94, SD=1.56).  
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Table 16: Descriptive statistic of the belief about medication scale items (n=308). 
 
Belief about medication questionnaire items 
 
Mean 
 
SD 
 
1- Without treatment I am sick 
 
3.50 
 
1.38 
2- My life would be impossible without my medications 3.12 1.47 
3- My health relies on medication usage 3.14 1.22 
4- My future health relays on my medication 4.00 1.20 
5- My medications prevent my health from becoming worse 3.86 1.11 
6- I worry from taking long life treatments 3.02 1.12 
7- My medications disrupt my life 3.02 1.59 
8- My medications are a mystery to me 3.27 1.04 
9- Having to take medications worries me 2.94 1.56 
10- I worry to become reliant on treatments 3.00 1.54 
11- These medicine give me unpleasant side effects 3.50 1.33 
Belief about Medication Scale 36.4 9.0 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
 
Descriptive statistics for the patient-doctor relationship questionnaire: 
The mean of the patient-doctor relationship scale was 34.6 (SD= 7.6) and had 
possible scores ranging from 9 to 45. As shown in Table 17. The reported higher mean 
for the scale responses was for the third item (Mean=4.40, SD=0.86) and the lower mean 
was reported for the ninth item in this scale (Mean=2.53, SD=1.55). 
Table 17: Descriptive statistic of the patient-doctor relationship scale items (n=308). 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Not at all appropriate, (2) Somewhat 
appropriate, (3) Appropriate, (4) Mostly appropriate, and (5) Totally appropriate 
 
Patient-doctor relationship questionnaire items  
 
Mean 
 
SD 
 
1-My physician helps me 
 
4.17 
 
1.05 
2- My physician have time for me 3.30 1.48 
3- I trust my physician 4.40 0.86 
4- My physician understands me 4.27 0.95 
5- My physician devotes time for me 3.43 1.47 
6- I agree with my physician about my symptoms 4.18 1.00 
7- I can talk to my physician easily 4.31 0.98 
8- I am content with my physician 4.05 1.16 
9- I can reach my physician easily 2.53 1.55 
Patient-Doctor Relationship Scale  34.6 7.6 
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Descriptive statistics for the perceived quality of healthcare support: 
The mean for the perceived quality of healthcare scale had possible scores ranging 
from 6 to 30. As shown in Table 18, the scale for the sample was 17.6 (SD= 4.7).  
Reponses to the second item in this scale reported the highest mean (Mean=3.59, 
SD=1.23) compared to the third item that reported the lower mean (Mean=1.99, 
SD=1.23).  
Table 18: Descriptive statistic of the perceived quality of healthcare support items (n=308). 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) Strongly Disagree, (2) Disagree, 
(3) Uncertain, (4) Agree, and (5) Strongly Agree. 
The descriptive analyses for the other factors were measured using Likert scale 
response items; the summed-scale responses are presented in Table 19. 
Table 19: Descriptive statistics for all independent variables’ scales. 
Scale Minimum Maximum Mean Median Std.Deviation Variance Skewness Kurtosis 
Perceived 
knowledge 
7 35 22.9 22.93 7.5 56 -.178 -.86 
Belief about 
medications 
11 55 36.4 37 9 82.8 -.380 -.452 
Patient-Doctor 
Relationship 
9 45 34.6 35 7.6 58.9 -.650 .112 
Perceived 
quality of 
healthcare 
support 
6 30 17.6 18 4.7 22.5 .407 .172 
 
 
Perceived quality of healthcare support scale items 
 
Mean 
 
SD 
 
1- Overall Support  
 
3.58 
 
1.22 
2- Hospital support  3.59 1.23 
3- Patient education  1.99 1.23 
4- brochures and booklets  2.10 1.34 
5- Easy refill for medications  3.37 1.49 
6- The need to buy the medications 3.01 1.42 
Perceived Quality of Healthcare Support Scale  17.6 4.7 
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Medication adherence  
Using the Hill-Bone Compliance scale of medications adherence the status of 
antihypertensive medications adherence was assessed. Table 20 shows the frequencies 
and percentages for each item in the scale.  
Table 20: Descriptive statistic of Hill-Bone Compliance scale 9-items (n=308). 
 Responses categories n (%)   
Scale item None of the 
time  
(1) 
Some of 
the time  
(2) 
Most of the 
time  
(3) 
All of the 
time  
(4) 
 
Mean 
 
SD 
1- How often do you forget to take your 
High Blood Pressure (HBP) medicine? 
147 (47.7) 140 (45.5) 13 (4.2) 8 (2.6) 1.61 0.69 
2- How often do you decide not to take 
your HBP medicine? 
193 (62.7) 71 (23.1) 32 (10.4) 12 (3.9) 1.55 0.83 
3- How often do you forget to get your 
prescription filled?  
233 (75.6) 50 (16.2) 16 (5.2) 9 (2.9) 1.35 0.71 
4- How often do you run out of HBP pills?  179 (58.1) 81 (26.3) 17 (5.5) 31 (10.1) 1.67 0.96 
5- How often do you skip your HBP 
medicine before you go to the doctor?  
193 (62.7) 80 (26) 24 (7.8) 11 (3.6) 1.52 0.78 
6- How often do you miss taking your 
HBP pills when you feel better?  
244 (79.2) 46 (14.9) 11 (3.6) 7 (2.3) 1.28 0.64 
7- How often do you miss taking your 
HBP pills when you feel sick? 
260 (84.4) 37 (12) 7 (2.3) 4 (1.3) 1.20 0.53 
8- How often do you take someone else’s 
HBP pills?  
286 (92.9) 15 (4.9) 5 (1.6) 2 (0.6) 1.10 0.40 
9- How often do you miss taking your 
HBP pills when you are careless?  
230 (74.7) 63 (20.5) 10 (3.2) 5 (1.6) 1.32 0.63 
Adherence scale     12.63 4.00 
Note: Scale, range is 1-5, assessed degree of agreement with each sentence: (1) None of the time, (2) Some of the 
time, (3) Most of the time, (4) All of the time. 
 
When considering the Hill-Bone Compliance scale as a continuous variable, the 
distribution of the scores for the main study were positively skewed (median=12.00, 
SD=4.00) indicating that most of the 308 participants in the main study reported lower 
scores on Hill-Bone Compliance scale (Figure 10). Hill-Bone Compliance scale scores 
range from 9 as minimum and 35 as maximum.  
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Figure 10: Distribution of Hill-Bone Compliance scale responses for the main study. 
 
The adherence scale scores were dichotomised into optimal adherence = 9, and 
suboptimal adherence > 9.  The reported results of the status of antihypertensive 
medications adherence for participants in the main study showed that only 86 (28%) of 
the sample had optimal adherence and that 222 (72%) had suboptimal adherence.  
5.2.4. Association between independent variables and medication adherence 
The descriptive analysis for the summed scales’ responses in a previous analysis 
(see Table 19) helped in identifying the median for all the scales. Bivariate analyses were 
used to assess the associations between the independent variables and medication 
adherence.   
Associations between socio-demographic, health-related factors and antihypertensive 
medication adherence: 
The data collected in the socio-demographic and health related factors included: 
patients’ gender, age, marital status, education status, employment status, smoking status, 
level of income, time since the first diagnosis with hypertension, the presence of 
comorbidities, the use of other medications, and the use of medication reminder-aids. 
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Table 21 shows the bivariate analysis for the associations between these factors and 
medication adherence. Only education status showed a significant relationship with 
antihypertensive medication adherence (OR=1.96, 95%CI = 1.03-3.74; p=0.038). 
Hypertensive patients with a formal level of education were 1.96 times more likely to 
report optimal antihypertensive medications adherence than those with non-formal 
education. The presence of comorbidities showed a borderline association OR= 1.53, 
95%CI= 0.91-2.55; p=0.050).  
 
Table 21: Bivariate results of the association between sociodemographic, health-related 
factors and antihypertensive medication adherence. 
 Antihypertensive Medications 
Adherence  
χ2  Tests  
Optimal 
Adherence 
Sub-optimal 
Adherence 
P value  OR [95% CI] 
 Frequency 
(%) 
Frequency (%) 
Gender Male 49 (28.0) 126 (72.0) 0.972 1.00 [0.61-1.66] 
Female 37 (27.8) 96 (72.2) 
Age 45 and less 18 (26.1) 51 (73.9) 0.700 0.88 [0.48-1.62] 
>45 68 (28.5) 171 (71.5) 
Marital status Married 72 (29.9) 169 (70.1) 0.147 1.61 [0.84-3.09] 
Non-Married  14 (20.9) 53 (79.1) 
Education Status Formal Education 19 (40.4) 28 (59.6) 0.038 1.96 [1.03-3.74] 
Non-formal 
Education 
67 (25.7) 194 (74.3) 
Employment status Employed 33 (25.2) 98 (74.8) 0.358 1.26 [0.76-2.11] 
Non-Employed 53 (29.9) 124 (70.1) 
Smoking status Smoker 15 (29.4) 36 (70.6) 0.795 1.09 [0.56-2.11] 
Non-Smoker 71 (27.6) 186 (72.4) 
Income <1350 USD 44 (30.3) 101 (69.7) 0.408 1.23 [0.74-2.03] 
1350 USD and 
more 
42 (30.3) 119 (73.9) 
Time since 
Hypertension 
Diagnosis 
3 years and less 30 (27.8) 78 (72.2) 0.967 0.98 [0.58-1.66] 
>3 years 56 (28.0) 144 (72.0) 
Co-morbidities With other disease 36 (33.6) 71 (66.4) 0.050 1.53 [0.91-2.55] 
Only hypertension 50 (24.9) 151 (75.1) 
Other medications  Take other 
medications 
36 (33.3) 72 (66.7) 0.120 1.50 [0.89-2.50] 
Only 
antihypertensive  
50 (25.0) 150 (75.0) 
The use of medications 
aids 
No medication aids 45 (25.6) 131 (74.4) 0.288 1.31 [0.79-2.16] 
Medication aids 41 (31.1) 91 (68.9) 
* Each pair of variables were examined separately 
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Association between perceived knowledge of hypertension and antihypertensive 
medications and medication adherence: 
The results of the bivariate analysis of the association between perceived 
knowledge of hypertension and antihypertensive medications and the status of 
antihypertension medication adherence are presented in Table 22. The results revealed 
that the perceived knowledge was not significantly associated with the status of 
antihypertensive medication adherence (OR=1.49, 95%CI=0.86-2.59; p=0.151). 
Table 22: Bivariate results of the association between the perceived knowledge and 
antihypertensive medications adherence. 
 Antihypertensive Medications 
Adherence  
χ2  Tests  
Optimal 
Adherence 
Suboptimal 
Adherence 
P value  OR [95% CI] 
 Frequency 
(%) 
Frequency (%) 
Knowledge  Low 
knowledge  
27 (31.4) 52 (23.4) 0.151 1.49 [0.86-2.59] 
High 
knowledge  
59 (68.6) 170 (76.6) 
 
Association between beliefs about medication and antihypertensive medications 
adherence:  
The patients’ beliefs about taking medications (necessity) had no significant 
association with antihypertensive medications adherence (OR= 1.38, 95%CI=0.83-2.28; 
p=0.209). On the other hand, the belief about taking medications (concern) showed a 
significant association with antihypertensive medications adherence (OR= 1.88, 
95%CI=1.14-3.12 p=0.013). The bivariate results showed that hypertensive patients with 
high levels of concern about taking their antihypertensive medications were 1.88 times 
more likely to report suboptimal medication adherence compared to those patients with 
low level of concern (Table 23). 
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Table 23: Bivariate results of the association between the beliefs about medication and 
antihypertensive medications adherence. 
 Antihypertensive Medications 
Adherence  
χ2  Tests  
Optimal 
Adherence 
Suboptimal 
Adherence 
P value  OR [95% CI] 
Belief Frequency 
(%) 
Frequency (%) 
Necessity Low 
Necessity  
35 (24.5) 108 (75.5) 0.209 1.38 [0.83-2.28] 
High 
Necessity  
51 (30.9) 114 (69.1) 
Concern  Low 
Concern  
48 (35.0) 89 (65.0) 0.013 1.88 [1.14-3.12] 
High 
Concern 
38 (22.2) 133 (77.8) 
  
Association between patient-doctor relationship and antihypertensive medications 
adherence: 
Patients’ relationship with their physician was significantly associated with 
antihypertensive medications adherence (p=0.005, OR= 0.47, 95%CI= 0.28-0.79). 
Hypertensive patients who reported poor relationship with their physicians were 0.47 less 
likely to report optimal antihypertensive medications adherence (Table 24).  
Table 24: Bivariate results of the association between the patient-doctor relationship and 
antihypertensive medications adherence. 
 Antihypertensive Medications 
Adherence  
χ2  Tests  
Optimal 
Adherence 
Suboptimal 
Adherence 
P value  OR [95% CI] 
 Frequency 
(%) 
Frequency (%) 
Patient-
Doctor 
Relationship 
Poor 
Relationship 
57 (35.4) 104 (64.6) 0.005 0.47 [0.28-0.79] 
Good 
Relationship 
29 (19.7) 118 (80.3) 
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Association between the perceived quality of healthcare and antihypertensive 
medications adherence: 
No significant relationship was found between the perceived quality of healthcare 
and the status of antihypertensive medications adherence (p=0.053, OR= 0.60, 95%CI= 
0.36-1.00) (Table 25).  
Table 25: Bivariate results of association between the perceived quality of healthcare and 
antihypertensive medications adherence. 
 Antihypertensive Medications 
Adherence  
χ2  Tests   
Optimal 
Adherence 
Suboptimal 
Adherence 
P value  OR [95% CI] 
 Frequency 
(%) 
Frequency (%) 
Perceived 
Quality of 
Healthcare 
Support 
Low Quality  34 (22.8) 115 (77.2) 0.053 0.60 [0.36-1.00] 
High 
Quality 
52 (32.7) 107 (67.3) 
 
 
5.2.5.  Predictors of antihypertensive medications adherence: A 
multivariate analysis 
The multivariate analysis approach aimed to address the second research objective 
that concerned about identifying the associated factors for antihypertensive medication 
adherence.  A binary logistic regression analysis with a backward elimination method 
was used to assess the predictors of medication adherence to determine the significant 
influential predictors for the antihypertensive medications outcomes.  
In the model, fifteen predictors were included (age, gender, education status, 
marital status, employment status, income, smoking, years of diagnosis, taking other 
medications, comorbidities, the use of medication aids, knowledge, belief, physician 
relationship, and healthcare service support). For the purpose of the analysis, some of the 
variables were recoded into dichotomous variables (i.e. years of diagnosis, and income). 
139 
 
This action was taken to overcome the problem of having small cell numbers (Field, 
2009).  
The results of the initial model of the binary logistic regression that included all the 
variables before elimination recorded a significant Omnibus test for the model 
(significance = 0.011). Further, the Hosmer and Lemeshow goodness of fit test was 
significant, with large Chi-square = 16.976, p= 0.030. The Pseudo R Square statistic 
indicated that the model, as whole, explained between 8% (Cox and Snell R Square 
=0.089) and 12.8% (Nagelkerke R Square = 0.128) of the variance in antihypertensive 
medications adherence.  
The results of the final model of the binary logistic regression using backward 
elimination recorded a significant Omnibus test for the model (significance = 0.003). 
Further, the Hosmer and Lemeshow goodness of fit test was not significant, with Chi-
square = 2.428, p= 0.965, which indicated that the model did not differ significantly from 
the observed data and that the model has a good fit. The Pseudo R Square statistic 
indicated that the model, as whole, explained between 7% (Cox and Snell R Square 
=0.077) and 11% (Nagelkerke R Square = 0.111) of the variance in antihypertensive 
medications adherence. The final model includes the fixed sociodemographic 
characteristics and all the factors that reported significance (p<0.05) (see Table 26).  
The outcome of the analysis showed that the Doctor-Patient relationship (p=0.038, 
OR=1.039, 95%CI= [1.00-1.07]), the belief of the necessity of taking antihypertensive 
medications (p=0.021, OR=1.067, 95%CI [1.01- 1.128]) and the concern of taking 
antihypertensive medications (p=0.002, OR=0.92, 95%CI [0.888-0.972]) were 
significant predictors for antihypertensive medications adherence after controlling for all 
other variables in the model.  
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The final model showed that for every unit increase on the Doctor-Patient 
Relationship scale, optimal adherence to antihypertensive medications increased by 3.9% 
(OR=1.040). In addition, for every unit increase in the belief of the necessity for taking 
antihypertensive medications, optimal adherence to antihypertensive medications 
increased by 6.5% (OR=1.070). On the other hand, for every unit decrease on the concern 
about taking antihypertensive medications score, there was a 7.3% (OR=0.929) decrease 
on reporting optimal adherence to antihypertensive medications.  
Table 26: Final multiple logistic regression model assessing the predictors of 
antihypertensive medication adherence. 
Predictors Coefficient 
(B) 
Odds 
Ratio 
 
95% CI limit 
P-
value 
Lower  Upper 
Gender (male) .063 1.066 .589 1.899 .829 
Age (>30-45) .260 1.297 .664 2.532 .447 
Income (<1350USD) .115 1.122 .650 1.935 .680 
Employment Status (Employed) .331 1.392 .798 2.427 .243 
Education Status (No formal 
education) 
.431 1.539 .682 3.477 .299 
Marital Status (Married) .477 1.611 .779 3.331 .199 
Doctor-Patient Relationship .039 1.040 1.00 1.078 .038 
Necessity Belief .065 1.070 1.01 1.128 .021 
Concern Belief -.073 0.929 .888 .972 .002 
 
5.3. Summary of the results 
This chapter included a detailed analysis of the data collected in two parts: the pilot 
study and the main study. The pilot study data analysis provided acceptable levels of 
reliability for the questionnaire items, and suggested some modification of the research 
instrument for the main study. The status of antihypertensive medications adherence was 
classified as optimal and suboptimal. The optimal adherents to antihypertensive 
medications in the main study accounted for 28% of the total sample, while 72% where 
classified as suboptimal adherents. After controlling for the sociodemographic variables, 
three significant predictors of antihypertensive medication adherence were identified in 
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the final multiple regression model. Among this group of Saudi hypertensive patients, 
those with good Doctor- Patient relationship and a greater belief in the necessity of the 
medication were more likely to report optimal medication adherence, while those with 
greater concern about the antihypertensive medication side effects were less likely to 
adhere to the medication.  
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Chapter Six: Discussion and Conclusion 
 
This chapter discusses the findings of the status of antihypertensive medication 
adherence and the associated factors of this adherence among a group of hypertensive 
patients attending one of the governmental hospitals in Jeddah city, Saudi Arabia. The 
strengths and limitations of this study and implications for improvements in 
antihypertensive medication adherence practice are also discussed in this chapter. 
6.1. The pilot study 
The pilot study conducted for this research project aimed to identify any issues with 
the developed and translated research instrument and to provide an overview for the 
future conducting of the main study. Consequently, there were two main significant 
outcomes of the pilot study which were the instrument modification and the adjustment 
of the recruitment strategy. 
The first issue encountered was the low response rate recorded for questions 
inquiring about medication names, dosage, reasons for use and side effects. Medication 
packages usually include pamphlets that contain some information about dosage, reasons 
for use and side effects of medications. However, it is not expected that all patients 
understand this information (Gazmararian, Williams, Peel & Baker, 2003). Yet it was 
still expected that patients would recall the information about their medication according 
to the physicians’ prescription given to them to follow. These questions were asked for 
the purpose of assessing patients’ recall of information about the medication they are 
using. 
Prior to conducting the pilot study there was no literature which explored Saudi 
Arabia patient’s ability to recall information about their medications. Therefore, 
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questions about their antihypertensive medication (i.e. names, dosage, reasons for use 
and side effects) were included in the pilot study. Since medication names in Saudi 
Arabia are transliterated into the Arabic language, most of the patients in the pilot study 
encountered difficulties recalling these names (response rate to medication names was 
0%).  Patients also had difficulties recalling other information related to their medications 
(doses (3.6%, 4), reasons for use (0%) and side effects (0%)).Therefore, these questions 
were removed before conducting the main study. Backes & Kuo (2012) stated that low 
health literacy is a main issue faced by patients from a diversity of educational 
backgrounds (educated and uneducated) this could explain why patients do not to recall 
medication names (Backes & Kuo, 2012).  
The second issue related to the instrument modification was removing the 
appointment-keeping items from the Hill-Bone Compliance scale. These items were 
removed for two reasons, the first being related to the results of the internal reliability. 
The second was that the Hill-Bone scale used in the pilot study included eleven items 
that were intended to measure medication adherence behaviour and appointment-keeping 
items. However, the internal consistency for the scale reliability analysis showed an 
acceptable level of Cronbach’s alpha if the appointment keeping items (item 3 and 4) 
were removed from the Hill-Bone Compliance scale of medication adherence. To explain 
further: the internal consistency for item 3 “How often do you make the next appointment 
before you leave the doctor’s office?” was .75 if this item was deleted and the internal 
consistency for item 4 “How often do you miss scheduled appointments?”, was .62 if the 
item was deleted. Therefore, items 3 and 4 were not included in the final questionnaire, 
so the Hill-Bone Compliance scale of medication adherence consisted of nine items. 
These nine items focusing on the medication adherence domain in this study reported a 
Cronbach's alpha of .76 for internal consistency. This result is in line with another study 
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that used these same nine items of the Hill-Bone Compliance scale to measure the 
medication adherence behaviour for hypertensive patients and that reported an acceptable 
internal reliability (Cronbach’s alpha of .77) after the instrument was translated into 
Korean (Song et al., 2011). 
Another reason that supported removing the appointment keeping domain was the 
different healthcare setting in King Fahad General Hospital (KFHJ) that was the location 
for the main study. The items included in the appointment keeping domain that were 
inquiring about making the next appointment before leaving the physician’s office and 
missing the next appointment were not applicable to the healthcare setting in KFHJ. This 
is because the appointment scheduling system in KFHJ is flexible as it is sometimes 
managed by patients in case of finding an available appointment with the same physician 
or by physicians or staff who put the patient on the waiting list to be managed again in 
appointments available in a shorter timeframe with the same physician. Tertiary 
governmental hospitals in Saudi Arabia experience high patient loads compared to other 
private or educational tertiary hospitals that experience lower patient loads (Al-
Doghaither & Saeed, 2000; Balbaid & Al-Dawood, 1997; Damanhouri, 2002); therefore, 
patients try hard not to miss their follow-up appointments with their physicians. For these 
reasons, the appointment keeping items in the Hill-Bone Compliance scale used for the 
main study were not considered relevant to the healthcare context of this research and 
were excluded from the questionnaire for the main study. 
During the pilot study, an issue of gender overrepresentation was observed. Most 
of the patients approached were male; because of transportation issues in the country, the 
few female patients who attended hospital clinics had to leave quickly after they were 
seen by their doctor. The main reason for this finding is that there is no public 
transportation system in Saudi Arabia and people rely on their private cars or taxis for 
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transportation. Saudi Arabian driving law forbids women from driving motor vehicles 
such as cars under any circumstances. For Saudi women to travel to achieve their needs 
such as work, education and receiving treatment, they need to be accompanied by a 
family male guardian, authorised driver or a taxi. Some families in Saudi Arabia do not 
like their women to travel with a male driver who is not a family member, therefore male 
family members take the role of driving them. Female patients have to leave quickly after 
they have completed their hospital visit to reduce the waiting burden on the driver.  
To overcome this issue in the main study, participants were approached earlier (at 
07:00 am) before they entered their clinics and they were recruited from the vital signs 
room. This was to assure sampling of more female patients than in the pilot study, since 
recruiting them with this same strategy (during their consultation time inside the clinics) 
resulted in an underrepresentation of female patients. 
Generally, the overall view of the pilot study sample demographic characteristics 
showed similarities to the main study. The majority of participants were older than 45 
years (76.4%), married (69.1%) and with a formal education (82.7%). In addition to that 
half of the participants had a middle-income (50%) and about half were unemployed 
(51.8%). These results were in line with the main study. However, the main significant 
difference that distinguishes between the two sample populations of the pilot and the 
main study is the number of female participants, education status and the level of income. 
In the main study, the main significant difference is that the representation of female 
participants was higher compared to the pilot study (43.2% vs. 23.6%). In addition, most 
participants were recorded as having no formal education (84.7%) and being from a low-
income background (47.4%). The possible reason could be related to the different sample 
locations and the reputation of the King Abdulaziz University Hospital (KAUH) for the 
pilot study, which is a government educational hospital in Jeddah city. The hospital 
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sought and gained an accreditation for its high service standards (Al Awa et al., 2011), 
therefore it could be possible that it attracts highly educated patients (82.7%) (Al Awa et 
al., 2011). Highly educated patients are more likely to be aware of the credentials and 
quality of the hospital. As highly educated patients are more likely to have higher 
incomes then the results showed higher proportion of those patients attending KAUH. It 
is important to notice that income is not an issue, given that both hospitals provide their 
services free of charge. The influence of patient education is pivotal, in that patients with 
a formal education have an awareness of the important advantages to be gained by a 
highly ranked hospital. So these patients perceived the quality and safer practices 
provided by the KAUH (Al Awa et al., 2011). 
6.2. Status of antihypertensive medication adherence 
The status of antihypertensive medications adherence for the 308 patients who 
were recruited from KFHJ is that 28% of the patients were optimal adherents and that 
72% of the patients were suboptimal adherents to their antihypertensive medications.  
The adherence rate found in this study is much lower than the rate of 
antihypertensive medications adherence estimated by the World Health Organisation in 
2003. WHO estimates that the optimal adherence levels of high blood pressure 
medications among hypertensive patients ranges from 50% to 70% (World Health 
Organisation, 2003). The estimated rates from WHO are based on findings from different 
studies published around the world. Therefore, variation on the predictable rates of 
adherence to antihypertensive medication reported by the WHO could be due to several 
reasons such as differences in study population, diversity of the method used to assess 
medication adherence, and duration of the follow-up among the studies. 
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To illustrate, studies focusing on assessing adherence to antihypertensive 
medication were conducted in different populations. For example, studies conducted in 
the developed countries with a developed healthcare system in place reported higher rates 
of adherence to antihypertensive medication compared to studies conducted in 
developing countries. This is because of the different healthcare systems and their 
approaches in the respective countries (WHO, 2003). Patients in developed countries 
benefit from the advanced healthcare systems where there is an increased effort to 
improve the health outcomes of patients with chronic conditions (Ong, Cheung, Man, 
Lau & Lam, 2007). For example, at the public health level, developed countries devote 
huge efforts to providing community screenings for the early detection of health 
problems, launching awareness campaigns to enhance the public’s understanding of the 
seriousness of chronic conditions and the importance of hypertension and its 
management, in addition to the efforts that are conducted in reviewing and updating the 
evidence-based practice guidelines used to treat hypertensive patients in these 
populations (Ong, Cheung, Man, Lau & Lam, 2007). 
In contrast, developing countries reported low rates of adherence to 
antihypertensive medications. In these countries, the healthcare system including 
hypertension management is in its early stages of development. Issues related to 
hypertensive patients’ practice such as adhering to high blood pressure medications and 
lifestyle modifications and struggles to this adherence due to different barriers are worth 
of research. Researchers are working toward identifying areas requiring improvements 
and based on the concluded outcomes of these steps, the future advancement will be 
towards working on enhancing public awareness about hypertension and on updating the 
evidence-based practice guidelines. Therefore, according to the provided overview of the 
disparity of hypertensive populations in terms of their practice that is guided by the state 
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of their healthcare system, it is important that the findings of the WHO are more detailed 
in considering this variance.  
The second reason is that studies that estimated the global rates of adherence to 
antihypertensive medications used different methods of assessments. Since there is no 
gold standard measurement to assess patients’ adherence to medications, it is not accurate 
to compare such studies with different assessment methods and populations (Hus et al., 
2014; Steiner & Prochazka, 1997). To elaborate, various subjective methods are currently 
used to assess medication adherence, such as the pill count method and the survey 
method. Results reported using the pill count method reflects the proportion of consumed 
pills while the results reported by surveys to assess adherence to medication reflects the 
proportion of patients’ reported/recalled adherence behaviour. Both method have 
weaknesses, that is, patients could have discarded some pills in order to present with 
good adherence, similarly they could have over-reported their adherence in the survey to 
present with good adherence. However, the use of the pill count method tends to give a 
close to accurate proportion of adherence in cases where the pill count was done when 
the patient was at least expecting it from the physician (Steiner & Prochazka, 1997).  
Therefore, it is impractical to compare the adherence to medication between two different 
methods of data collection. 
Thirdly, it may be that this discrepancy between the WHO data and the current 
study results more probably from the study designs and methodologies used to assess 
adherence to antihypertensive medications, mainly in terms of the length and frequency 
of the assessment period. Accordingly, the duration of follow-up plays a vital role in the 
estimation of the adherence rate. Assessing adherence to antihypertensive medications in 
a specific time reports the recent adherence behaviour. For example, in cross-sectional 
studies, the use of surveys to assess adherence requires recalling information about the 
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patient’s recent adherence behaviour for the last week, fortnight, or month. The longer 
the period of time over which the information needed to be recalled (Polit & Beck, 2008), 
for example, adherence behaviour in the last month, the more likely the respondent might 
forget and report inaccurate information.  
This is similar to reports of the findings from blood pressure reading assessed in a 
single clinic visit that shows the outcome of recent consumption of antihypertensive 
medications as the reduction of high blood pressure can be achieved after 24 hours of 
ingesting most of the antihypertensive medications (the duration of action of 
antihypertensive medications of the drug dosing interval for 24 hours) (Satoskar, 
Bhandarkar & Rege, 2006). Assessing adherence to antihypertensive medication over a 
longer period of time shows better results of medication adherence behaviour because it 
monitors patient behaviour on a frequent basis and therefore reports the outcomes of 
long-term adherence.  
The result of the current study differed from the findings of other studies conducted 
in developed and developing countries such as the USA and Middle Eastern countries 
that used a similar research design to the present study. In terms of developed countries, 
a much higher proportion of optimal adherence to medications was reported in a cross-
sectional American study that used the 4-item Morisky Medication Adherence Scale 
(MMAS-4) (Marcum et al., 2013). The study included 897 patients with chronic vascular 
conditions (coronary heart disease, diabetes mellitus, and/or hypertension), and identified 
59.3% optimal patient adherence to their medications (Marcum et al., 2013).  
With regard to the results from developing countries, the current finding of optimal 
adherence in the current study is also lower and not consistent with the latest published 
studies from the Middle East that reported antihypertensive medications optimal 
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adherence rates between 39.6% and 88.6%. To elaborate, a cross-sectional study 
conducted in Palestine using the 8–item Medication Adherence Scale (MMAS-8) among 
450 hypertensive patients found 45.8% optimal adherence to antihypertensive 
medications (Al-Ramahi, 2013). In Pakistan, a study of 438 hypertensive patients who 
were recruited from two tertiary hospitals measured antihypertensive medications 
adherence using the MMAS-4. The study found that 77% of the participants reported 
adherence to antihypertensive medications (Hashmi et al., 2007). The same method of 
assessments was applied for 250 hypertensive patients attending the outpatient clinics in 
United Arab Emirates. The results of analysis using the 4-item MMAS-4 identified 
54.4% of the participants as adherents to antihypertensive medications (Bader, Koprulu, 
Hassan, Ali, & Elnour, 2015).  
In Egypt, 316 hypertensive patients were surveyed about their antihypertensive 
medication adherence, and 74.1% were found to be optimal adherents (Youssef & 
Moubarak, 2002). Levels of antihypertensive medication adherence in the study 
conducted in Egypt, were determined by reviewing participants’ responses to the number 
of missed pills (Youssef & Moubarak, 2002). In Kuwait, a cross-sectional study of 154 
patients recruited from a hypertension clinic that used a pill count method to identify 
antihypertensive medications adherence found the adherence rate very good as 88.6% of 
the participants were considered optimal adherents. Subjects who consumed less than 
80% of the prescribed medications were labelled as non-adherents (Al-Mehza, Al-
Muhailije, Khalfan, & Al-Yahya, 2009). Antihypertensive medications adherence was 
measured in 250 hypertensive patients attending a clinic in one of the healthcare centres 
in Iran. Adherence rate was defined as ‘the proportion of the amount of the 
antihypertensive drugs used by the patients compared to the amount of prescribed drugs 
during one month’. The study revealed that 39.6% were optimal adherents to 
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antihypertensive medications by reporting more than 90% consumption of their 
medications (Hadi & Rostami-Gooran, 2004). In Sudan, antihypertensive medications 
adherence was measured for 198 hypertensive patients attending one of the teaching 
hospitals. Adherence rate was calculated using an equation that included the number of 
pills prescribed and missed pills for a specific prescription period. Antihypertensive 
medications optimal adherence was reported in 56.6% of the study sample (Elzubier, 
Husain, Suleiman, & Hamid, 2000).  
As has been demonstrated, the lower proportion of optimal adherence found in the 
present study is a reflection of the differences in the characteristics of the study samples 
between this study and the other studies conducted in the Middle East. This result is 
closer to those from previous studies conducted in different cities in Saudi Arabia. A 
study that was conducted in Almadina city in Saudi Arabia found that among 900 
patients, 22.3% were adherent to their antihypertensive medications (Mahmoud, 2012). 
Another study in Alkhobar city that surveyed 190 hypertensive patients attending 
primary healthcare centres found that 34.2% were adherent to their antihypertensive 
medications (Al-Sowielem & Elzubier, 1998) and of the 408 patients with chronic illness 
included in the study that was conducted in Riyadh city, 43.1% were found to have 
optimal adherence (AlHewiti, 2014). The findings of the present study fall within the 
range of recorded results from studies conducted in Saudi Arabia that reported optimal 
adherence rates of antihypertensive medication between 22.3% and 43.1% indicating that 
there was a lower range of optimal adherence among hypertensive patients compared to 
studies from the Middle East (39.6% and 88.6%).   
To understand the discrepancy of the results from the previously mentioned results 
from the studies conducted in developed and developing countries, highlighting 
differences with data collection methods used, sampling strategies and study sites would 
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provide a clearer picture of the current findings. In terms of the data collection method 
used to estimate medication adherence, previous studies used the pill counting method 
(Al-Mehza, et al., 2009; Khalil & Elzubier, 1997), questions with a ‘yes’ or ‘no’ response 
to measure level of adherence (MMAS-4 and MMAS-8) (Al-Ramahi, 2013; Bader et al., 
2015; Hashmi et al., 2007; Marcum et al., 2013) and patients’ self-estimate of the missed 
antihypertensive medication doses (Hadi & Rostami-Gooran, 2004;Youssef & 
Moubarak, 2002). These methods have the potential of overestimating the proportion of 
medication adherence and reporting a falsely high proportion of good adherence since 
patients could distort their adherence behaviour by discarding some medications before 
the assessment, over-reporting their responses in the survey or under-estimating the 
number of missed doses to show good adherence to medications. The current study used 
a different method for data collection (Hill-Bone Compliance scale) with four Likert 
scale responses which gave more options to respondents to report their perceived 
adherence to medications. This scale focuses on hypertensive patients’ behaviour 
regarding their medication consumption. The validity and reliability of the different 
translated and applied versions of this scale showed the Hill-Bone Compliance scale as 
a reliable and useful tool for detecting non-adherent patients in outpatient settings (Culig 
& Leppée, 2015). 
Another reason for the discrepancy of the current study findings is the differences 
between primary healthcare clinics and outpatient departments’ settings in tertiary 
hospitals. Outpatients departments in tertiary governmental hospitals in Jeddah city 
experience high patient loads and delays in consultation time compared to the more 
relaxed environment in the primary clinics which experience lower patient loads. These 
issues were discussed in previous studies as reasons for patients’ dissatisfaction with the 
quality of the services provided (Al-Doghaither & Saeed, 2000; Balbaid & Al-Dawood, 
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1997; Damanhouri, 2002). These issues affect the medication adherence practice as 
patients dissatisfied with the healthcare services provided by outpatients departments 
tend to have low expectations of the quality of the services, which in turn affects their 
commitment to the services including the treatment management plans (e.g. medications) 
(Al-Doghaither & Saeed, 2000).  
A major issue that patients attending outpatient department in governmental 
hospitals face is the absence of continuity of care. The impact of the lack of long-term 
physician–patient relationships on medication adherence is explained further in this 
chapter. Patient dissatisfaction with the quality of the healthcare services in outpatients 
departments could be the reason for reporting a high proportion of suboptimal adherence 
to antihypertensive medications in the present study (Al-Doghaither & Saeed, 2000).   
The low levels of antihypertensive medication adherence among patients in Saudi 
Arabia found in this and other studies, suggest the need for a national plan to increase 
both awareness and blood pressure control among hypertensive patients in Saudi Arabia. 
A recent national study (El Bcheraoui et al., 2014) revealed that 55% of patients who 
take antihypertensive medications in Saudi Arabia have uncontrolled blood pressure. 
Hypertensive patients in Saudi Arabia have reported some issues in other studies that 
affected their adherence to antihypertensive medications, such as inadequate information 
given to patients about their medications (Al-Khaldi & Al-Sharif, 2005), 
misunderstanding of antihypertensive medications (Khalil & Elzubier, 1997) and 
negative beliefs about medications (AlHewiti, 2014). However, in the current study the 
belief about antihypertensive medications and physician–patient relationships were 
found to be additional significant predictors in the sample population.  
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6.3. Predictors of antihypertensive medication adherence 
The findings of this study show that the significant factors that influence 
antihypertensive treatment adherence include patients’ specific belief of medications 
such as the concern of taking antihypertensive medications and the belief of the necessity 
of taking antihypertensive medications, in addition to the provider-patient relationship. 
Other factors, such as sociodemographic factors, health-related factors, patients’ 
knowledge about hypertension and antihypertensive medication adherence, and the 
provision of healthcare support were not statistically significant. 
1- Individual-related factors 
According to the current study, the sociodemographic factors (age, gender, 
marital status, income, employment and education status), health related-factors 
(duration of hypertension, presence of comorbidities, smoking, the use of reminder aids) 
and knowledge of hypertension and antihypertensive medications are not significant 
predictors for antihypertensive medication adherence in this population. 
 Age 
Age was not a significant predictor of the status of antihypertensive medications in 
the current study findings. There are few studies that have focused on age as factor in 
relation to antihypertensive medication adherence, with a strong emphasis focused on the 
role of an increase in age in association to adherence.  
A cross-sectional study of 316 hypertensive patients in Turkey which used  the 
following age group categories (i.e. less than 49 years, 50–59, 60–69 and 70–79 years 
old), found that age was p = 0.05 significantly associated with antihypertensive 
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medication adherence. The study showed that 75.8% of 33 patients aged 70 years and 
older reported poor adherence (Karakurt & Kaşikçi, 2012). 
In other studies there was a specific focus on antihypertensive medication 
adherence in one age group, patients aged 65 years and above. In a cohort study of 2,180 
hypertensive patients aged 65 years and older who were randomly selected from the 
roster of a large managed care organisation in South-eastern Louisiana (Krousel-Wood 
et al., 2010), and another cross-sectional study that used data from the Chronic Condition 
Data Warehouse of the Centers for Medicare and Medicaid Services in America of 9,827 
older adults diagnosed with hypertension, chronic heart failure and age-related problems 
(e.g. Dementia) (Rattinger et al., 2012), age was found to be a significant predictor of the 
level of adherence. Their findings suggested that older adult hypertensive patients are 
less adherent to their medications (Krousel-Wood, et al., 2010; Murray & Callahan, 2003; 
Rattinger, et al., 2012). Such poor adherence among patients older than 65 years could 
be explained as related to some aging-related health conditions such as loss of cognition 
and vision problems which make it difficult for them to adhere to their treatments 
(Rattinger et al., 2012).  
Additionally, studies that were conducted in different cultural contexts reported 
contradictory findings. The role culture could have influenced the findings. This is since 
patients who live in a culture where extended families are the norm receive family 
support which greatly affects their medication adherence]. Since the above studies were 
conducted in the context of greatly differing cultures, it seems that the factor of age in 
these studies was modified by other factors related to culture, such as the differing roles 
of family members.  
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A population based study of 29,960 hypertensive patients in Bangladesh which 
considered different age ranges identified that age was a significant factor for 
antihypertensive medications adherence (p < .05). The age groups were divided as 
follows: < 40, 40–49, 50–59, and 60 and above. According to this study, the presence of 
low adherence to antihypertensive medication decreased as the age increased for both 
male and female participants. For 119 males aged 60 years and above, the proportion of 
low adherence was 20.8% and for 128 females from the same age group the proportion 
of low adherence was 16.7% (Khanam et al., 2014).  
Aging contributes to decreased self-reliance and therefore to a decrease in health 
management including adherence to treatment regimens (Hashmi et al., 2007; Karakurt 
& Kaşikçi, 2012). However this may change if there were some supportive factors. 
Adults from different age groups in Saudi Arabia are usually living with extended family, 
and they receive support and reminders about taking their medications from their family 
members. In the Saudi Arabian cultural context, it is not common to see adults and 
especially elderly family members living in isolation or in nursing homes. This is due to 
the family structure within Saudi Arabia that values the necessity of providing care for 
their family members based on cultural and religious beliefs that are similar to other 
countries such as Pakistan and Bangladesh. Findings from other studies conducted in the 
Middle East may better align with the current results due to the similar cultural context. 
However there have been no other studies in the Middle East that have investigated the 
impact of family support on medication adherence of older adults diagnosed with 
hypertension. 
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 Gender 
The present study showed that gender is not a significant predictor for 
antihypertensive medication adherence among this group of hypertensive patients in 
Jeddah city. Previous studies found differences in levels of adherence among male and 
female hypertensive patients but reported no significant results in the regression analysis 
because the influence of this factor on antihypertensive medication adherence was 
mediated by other factors (Holt et al., 2013; Li, Wallhagen, & Froelicher, 2008).  
The current study results regarding the lack of association of gender with 
antihypertensive medication adherence is in line with some previous studies. A study of 
144 hypertensive patients in the United States of America (75 women and 69 men) found 
that women reported higher antihypertensive medication adherence compared to men 
(men = 69%, women = 75%) (Li, Wallhagen, & Froelicher, 2008b). However, with this 
reported difference in adherence, gender was not reported as a significant predictor of 
adherence in this study (p >0.05) and instead it was influenced by another cultural factor 
(the length of stay in the United States of America). For example, the study reported that 
for men, a shorter length of stay in the United States of America was negatively 
associated with no adherence (OR = 0.16; 95% CI:0.05, 0.57) (Li, Wallhagen, & 
Froelicher, 2008). 
Similarly, a cohort study of 911 men and 1283 women with hypertension found 
no significant association between gender and medication adherence (p >0.21) (Holt, et 
al., 2013). In this study, poor sexual functioning (OR = 2.03, 95% CI = 1.31-3.16) and 
body mass index of 25.0 kg/m2 or more (OR = 3.23, 95% CI = 1.59–6.59) were 
significant factors for adherence to antihypertensive medications for male hypertensive 
patients while dissatisfaction with communication with their healthcare provider 
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(OR = 1.75, 95% CI = 1.16–2.65) and depressive symptoms (OR = 2.29, 95% CI = 1.55-
3.38) were significant factors for female hypertensive patients.  
The difference by gender in level of adherence in other studies was influenced by 
other factors such as satisfaction with healthcare providers (Braverman & Dedier, 2009; 
Khan, Shah, & Hameed, 2014). In a cross-sectional analysis of 2,194 hypertensive 
patients from a cohort study of medication adherence in older adults in Louisiana (USA) 
to assess factors associated with antihypertensive medication adherence, dissatisfaction 
with healthcare providers’ reasons was found to be the reason for less adherence to 
antihypertensive medications for hypertensive American women compared to men 
(OR = 1.75, 95% CI = 1.16-265) (Holt et al., 2013).  
Since the focus of the current study was to identify factors associated with 
antihypertensive medication adherence among hypertensive patients, the regression 
analysis in the current study has not identified age as a significant factor. It is vital to 
recommend investigating gender-specific related factors to antihypertensive medications 
adherence in Saudi Arabia. Awareness of the differences is crucial for healthcare 
providers in order to provide appropriate advice for patients that will help them to cope 
effectively with their potential health threats. 
 Marital status  
Marital status is not a significant predictor of antihypertensive medications 
adherence in this study. Some studies suggest that adherence to medication for patients 
with hypertension is higher  among those who are married, and appear to have better 
control of their hypertension (DiMatteo, 2004; Trivedi, Ayotte, Edelman, & Bosworth, 
2008). According to a meta-analysis of data gathered from a review of medical studies 
in the literature, when compared to patients who were single, married patients 
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demonstrated a better adherence to medications and physician’s recommendations 
(DiMatteo, 2004).  
A study of 636 hypertensive patients in the United States of America found that 
being married was associated with better medication adherence on the multiple 
regression analysis (OR.166, p < 0.05) (Trivedi et al., 2008). The practical support 
provided by a patient’s partner, which includes reminding the patient to take the 
medications is associated with increased levels of adherence (Shumaker & Hill, 1991). 
A Similar study conducted in Pakistan found that among 460 hypertensive 
patients marital status is not a significant predictor for adherence because of the 
availability of the family support for single or married individuals (Hashmi et al., 2007). 
The context of the Saudi Arabian culture similar to Pakistan for non-married and married 
individuals may explain the difference in the current study results. In Saudi Arabia, non-
married individuals often live with other family members, parents or siblings and 
therefore the family support available for them is similar to that of married individuals. 
However, it is valuable to suggest further research in Saudi Arabia to investigate the level 
of family/partner support provided to hypertensive patients in Saudi Arabia.  
 Income  
Patients’ income was not a significant predictor of antihypertensive medications 
in this study. In contrast, some studies found that patients’ financial situation was a 
significant predictor for medication adherence (Khanam et al., 2014; Vawter, Tong, 
Gemilyan, & Yoon, 2008), because hypertensive patients with low incomes struggled to 
adhere to antihypertensive medications due to their cost (Herttua, Tabak, Martikainen, 
Vahtera, & Kivimaki, 2013). Different studies stated that patient’s low socio-economic 
status was a barrier in medication adherence because of the struggle to afford the cost of 
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medications (Abdulazeez, Omole, & Ojulari, 2014; Brown & Bussell, 2011). This is not 
relevant to the present study population because regardless of patients’ income, 
medications in Saudi Arabian government hospitals are dispensed free for citizens. 
Therefore, patients with low income do not experience any issues that should prevent 
access to medications.  
 Employment  
The findings of the current study showed that employment status of hypertensive 
patients is not a significant predictor of antihypertensive medication adherence. There 
are few studies in the field to support the relationship between employment status and 
medication adherence. A population-based study of 85,098 hypertensive patients with 
disabilities and 2,368,636 without disabilities in South Korea suggests that being 
employed is a significant supporting factor of antihypertensive medication adherence 
(Park, Kim, Jang, & Koh, 2013). The Park et al., (2013) study concluded that daily work 
routine had a positive influence on medication adherence. One possible explanation for 
this could be that employed people tend to have daily work routines that may assist in 
developing daily routines of medication as part of their normal pattern of behaviour 
(Park, et al., 2013). The introduction of daily routine activities provides a context in 
which a patient can develop a daily habit that incorporates their medication doses within 
the prescribed scheduled regimen. According to Radomski and Davis (2002) this habitual 
conditioning is due to the minimum cognitive process required by the brain when it is no 
longer heavily reliant on memory and decision making processes (Radomski & Davis, 
2002).  
In contrast, one may posit that when patients are experiencing instability in their 
daily routine and are exposed to complex circumstances in their daily activities, for 
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example, the irregularity of shift work, it is this which often contributes to the lack of 
adherence to a medication regimen.  A cross-sectional study that was conducted with 
2,445 patients in Hong Kong also supported employment status as significantly 
associated with antihypertensive medications adherence (Kang et al., 2015). The study 
reported that employed patients in either full-time or part-time jobs were less likely to be 
medication adherent (adjusted OR [AOR] = 0.782, 95% CI 0.628–0.975, p <0.05). 
Another cross-sectional study (Lee et al., 2013) of 1,114 hypertensive patients conducted 
in the out-patient clinics in the New Territories Region in Hong Kong agreed with the 
previous results of Kang et al.’s study (2015). Employed hypertensive patients reported 
poor antihypertensive medication adherence (31.9%). The reason given for these results 
was that employed patients were occupied with their work duties, had the potential to 
disturb their medication schedule.  
The type of employment status plays a role in medication adherence. Patients with 
a scheduled work routine tend to positively adhere to their medications because of a 
developed daily habit which helps to assimilate a medication regimen within their 
scheduled time. However, when there is a discrepancy in  the pattern of work routine, 
such as shift work, patients tend to be less adherents to their medications, since they have 
not maintained a regular habit for their scheduled medication.  
The disparity between the findings of the current study and those of previous 
studies may be the result of cultural differences in work patterns in Saudi Arabia. It is a 
challenge for the current study to make a clear connection between those adhering to the 
prescribed medication regimen with their commitment to a daily work routine. This is 
due to the inconsistent nature and the structure (i.e. full-time, part-time or shift work) of 
the employed participants being inconsistent. For instance, the Saudi Arabian attitude 
towards work and lifestyle are generally not structured with fixed job routines when 
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compared to other cultures, such as which exists in Western and Asian populations. 
Therefore, it cannot be assured that this variable has the same impact in Saudi Arabia. 
 Education status 
Patient’s level of education was not a significant predictor of antihypertensive 
medication adherence in the current study. The current study result is similar to previous 
findings that assessed factors affecting antihypertensive medications adherence for 150 
hypertensive patients in Brazil (p >0.05) (Nunes, de Silva, Bernardino, Oliveira, & Neto, 
2015). The result of the current study refutes the findings that found education level as a 
significant predictor for antihypertensive medications adherence (p <0.05) (Zyoud, Al-
Jabi, Sweileh, & Morisky, 2013). Zyoud et al.’s study (2013) surveyed 410 Palestinian 
hypertensive patients using the Morisky Medication Adherence Scale (MMAS-4), found 
that there was 0.12 unit increase on the MMAS score as the educational level of patients 
increased. Similarly, a study of 410 hypertensive patients using (MMAS-4) to assess 
adherence reported that patients’ educational level was a significant predictor (Hashmi 
et al., 2007).  
A patient’s level of education was claimed to influence medication adherence, 
therefore educated patients were expected to report better adherence to medications 
compared to patients with less or no educational backgrounds (Bader et al., 2015). 
However, the fact that poor health literacy is an issue that can be found in educated and 
uneducated patient groups alike indicates that medication adherence can be identified as 
an issue for both patients groups. (Gazmararian, Williams, Peel & Baker, 2003). Health 
literacy levels can be improved by providing information about the illness and its 
treatment (van der Heide et al., 2013). In Saudi Arabia, patient education clinics are 
widely available in the outpatient departments of governmental hospitals to assist patients 
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with the management of their chronic illness in terms of providing information about 
their illness and treatment, assessing and monitoring dietary intake, exercise programs 
and smoking cessation programs (Alsultan, Mayet, Khurshid & Al-jedai, 2013). In the 
current study sample, patients with hypertension were required to attend the health 
education clinics as part of their health condition management to be provided with 
information and care plans. This could explain the lack of association between education 
status and medication adherence. All patients could receive information about their 
antihypertensive medications during their visits to the patient education clinics, though 
the exact content of information is not known. 
- Knowledge of hypertension and antihypertensive medication  
Assessing patients’ perceived knowledge of their illness and the medications they 
use provides an overview of their medication adherence behaviour (Almas, Godil, Lalani, 
Samani, & Khan, 2012). Hypertensive patients in the current study were perceived to 
have moderate to good knowledge and understanding about the side effects, benefits of 
treatment, complications of uncontrolled blood pressure, symptoms and signs of blood 
pressure that is uncontrolled and elevated and normal levels of blood pressure 
(Mean = 22.9, SD = 7.5 out of a maximum score of 35). Patients’ knowledge about 
hypertension and antihypertensive medications in this study was not a significant 
predictor of antihypertensive medication adherence in the multivariate regression 
analysis.  
Saudi hypertensive patients in a previous study demonstrated misunderstanding 
of the continuity of adherence to antihypertensive medications (Al-Sowielem & Elzubier, 
1998; Khalil & Elzubier, 1997). They thought that they could stop taking their 
medications when their blood pressure symptoms did not persist which contributed to 
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poor adherence to antihypertensive medications and therefore the presence of 
complications. The current study results contradict other studies that showed knowledge 
as a significant predictor influencing the adherence to antihypertensive medications 
(Karaeren et al., 2009; Morgado, Rolo, MacEdo, Pereira, & Castelo-Branco, 2010; 
Saleem et al., 2011). The possible explanation could be due to the different health care 
settings where these studies were conducted.  
The possible explanation for the difference in these findings is that the sample in 
the current study was recruited from tertiary hospital. Previous studies conducted in 
Saudi Arabia recruited participants from primary health care centres. Patient education 
in primary health care centres in Saudi Arabia claimed to be below expectations for 
patients with chronic illness including hypertension (Kandasamy, Al-Dalee, & Aljubran, 
2012). Patient education clinics are available in governmental hospitals in Saudi Arabia. 
Patients with chronic illness are referred to these clinics to receive health education about 
different aspects of their illness such as lifestyle modification. It is possible that the 
patients in the current study had benefited from patient education clinics and had an 
improved knowledge and understanding of their illness and the treatment provided. The 
education support provided in hospital clinics improves patients’ knowledge and 
therefore their adherence level to the physician’s advice regarding illness management 
(Sharaf, 2010). The current study location is supported with patient education clinics for 
patients attending for chronic illness management. Despite the availability of health 
education clinics, the quality of the provided information and how patients’ beliefs 
interpreted the received information was not investigated. The quality of the provided 
information is vital in influencing changes in patients’ practice. Patients could receive a 
sufficient amount of information, however this may not be of a quality to address their 
needs. Furthermore, patients’ beliefs influence their information processing. This is 
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because they have different beliefs about health and illness that influence the way of 
processing the received information (to be discussed further below). 
The interventions conducted to increase patients’ knowledge about high blood 
pressure and its medications showed that knowledge alone has insignificant impact on 
patients’ medication adherence practices (Amado Guirado et al., 2011; Karaeren et al., 
2009). It was stated that knowledge about the health condition and treatments alone is 
not enough to change patients’ behaviour regarding medication adherence, as patients’ 
require time to adjust before their adherence behaviour changes (Magadza, Radloff, & 
Srinivas, 2009). 
- Beliefs  
Previous studies have suggested that most hypertensive patients do not adhere to 
medications prescribed due to excessive concerns about taking antihypertensive 
medications despite their necessity (Alhalaiqa et al., 2011; Horne, Weinman, & Hankins, 
1999; Maguire, Hughes, & McElnay, 2008). The findings of the present study showed 
that patient’s specific belief aspects (necessity and concern) about antihypertensive 
medications were significant predictors of medications adherence. The multivariate 
regression showed that the belief of the necessity of taking antihypertensive medications 
is positively correlated with antihypertensive medications and explained a 7% increase 
in the optimal adherence score while the concern about taking antihypertensive 
medications was negatively correlated with adherence and explained an 8% decrease in 
the optimal adherence to antihypertensive medications.  
A previous study in Saudi Arabia showed supportive results to the current study 
findings in terms of identifying concepts of belief about taking medications as a 
significant predictor of antihypertensive medication adherence. The specific belief 
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(necessity and concern) about medications use was found to be a significant predictor for 
medications adherence and explained 27.7% of the variance in medication adherence for 
the study sample. The main difference is that their study included a sample of patients 
with chronic conditions such as diabetes, hypertension, hyperlipidaemia, asthma, and 
hypothyroidism; while this study focused only on hypertensive patients.  
The specific belief related to use of antihypertensive medications among 
hypertensive patients was investigated in different populations. A study that was 
conducted in Peru of 115 hypertensive patients reported 57.4% patients with low 
adherence to antihypertensive medications. Patients who reported a higher score on the 
concern scale were lower adherents (PR 0.59, 95% CI 0.39–0.91) and patients whose 
necessity score outweighed their concerns were more likely to be adherents (PR 2.65; 
95% CI 1.21–5.81) (Fernandez-Arias, Acuna-Villaorduna, Miranda, Diez-Canseco, & 
Malaga, 2014). This finding was supported in another study that was conducted in the 
United States with 117 hypertensive patients. Reporting a concern about taking 
antihypertensive medications negatively associated with antihypertensive medications 
adherence (p <0.05) (Rajpura & Nayak, 2014). 
Patients’ specific belief (necessity and concern) of taking medications could be 
affected by other factors such as the presence of other illness, rather than by any beliefs 
held about the medications themselves.  A study conducted in 97 community pharmacies 
across Northern Ireland with 327 patients explored the impact of depression symptoms 
and medications beliefs on antihypertensive medication adherence (Maguire et al., 2008). 
The findings of this study reported that patients’ beliefs were not significant predictors 
of antihypertensive medication adherence and that higher levels of depressive symptoms 
were associated with higher levels of concern about taking antihypertensive medications 
(Maguire et al., 2008). From the previous findings, it could be argued the belief about 
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taking antihypertensive medications for hypertensive patients with psychological 
symptoms is affected by the presentation of their psychological illness. 
Further investigation is recommended to investigate the role of psychological 
symptoms of hypertensive patients on antihypertensive medication regimes in Saudi 
Arabia.  
It is claimed that patients’ knowledge about their health condition determines 
their beliefs about treatment and medication, and when healthcare providers fail to 
provide relevant information or educational support to hypertensive patients related to 
the medications, patients’ beliefs about the necessity of taking medications decreases and 
their level of concern increases (Kim et al., 2007). Patients in the present study can 
receive information about antihypertensive medications during their follow-up with their 
physicians or ask the pharmacists any questions that concern them about their 
medications, which might influence their medication taking practices. However, the 
quality of this information on influencing patients’ beliefs about antihypertensive 
medications is unknown. Clearly, however, information should be tailored to address 
patients’ needs and to enhance a mutual level of understanding; this is because patient’s 
beliefs about medications is specific to the particular individual. When designing a 
treatment regimen, health care providers should take into consideration the patient’s 
personal beliefs about illness and treatment and the corresponding information should be 
actively solicited before designing a medication regimen (Smith & Hoesli, 2011).  
- Health and health behaviour-related factors  
 Duration of hypertension  
Medication adherence for patients with hypertension that have been recently 
diagnosed often shows lower levels when compared to patients diagnosed with 
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hypertension over a longer term (Mazzaglia et al., 2009; Ramli, Ahmad, & Paraidathathu, 
2012). Previous studies show that consistent adherence to medication is often poor during 
the first six months after initial diagnosis, but this inconsistent adherence behaviour can 
continue for up to four years (Mazzaglia et al., 2009). Suboptimal adherence in the 
current study was similar between newly diagnosed hypertensive patients (diagnosed for 
more than 6 months but less than three years) and those who have been diagnosed with 
hypertension for more than three years (72.2% vs. 72%). The regression analysis showed 
that time of diagnosis was not a significant predictor of antihypertensive medications 
adherence in the current study sample. The findings of this study are similar to a previous 
cross-sectional study of 635 hypertensive patients attending primary healthcare clinics in 
Malaysia that reported the duration of hypertension as a not significant factor to 
medication adherence (p >0.05) (Ramli et al., 2012). 
The reason for this finding could be related to other factors that supported 
hypertensive patient’s medication adherence during early or late stages of their illness 
such as the particular beliefs of patients as regards their illness and treatment. However 
with this finding, this result raises questions about how the medication regime for 
hypertensive patients in Saudi Arabia is established from the beginning of their diagnosis 
and maintained throughout their illness.  
 The presence of comorbidities 
The presence of comorbidities was not a significant predictor of antihypertensive 
medications adherence in the current study. This is in line with a study conducted in the 
United Arab Emirates with 250 hypertensive patients (p >0.05) (Bader et al., 2015). In 
contrast, a previous study in the USA found patients with diabetes and hypertension were 
more likely than those with only hypertension to adhere to prescribed medications, as 
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they had multiple health issues that required multiple medications (Loeppke et al., 2011). 
The authors argued that patients with multiple symptoms from comorbidities and 
hypertension need to adhere to prescribed medications in order to control their symptoms 
effectively. Another explanation proposed by Hashmi et al. (2007) is that patients taking 
multiple medications are more cautious with their treatments compared with those who 
receive a single therapy (Hashmi et al., 2007). Possible reasons for patients with 
comorbidities to adhere better to their medications is because they perceive more strongly 
the seriousness of their health condition and want to prevent further complications, in 
addition to experiencing more frequent or more severe symptoms of their other 
conditions which encourage them to adhere to their medications.  
Frequently scheduled follow-ups promotes medication adherence via frequent 
monitoring and assessment of medication adherence (Jose & Jimmy, 2011). In terms of 
identifying whether the presence of comorbidities is associated with antihypertensive 
medication adherence, the results of this study are not in line with other research. The 
possible reason that could have affected the current study findings is based on whether 
patients were diagnosed with hypertension only or with other conditions along with 
hypertension. Both patients with or without comorbidities undergo frequent check-ups 
and assessment. Hypertensive patients are required to attend the clinics for regular blood 
pressure monitoring and some cardiovascular examinations (i.e. a blood test for 
cholesterol level) if required, in order to prevent complications. Patients with 
comorbidities such as cardiovascular complications and/or diabetes are also required to 
maintain their frequent follow-ups in order to monitor their health condition and assess 
for improvements in their health status or the need of treatment alterations. Therefore, in 
both cases, medication adherence could be enhanced by these frequent check-ups. This 
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is because during these check-ups, physicians assess patients’ medication adherence, 
which can encourage patients to take their medication. 
 Smoking 
Smoking in this study was not a significant predictor for adherence. Similar 
results were observed in other studies (Hyre, Krousel‐Wood, Muntner, Kawasaki, & 
DeSalvo, 2007). In Saudi Arabia, a community-based cross-sectional study assessed the 
adherence to the therapeutic plan for hypertensive patients attending the primary health 
care centres. The study showed that 760 patients were rated as poor adherents and 140 
were rated as fair-to-good adherents. The results recorded a statistically significant 
finding of smoking status between “poor” and the “fair-to-good” groups (p < 0.05) for 
non-smokers, active smokers and passive smokers (Mohamoud, 2012).  
The difference of the current study finding and the previous study might be 
because during their follow-up visits, those hypertensive patients are usually told by their 
physicians to stop smoking. Smoking cessation clinics are available in government 
hospitals in Saudi Arabia for patients with respiratory problems, such as Asthma and 
COPD. Although the role of these smoking cessation clinics with hypertensive patients 
has not been investigated in Saudi Arabia, patient education clinics on the other hand 
have the same provision in regards to supporting patients with chronic illness to stop 
smoking in order to help manage their illness. 
The previous studies (Mohamoud, 2012; Hyre, et al., 2007) have not provided a 
clear explanation of the role of smoking status in antihypertensive medication adherence. 
The role of smoking status in relations to medication adherence can be explained in two 
possible ways. The first relates to actively smoking patients. As part of the practitioner 
guideline for hypertension, lifestyle modifications for hypertension involve changes in 
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diet, the maintenance of an exercise regimen and smoking cessation.  Healthcare 
providers’ work involves facilitating these modifications for patients through education, 
assessment and monitoring.  
With regard to smoking cessation, smoking patients receive some education and 
training in order to help them to quit smoking. Therefore, they are aware of the impact 
of smoking on their health condition and are potentially working to make improvements. 
The early stages of smoking cessation training barely shows improvements, due to the 
challenges experienced by the smoker such as coping with stress, cravings, nicotine 
dependency and mood changes (Poulsen et al., 2015). These symptoms are some reasons 
for people to resume smoking which can add to the confusion experienced by those 
attempting to quit smoking in terms of the symptoms they face: they are unsure whether 
to attribute their symptoms to the effects of smoking cessation or to their hypertension 
symptoms. Yet it is possible that these patients could show a good level of adherence to 
their antihypertensive medications. This adherence may not only relate to the experienced 
symptoms of hypertension (i.e. headache) but also to improving the previously 
mentioned symptoms that smokers experience when they are not smoking.   
The second possible explanation is in the case of ex-smokers and non-smokers 
who had maintained a healthy lifestyle. Successful quitters and non-smokers reported 
having an improved quality of life and better health status compared to actively smoker 
patients (Hanus, Simoes, Amboni, Ceretta & Tuon, 2015). Accordingly, patients with an 
improved quality of life reported good adherence to their medications (Piper, Kenford, 
Fiore & Baker, 2012). This is because those patients were enthusiastically working 
toward having a better health condition and part of this work requires adhering to the 
prescribed medications to maintain a good quality of life. Despite of the potential 
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significance of smoking as a single variable in medication adherence, no studies have 
been conducted into its possible impact on antihypertensive medication adherence.  
 The use of reminder aids 
Results from previous studies were inconclusive about the factor of medication 
reminders to improve adherence to medication, but suggest that adopting reminders 
supported by new technology for patients, such as electronic messages that remind about 
medication and pharmaceutical databases could positively influence clinical outcomes 
for patients with health problems and improve adherence to medication (Rittenhouse, 
1996; Vervloet et al., 2012). 
The available studies that considered the use of medication reminders as a factor 
that could influence antihypertensive medications, were interventional studies designed 
to target patients with low adherence to medications for the intention of drawing 
conclusions about the impact of the use of medication reminder aids on enhancing 
medications adherence behaviour (Gaziano et al., 2014; Kamal et al., 2015; Sarkar, 
Sivashankar, & Seshadri, 2015).  
Reminder aids for adherence to medication for hypertensive patients were not 
found to be a significant predictor of adherence in this study. This could be because of 
the previously mentioned explanations that could have assisted the patients in the present 
sample in adhering to their medications, such as the role of family members or partner 
support in reminding patients to take their medications.  
2- Physician-Patient Relationship  
A good physician-patient relationship was associated with better medication 
adherence in the current study. The physician-patient relationship covers aspects such as 
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communication and continuity of care. With the focus on communication as a concept of 
physician-patient relationships, the present study result is in line with the international 
literature.  
A previous study found that physician communication is a positive predictor of 
medications adherence and that there is a 19% chance for patients to contribute to 
medication non-adherence if physician communication was poor (Zolnierek & Dimatteo, 
2009). Another study also found that collaborative communication between patients and 
physicians is a significant predictor enhancing medications adherence (Schoenthaler et 
al., 2009). The cross-sectional study included 439 hypertensive patients with poorly 
controlled hypertension in New York and found that collaborative physician-patients 
communication was associated with increased antihypertensive medication adherence (p 
<0.05) (Schoenthaler et al., 2009). 
Previous research has argued that for trust to be established between patients and 
physicians, the patients should expect a long-term professional relationship and clear 
communication of knowledge and advice (Thom, Kravitz, Bell, Krupat, & Azari, 2002). 
Previous research has shown that patients who kept a continuity of care with their 
physicians had been more adherent to their treatment (Chen, Tseng, & Cheng, 2013; 
Hansen et al., 2015). 
Effective interaction between physicians and their patients is possibly the most 
important factor in ensuring adherence to medication (Stavropoulou, 2011).  The 
physician is the one who diagnoses a patient as being hypertensive and therefore 
prescribes the required pharmacological therapy. It is during this process that the 
physician discusses the disease with the patient, and prescribes appropriate medication. 
It is also the ideal opportunity for the clinician to discuss the importance of adherence 
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with the patient. During follow-up consultations, the physician should discuss the success 
of the prescribed treatment with the patient, such as blood pressure control, adherence to 
the prescribed medications, any side-effects with the treatment, issues relating to care 
and medication, and the need for changes in therapy, and do so in a non-confrontational 
manner. Physicians can implement a number of changes for patients; for example, for 
those patients having side effects, there may be a change in medication required. Patients 
with complex medication regimens may require a simplified dosing schedule, or if the 
cost of medication is of concern, a switch to less expensive, generic drugs may be 
appropriate. An effective partnership between providers is essential for the successful 
management of hypertension. There should be a willingness to ‘initiate, evaluate, and 
increase doses of medication if required’, with patients keen to adhere to the medication 
regimen (Stavropoulou, 2011). The Saudi Arabian context has its own unique culture. 
Further research is needed to explore the broader cultural contextual issues that influence 
the physician-patient relationship. Such research would contribute to a better 
understanding of strategies that could enhance patients’ medication adherence.  
To elaborate on the current study findings, the communication between patients 
and physicians in Saudi Arabia is at an early stage of investigation, as this issue has not 
been sufficiently studied in previous research, and possibly it has an important influence 
on adherence to medication for hypertensive patients in this country. However, in Saudi 
Arabia, general hospitals operate outpatient clinics where consultations are arranged with 
different medical graduates or physicians each time a patient attends, so, although a 
senior physician supervises patients’ treatments, patients have a limited likelihood of 
seeing the same medical practitioner more than once. If patients request consultations 
with the same physician, then their names are added to a waiting list, because the number 
of consultations at outpatient clinics is high. Therefore, long-term relationships between 
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healthcare providers and patients cannot be effectively established due to this lack of 
continuity.  
3- Healthcare-system related factors 
The findings of this study showed that healthcare support factors are not significant 
predictors for antihypertensive medication adherence among this group of patients in 
Saudi Arabia. The healthcare support factors focused on assessing patients’ perception 
about the quality of the educational and medication support provided for hypertensive 
patients in governmental hospitals.  
With regard to quality of the educational support provided, which includes 
education sessions or materials, there are at least two possible explanations for the 
reported finding of the health support factor in the current study findings. First, the 
current study patients receive information about their medications during their follow-up 
visit, therefore the need for education sessions and resources to support adherence were 
not required for participants. In addition, most of the health resources provided in the 
outpatient departments such as brochures and patient education sessions are focussed 
heavily on the management of chronic health conditions.  
The few studies in the field have focused on this factor as part of an educational 
intervention when the health education materials were provided for patients during the 
conducting of the study. For example, the results of a randomised control study of 120 
hypertensive patients in Turkey who received six months of education sessions regarding 
lifestyle management and medication adherence reported that patient education and 
resourcing hypertensive patients with information were significant factors in improving 
adherence (Hacihasanoğlu & Gözüm, 2011). These results are in line with the findings 
of a literature review of 97 research articles published between 1979 and 2002 which 
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focussed on interventions for improving medication adherence in hypertensive patients 
(Gwadry-Sridhar et al., 2013). 
A study in Saudi Arabia that was conducted to evaluate the quality of the available 
health education materials in primary healthcare settings reported the inadequacy of the 
essential resources such as booklets, pamphlets and videotapes to conduct health 
education (Al-Khaldi & Al-Sharif, 2005). Governmental hospitals in Saudi Arabia are 
supported with health education materials, patient education clinics and patient education 
sessions (Al-Khaldi & Al-Sharif, 2005).  It is important to note that there is little attention 
made toward assessing the quality of the health educational resources provided from 
governmental hospitals in association with antihypertensive medication adherence. 
Antihypertensive medications are long term medications that need continual 
replenishing. One of the barriers in adherence to medications is the cost which hinders 
the continuity of treatment for patients with low incomes (Herttua et al., 2013). The main 
explanation for the current result is that medications are provided for free in the local 
hospital pharmacy in governmental hospitals in Saudi Arabia and therefore patients do 
not have any difficulties managing the cost of medications. Another possible reason for 
the current results in terms of the quality of medication support could be that the present 
study participants faced no issues with finding the prescribed medications in the 
governmental hospital pharmacy that made them avoid the necessity of purchasing their 
medications from local community pharmacies.  
6.4. Implications for practice  
As the findings showed a high prevalence of suboptimal adherence (72%), these 
results support the value of assessing patients’ status of adherence in outpatient clinics in 
tertiary hospitals in Saudi Arabia. The translated Hill-Bone Scale can be used as a method 
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of assessment by healthcare providers in Saudi Arabia. By identifying suboptimal 
adherent patients, the healthcare provider can intervene early in addressing the barriers 
to optimal adherence and find possible solutions that enhance adherence and that is 
customised to the specific patient’s needs. As hypertension is a health condition that 
appears in older patients, those patients are at risk for developing complications related 
to factors of age. Therefore those patients would benefit the most from the early detection 
of this issue by preventing the further risk of developing other hypertensive related 
complications or other complications related to suboptimal adherence to medication. In 
the long term this will reduce the financial burden on the healthcare system in Saudi 
Arabia by reducing the costs of treating complications related to suboptimal adherence.  
Further, the findings of this study highlight that physicians’ relationships with 
hypertensive patients are a significant predictor of antihypertensive medications 
adherence in the study sample. Physicians in Saudi Arabia need to be notified about the 
importance of this finding. The substantial advantage of good physician-patient 
relationships was confirmed, in the literature, to result in successful outcomes regarding 
patients’ medication adherence practices. Positive correlations between adherence of 
patient to their course of therapy and provider communication styles have been 
demonstrated in correlational studies. The clarity of indicative and treatment guidance 
has been linked with adherence to temporary but not too long lasting treatments and acute 
diseases. Provision of continuous care to the patients is a positive correlate of adherence 
(Zolnierek & Dimatteo, 2009). It is to be noted that patients undergoing continuous care 
and who are dynamically involved in the care procedure have better adherence behaviour 
and health consequences. Friendliness and responsiveness of the clinician appear to be 
fundamental factors. Better consequences have been observed in the patients who share 
information, create associations and provide emotional encouragement as compared to 
178 
 
those who do not communicate. In addition, satisfaction is another important factor as 
patients who are satisfied with their provider and medical treatment tend to stick to their 
treatment regimen. Such outcomes can provide guiding principles to the providers by 
identifying  a better environment that can be created, which reflects an association with 
their patients and encourages the debate of healing options, cooperation with the 
treatment and clear decision-making process regarding adherence (Schoenthaler et al., 
2009). In the case of improving health, information that motivates the patient is usually 
provided by the health care providers. Nevertheless, it is evident that providing the 
provision of incomplete information, a lack of motivation to improve, and a lack 
knowledge have a negative impact on the therapeutic relationship. To have better results, 
it is essential to have a more organized, considered and culturally appropriate 
communications between provider and patient. 
Dimensions of the provider-patient relationship that involves the communication 
process, patient’s engagement in the management plan and sustaining a longer-term 
relationship need to be shaped in Saudi Arabia. The provided hypertension guidelines for 
health providers in Saudi Arabia addressed sufficiently information regarding the 
therapeutic management for hypertension (Hansen et al., 2015; Stavropoulou, 2008). 
However, aspects of provider-patient relationship were not highlighted. Hypertension is 
a chronic health condition and the literature has comprehensively addressed that the 
physicians’ relationship with patients with chronic health conditions is a vital step in 
advancing therapeutic management. The provided hypertension guideline for healthcare 
providers in Australia, for example, involved some suggested strategies for healthcare 
providers to maximise their patients’ adherence to therapeutic plans for hypertension. 
Similar steps for the Saudi Arabian members of the healthcare profession is encouraged, 
especially given that the problem was highlighted as significant in this study.  
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The health care system can contribute to the provider role in medication adherence 
as it directs providers to plan, order appointment lengths, assign resources, manage fee 
structures and create organizational main concerns. The behaviour of a patient is affected 
by the operation of the health system. In addition, systems direct appointment length and 
time period of therapy, and sources usually state that their plans permit inadequate time 
period to deal with adherence behaviour sufficiently. Fee structures are decided by the 
health systems and as a matter of fact, many health systems have shortage of economic 
handling for patient counselling and education. Systems assign resources in such a 
manner that may possibly lead to intensified stress and increased requirements for the 
providers and that have, sequentially, been linked with reduced patient adherence (Beune 
et al., 2014). Steadiness of care and patients that is determined by health systems validate 
better adherence when they take care from the same provider over a certain period of 
time. Systems direct information sharing is basically the capability of clinics and 
pharmacies to distribute information pertinent to patients’ behaviour in the direction of 
recommendation refills possess the tendency to enhance adherence (Al-Khaldi & Al-
Sharif, 2005). Systems decide the kind of communication between doctors and patients 
that keeps the patient involved in health care. In fact, this may possibly be the modest 
and most economical way of enhancing adherence. 
Pharmacists can actively participate to improve patient’s medication adherence as 
they offer their services in this case as they provide information about different medicines 
and their usage, instruct the public regarding the use of medicines, monitor the entire 
course of therapy and identify problems occurring during therapy (Davis, Packard & 
Jackevicius, 2014). As pharmacists are well-trained and have sound knowledge about 
health care, they have the potential to enhance the adherence level of medicine for a 
longer period of time. It is an obligation of every pharmacist to provide comprehensive 
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and impartial advice that comprises of activities to protect good health as well as enhance 
the quality of life, and to prevent poor health. Keeping in view pharmaceutical care, it is 
a comparatively new concept of practice and its objective is to enhance the patient’s 
health-associated quality of life and to accomplish positive clinical consequences (Davis, 
Packard & Jackevicius, 2014).. This concept involves: imparting knowledge regarding 
the steps that are required while caring for the patient about their medicines and the 
circumstances for which they are recommended to make sure maximum healing 
advantages and safety. In addition to revising the patient’s treatment history, constant 
observation of the patient’s therapy, inspecting for probable unfavourable effects and 
serving the patient’s potential to take medications correctly and to adhere to the 
prescribed therapies (Aljumah & Hassali, 2015). 
According to Canadian nurses’ guideline for managing hypertensive patients 
(Registered Nurses’ Association of Ontario, 2005), nurses have a major role in 
enhancing medication adherence for patients with chronic illnesses. This role is seen in 
the assessment, monitoring and promotion of health care to patients. As part of the 
nursing role is conducting patient assessments, this phase should not neglect the 
gathering of information concerning medication-taking practice and the assessment of 
adherence during each patient’s visit. Endeavouring to establish and maintain the 
therapeutic relationship with patients is helpful to in exploring patients’ expectations and 
beliefs about medications. As nurses have a vital role in patient education, promotion of 
medication adherence can contribute through provision of the required information that 
supports patients’ adherence. In addition, nurses’ role in promoting adherence involves 
phone call reminders and establishment of a routine to in facilitating medication 
adherence. Monitoring and follow-up to support adherence involves patients receiving 
appropriate follow-up (i.e. telephone calls) after their visit, remind them about 
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subsequent appointments, so as to keep them in care. In Saudi Arabia, nurses are prepared 
during their training and practice to carry out this role in order to support medication 
adherence (Almalki, FitzGerald & Clark, 2011b). However, despite these stringent 
guidelines and the emphasis upon them during nurses training and clinical practice in 
Saudi Arabia, little hospital oversight or research attention has been paid to whether or 
not this nursing role is normally implemented.   
Hypertensive patients in Saudi Arabia have a low level of awareness about 
hypertension as a serious health condition. This is especially so in that the nature of 
hypertension as a health condition supports this perception by showing no continuously 
noticeable symptoms. Although the findings of this study are not generalised for the 
whole hypertensive population in Saudi Arabia, this misperception about hypertension 
as a serious health condition was confirmed in previous studies. Healthcare providers are 
required to contribute in improving the health awareness of hypertensive patients in Saudi 
Arabia. A first step can start simply in the clinic by assessing patients’ perceptions about 
hypertension and antihypertensive medications and therefore communicating with them 
the importance of committing to the therapeutic treatment plan, or by raising health 
awareness in the community about hypertension. The responsibility of correcting 
hypertensive patient’s perceptions about hypertension and antihypertensive medications 
should not be limited to physicians in the clinic only; it is a responsibility for other 
healthcare providers who deal with this patient group, such as nurses, nutritionists and 
pharmacists. 
6.5. Implications and recommendations for future research  
This study has highlighted several interesting implications and findings that are 
worthwhile recommending to future researchers. The pilot study presented a valid and 
reliable Arabic instrument that will be useful for future research in Arabic speaking 
182 
 
populations in order to assess antihypertensive medications adherence (Hill-bone Scale). 
However, combination with other methods of assessing antihypertensive medications 
adherence is recommended to confirm the results of the tool’s findings. 
The main study has highlighted the predictors of antihypertensive medications 
adherence in a small patient population attending a general hospital. Future research is 
recommended to explore these predictors in a broader hypertensive population in Saudi 
Arabia and to compare these findings with the ones presented in this study. This study 
was limited to three main dimensions, individual-related factors, healthcare provider 
factors and the healthcare system. It is believed that there are other factors affecting 
antihypertensive medications adherence which were not investigated in our study. 
Therefore, future research is recommended to include some of these factors such as the 
psychological status of hypertensive patients, quality of life, and patients’ satisfaction 
with the quality of healthcare services.  
The significant predictors in this study may inform future study designs that will 
support these predictors as follows. First, this study found that patients’ belief about 
antihypertensive medications was a significant predictor, therefore, studies are required 
to conduct interventions and recommend possible solutions for improving the perceived 
belief about taking antihypertensive medication adherence in hypertensive patients in 
Saudi Arabia. In addition, hypertensive patients’ health perception regarding health 
conditions and the prescribed medications need to be investigated. This can be done by 
conducting a qualitative study or assessing this factor thoroughly through study design 
similar to this study. 
Second, this study found that the physician – patient relationship is a predictor of 
adherence. Further exploration on the impact of this relationship on adherence is 
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encouraged through conducting qualitative research. Qualitative researchers are 
encouraged to investigate this by interviewing hypertensive patients and healthcare 
providers to explore this issue from these two different perspectives.  
6.6. Strengths and limitations 
To the researcher’s knowledge, this is the first study to identify the factors affecting 
antihypertensive treatment adherence in Saudi Arabia. It contributes to scientific 
knowledge in three ways: 1) It has validated a reliable measurement tool for measuring 
levels of antihypertensive adherence with patients who speak the Arabic language; 2) it 
has reported a low proportion of optimal adherence to antihypertensive medication in the 
sampled hypertensive patients attending a general hospital in Saudi Arabia; and 3) it has 
identified that the predictors for antihypertensive medication adherence practices are the 
concern and the necessity of taking antihypertensive medications and physician–patient 
relationships. 
The current study has a number of limitations. Firstly, it draws on the findings from 
308 hypertensive patients attending one public hospital in Jeddah city. In terms of the 
sample location, KFHJ is one of the largest public hospitals in Jeddah city and it is similar 
other public hospitals in Saudi Arabia in its approach to delivering healthcare to 
hypertensive patients, as the Ministry of Health in Saudi Arabia has a highly centralised 
structure for all public hospitals operated by their system (Jannadi, Alshammari, Khan, 
& Hussain, 2008).  
Furthermore, the study recruited participants using a convenience sampling 
strategy and therefore cannot be generalised. The results of the present study would have 
been more comprehensive if it had considered other public hospitals in Saudi Arabia, a 
larger sample size and random sampling. To overcome this limitation, future studies in 
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Saudi Arabia are warranted to include these strategies. Such a step would gather new 
findings that would support or refute the current results by presenting another picture of 
hypertensive patients’ adherence practice on a broader level.  
The cross-sectional study design prevents any claim of causality between 
adherence and its predictors (Polit & Beck, 2008). Applying this study using a different 
methodological design has clarified other facets of the issue of low adherence to 
antihypertensive medications. For example, this study has identified patient’s beliefs and 
relationships with providers as significant predictors to antihypertensive medication 
adherence. It would be worthwhile conducting a mixed-methodology to include a 
qualitative approach that could explore these predictors thoroughly. Qualitative 
approaches provide more depth, since they can explore more findings than a structured 
survey cannot reveal.  
This study relied on findings from using a survey method. The use of a self-
administered survey method is liable to recall bias regarding the information about 
adherence. It is suggested to strengthen the current findings to include a combination of 
different methods of assessing antihypertensive medication adherence. The Medication 
Events Monitoring System (MEMS®) has been found to provide reliable results in terms 
of identifying adherence status (Bovet, Burnier, Madeleine, Waeber, & Paccaud, 2002; 
Grigoryan, Pavlik, & Hyman, 2012), however, this method requires greater financial 
resources. Follow-up with frequent and regular blood pressure monitoring in addition to 
using a validated medication adherence assessment tool (a survey) would render the 
findings more reliable. This would require a longer period of time and good tracking 
system for patients to record changes in adherence. 
185 
 
The conceptual framework was limited to three domains, i.e. the individual-related 
factors, physician-patient related factors and healthcare-system- related factors that were 
drawn from the literature review of studies focused on factors which are associated with 
antihypertensive medication adherence. Conducting a similar study which incorporated 
a theoretical approach would contribute to the findings by adding more elements of the 
applied theory to the current elements included in the conceptual framework of this study. 
In addition, the assessed factors in the current study contributed to a12% (R=0.12) change 
in the status of antihypertensive medication adherence. This indicates that there are other 
potential factors associated with adherence. There are other factors that have shown to 
be associated to adherence that were not included in this study, such as the role of quality 
of life (QOL) (Hanus et al., 2015), self-efficacy (Bane, Hughe & McElnay, 2006) and 
psychological illness in antihypertensive medication adherence (Bautista et al., 2012; 
Maguire et al., 2008).  
Impairment of the QOL is a major reason for patients not to adhere to a treatment 
regimen including medications. Assessing hypertensive QOL is vital to understanding 
patients’ medication adherence practice. Antihypertensive medications are life-long 
medications, so patients continuing on these medications as prescribed should have a 
good QOL that supports the continuation of treatment (Hanus et al., 2015). In addition, 
the side-effects related to the long-term use of antihypertensive medications have been 
shown to affect hypertensive patients’ QOL, therefore assessing this factor is required in 
order to explain the status adherence for hypertensive patients (Nunes, 2001). Such a 
study that would consider this factor, with its multifaceted characteristics, would be 
highly recommended to reveal a new dimension of hypertensive patient’s medication 
adherence practice in Saudi Arabia.  
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There are some factors such as the role of self-efficacy and social support in 
relation to antihypertensive medication adherence. Previous studies have found that 
improved self-efficacy and social support were associated with greater medication 
adherence (Bane et al., 2006; Criswell et al., 2010). Self-efficacy in terms of medication 
adherence is defined as a patient’s ability to take medications in various challenging 
situations, such as not feeling well, having adverse effects, and the ability to integrate 
medications into daily life routines (Bane et al., 2006). In turn, social support evaluates 
family communication, relationships and the support which patients receive from their 
families regarding illness and treatment. It was found that patients with a low level of 
social support experience less medication adherence. Studies that have focused on 
enhancing elements related to self-efficacy and social support for hypertensive patients 
have shown significant improvements in antihypertensive medication adherence and 
blood pressure control (Bane et al., 2006; Criswell et al., 2010). Therefore, it is crucial 
to assess the role of self-efficacy in relation to antihypertensive medication adherence for 
hypertensive patients in Saudi Arabia. The family role in the culture of Saudi Arabia is 
identified as supportive of ill family members, however, it is not known how this factor 
supports patients’ medication adherence (Bane et al., 2006; Criswell et al., 2010). In 
short, the combination of a higher level of self-efficacy and social support can improve 
medication adherence.  
Patients with psychological conditions such as anxiety and depression are at 
increased risk for medication non-adherence (Bautista et al., 2012; Maguire et al., 2008). 
Studies have found that patients who experience some psychological symptoms 
encounter difficulties with managing their health illness (Bautista et al., 2012; Maguire 
et al., 2008). The effect of these symptoms is mainly on patients’ perceptions of their 
capacity to care for themselves in their illness (Maguire et al., 2008). Focusing on this 
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specific factor, which considers the role of physiological symptoms with 
antihypertensive medication adherence could potentially yield different findings 
(Bautista, Vera-Cala, Colombo, & Smith, 2012). 
Furthermore, the process of validating the developed research instrument was 
initially achieved by translating the questionnaire from English to Arabic, conducting the 
pilot study and then finalising by conducting a Principal Component Analysis (PCA) on 
the main study. An additional potential limitation is in the methodological rigour of the 
sequence of this process. Although the findings of the two conducted steps (pilot and 
main) reported satisfactory outcomes in terms of the validity and reliability of the used 
research instrument, adhering to sequential and inclusive steps would present more 
meticulous findings. For example, content analysis is an integrated step in the process of 
developing a research instrument (Polit & Beck, 2008). This step was not applied during 
the research instrument development process, because the study incorporated a readily 
available scales for assessing most of the factors in the study paradigm. Considering more 
factors related to antihypertensive medication adherence in future studies would 
eventually encourage the development and the inclusion of new items in the current 
research instrument and therefore would require conducting the content validity as an 
essential part of the development process. Furthermore, testing the validity of the 
research instrument was achieved by applying a PCA on the main study. This step would 
ideally have been applied earlier if the sample size of the pilot study had been sufficient. 
A requirement of a factor analysis including a PCA is that there should be a sufficient 
sample size so there is enough information upon which to base the analysis (Field, 2009).  
Therefore, to conduct a PCA, the sample size should include a number that is five times 
the number of variables (Field, 2009). For this study, there were 42 item scores and 
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therefore the adequate number for conducting the analysis would have been 210 in order 
to satisfy the sample size of the main study.  
Identification of the predictors associated with antihypertensive medication 
adherence was achieved by a regression analysis. Structural Equation Modelling (SEM) 
is a potential method for testing these predictors. However, a major assumption of SEM 
is having an extremely large sample size. Over 80% of the studies that applied SEM to 
an insufficient sample size drew false conclusions (Field, 2009). To conduct SEM it is 
recommended to have a minimum of ten cases for each measurement (Field, 2009). The 
present study included 42 item score, therefore to conduct the analysis a sample size of 
420 (i.e. 174 more than the calculated sample size for the main study) would be required.  
6.7. Conclusion  
The main conclusion of this study is that a substantial proportion of hypertensive 
patients attending public hospitals reported suboptimal levels of antihypertensive 
medication adherence. There were several factors that showed significant association to 
antihypertensive medication adherence. Hypertensive patients in the current study 
revealed some significant predictors that associated to their suboptimal adherence: 
patient’s specific belief about antihypertensive medications (concern and necessity) and 
physician-patient relationship. Based on these findings, the research supports the 
implementation of tailored interventions, targeting these predictors, in which 
hypertensive patients’ medication practice is enhanced. This is by focusing on issues 
related to beliefs about antihypertensive medications and physician-patient relationship. 
Evaluating hypertensive patients’ beliefs is important to explore areas of concerns 
and misunderstandings about using antihypertensive medications. Educational 
interventions in this regard are vital to improve hypertensive patients’ knowledge and 
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therefore to correct their belief about their treatment. In addition, exploring the nature of 
physician-patient relationship in Saudi Arabia is significant step that should take a place 
in order to reveal the role of this relationship hypertensive patients’ medication practice. 
There is paucity of the research that considered the role of physicians’ relationship to 
hypertensive patients’ management in Saudi Arabia. Improving the therapeutic 
relationship between the healthcare provider and hypertensive patient showed significant 
contribution to patients’ medication adherence.   
Although the current study has not considered all factors associated with 
antihypertensive medication adherence due to its concise conceptual framework, the 
mentioned above findings are substantial to reveal some of the challenges in Saudi 
hypertensive patients’ medication practice.   
The current study is one of the few studies in Saudi Arabia that used survey method 
to assess medications adherence and to investigate factors affecting antihypertensive 
medications adherence. Future studies using representative sample, qualitative approach 
and exploring more factors, may provide additional information that will guide future 
interventions for antihypertensive medications adherence issue in the Saudi Arabian 
hypertensive population.  
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Appendix B: Research Instrument  
 
1- Pilot study  
English Questionnaire 
 
 
 
 Medication information 
Please complete the following information about the medication you use for your high 
blood pressure 
Number Medication name Reason for use Side effect 
    
    
    
 
 Personal Information 
Please complete the following information about yourself. 
Part 1: Sociodemographic, health and health behaviour data 
1 Gender  
 Male 
 Female 
 
2 Age  
 
 18-30 
 More than 30 years or less than 45 
 More than 45 years  
 
3 What is the highest level of 
education you have completed? 
 
 
 No formal schooling 
 Less than primary  school 
 Primary school completed 
 Secondary school completed 
 High school completed 
 College/University completed 
 Post graduate degree 
 
4 
 
What is your marital status?  Single 
 Married 
 Divorced 
 Widowed 
 
 
 
5 Which of the following best 
describes your main work status 
over the past 12 months? 
 
 
 
 Government employee 
 Non-government employee 
 Self-employed 
 Non-paid employed 
 Student 
 Housewife 
 Retired 
 Unable to work 
6 If you don’t know the amount, can 
you give an estimate of the annual 
household income if I read some 
options to you? Is it  
 
 Equal or less than 5000 SR                             
 Between 5000 SR and 10000SR              
 Equal or more than10000                               
7 When you did first diagnosed with 
hypertension? 
 
 More than 6 months to one year 
 More than one year to three years 
 More than three years 
 
 
Part 2: Knowledge  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 I have good knowledge about my 
high blood pressure condition   
□ □ □ □ □ 
2 I know the target level of normal 
blood pressure 
□ □ □ □ □ 
3 I know the symptoms of having high 
blood pressure  
 
□ □ □ □ □ 
4 I know the complications of untreated 
high blood pressure  
 
□ □ □ □ □ 
5 I know how to deal with my high 
blood pressure symptoms 
 
□ □ □ □ □ 
6 I know the benefit of high blood 
pressure medications  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
7 I know the side effects of the 
medications I use 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
 
 
 
 
 
 
 
 
Part 3: Beliefs about Medication  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 Without my medications I would be 
very sick  
□ □ □ □ □ 
2 My life would be impossible without 
my medicines 
□ □ □ □ □ 
3 My health at the present depends on 
my medicines  
□ □ □ □ □ 
4 My health in the future will depend on 
my medicines  
□ □ □ □ □ 
5 My medicines protect me from 
becoming worse  
□ □ □ □ □ 
6 I sometimes worry about becoming 
too dependent on my medicines  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
7 My medicines disrupt my life  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
8 My medicines are a mystery to me  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
9 Having to take medicines worries me  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
10 I sometimes worry about long-term 
effects of my medicines 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
11 These medicines give me unpleasant 
side effects 
□ □ □ □ □ 
Part 4: Patient-Doctor Relationship  
 
 How  
Items  
Not at all 
appropriate 
(1)  
Somewhat 
appropriate 
(2) 
Appropriate 
 
(3) 
Mostly 
Appropriate 
(4) 
Totally 
appropriate 
 
(5) 
1 My physician helps me   □ □ □ □ □ 
2 My physician has enough time for me □ □ □ □ □ 
3 I trust my physician □ □ □ □ □ 
4 My physician understands  me □ □ □ □ □ 
5 My physician is devote time for me  □ □ □ □ □ 
6 Me and my physician agree about my 
medical symptoms  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
7 I can talk to my physician  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
8 I feel content with my physician’s 
treatment 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
9 I can reach my physician easily 
 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
 
 
Part 5: Health Care Support  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 I find the healthcare providers 
supportive for patients with high 
blood pressure  
□ □ □ □ □ 
2 I find the hospital services supportive 
for patients with high blood pressure 
□ □ □ □ □ 
3 I am supported with patients 
education session 
□ □ □ □ □ 
4 I am supported with education 
resources/ materials about high blood 
pressure 
□ □ □ □ □ 
5 It is easy to refill my drugs from the 
hospital pharmacy every time 
□ □ □ □ □ 
6 I  require to buy my medication from 
local pharmacy  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
Part 6: Medication Adherence 
 
 How  
Items  
Strongly disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
1 How often do you forget to take your 
hypertension medicine? 
 
□ □ □ □ 
2 How often do you decide not to take 
your hypertension medicine? 
 
□ □ □ □ 
3 How often do you forget to get 
prescriptions filled? 
 
□ □ □ □ 
4 How often do you run out of 
hypertension pills? 
 
□ □ □ □ 
5 How often do you skip your 
hypertension medicine before you go 
to the doctor? 
 
□ □ □ □ 
6 How often do you miss taking your 
hypertension pills when you feel 
better? 
 
 
□ 
 
□ 
 
□ 
 
□ 
7 How often do you miss taking your 
hypertension pills when you feel 
sick? 
 
□ □ □ □ 
8 How often do you take someone 
else’s hypertension pills? 
□ □ □ □ 
 
 
 
9 How often do you miss taking your 
hypertension pills when you are 
careless? 
□ □ □ □ 
10 How often do you get the next 
appointment before you leave the 
clinic? 
□ □ □ □ 
11 How often do you miss scheduled 
appointments?  
□ □ □ □ 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 eriannoitseuQ cibarA detalsnarT
 
 
 معلومات عن الأدويه المستخدمه لارتفاع ضغط الدم 
 فضلا قم باستكمال البيانات التاليه عن الأدويه المستخدمه لارتفاع ضغط الدم
 العدد اسم الدواء سبب الاستخدام الاعراض الجانبيه
    
    
 
 القسم الأول: المعلومات الشخصية  
 الرجاء قم باستكمال البيانات التالية:
 البيانات الشخصيه 
  الجنس 1
  ذكر      
  أنثى      
 
  ما هو عمرك؟ 2
 
  لا يوجد تعليم رسمي      ما هو أعلى مستوى تعليمي أكملته ؟ 3
  أقل من الابتدائي      
  أكملت الشهادة الابتدائية      
  التعليم المتوسط     
  أكملت الشهادة الثانوية      
  أكملت البكالريوس     
  شهادة عليا (ماجستير/دكتوراه)     
  لاأرغب في الإجابه      
 
  أعزب      ما هو وضعك الاجتماعي ؟ 4
  متزوج     
  مطلق     
  أرمل     
  لا أرغب في الإجابه    
أي مما يلي هو الوصف المناسب لعملك الأساسي خلال السنه  5
 الماضيه؟
  موظف حكومة     
  موظف غير حكومي    
  عمل خاص    
  طالب     
  ربة منزل     
  متقاعد     
  غير موظف ( قادر على العمل)    
  غير موظف (لأني غير قادر على العمل)    
  لاأرغب في الإجابه    
 6
 
 هل يمكنك إعطائي تخمين للدخل الشهري للأسرة؟ 
 هل هو
 
  ريال سعودي 0005 أقل من
  ريال سعودي 00001-0005مابين 
  ريال سعودي 00001أكثر من 
 
  سنه أقل من متى تم تشخيصك للمره الاولى بحالة ارتفاع ضغط الدم 7
 الجزء الأول : المعلومات الشخصية والصحية للمريض
 
 
  مابين سنه الى سنتين    
 أكثر من سنتين الى ثلاث   
  أكثر من اربع سنوات    
 
  الثقافه الدوائيه: الثاني الجزء 
أوافق 
 بشده
  )5(
 أوافق
 
  )4(
 لااعلم
 
  )3(
 أعارض
 
  )2(
اعارض 
 بشده
 
  )1(
   الأسئله
 1 اا  دي معرفه جيده عن حالة ارتفاع ضغط الدمل  □ □ □ □ □
 2  اعرف المعدل الطبيعي لضغط الدم □ □ □ □ □
 3  اعرف الأعراض المصاحبه لارتفاع ضغط الدم □ □ □ □ □
 4   المضاعفات المترتبه عن عدم معالجة ارتفاع ضغط الدماعرف ماهي  □ □ □ □ □
 5  لدي معرفه بالتعامل مع اعراض ارتفاع ضغط الدم □ □ □ □ □
 6  اعرف فائدة ادوية ارتفاع ضغط الدم □ □ □ □ □
 7  لدي معرفه بالاعراض الجانبيه لارتفاع ضغط الدم □ □ □ □ □
              الجزء الثالث: الإعتقاد الدوائي   ال
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
 الأسئله
  
 1   ن غير الادويه أصبح مريضام □ □ □ □ □
 2  حياتي ستصبح مستحيله منغير وجود الدواء □ □ □ □ □
 3  حالتي الصحيه الحاليه تعتمد على الادويه □ □ □ □ □
 4  حالتي الصحيه المستقبليه تعتمد على الأدويه  □ □ □ □ □
 5  أدويتي تحمي حالتي الصحيه من التدهور □ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 
 □
 6  بعض الاحيان أقلق بأن اصبح معتمدا على الأدويه
 
 □
 
 □
 
 □
 
 □
 
 □
 7  الأدويه التي استعملها تشكل عائق في حياتي 
 
 □
 
 □
 
 □
 
 □
 
 □
 8   استعملها شيء غامض بالنسبه ليالأدويه التي 
 
 □
 
 □
 
 □
 
 □
 
 □
 9  وجوب أخذ الادويه يقلقني
 
 □
 
 □
 
 □
 
 □
 
 □
أقلق بعض الأحيان من ظهور أعراض جانبيه في المدى البعيد نتيجه للأدويه 
 التي اتناولها 
 01 
 11  الأدويه التي استعملها أصابتني بأعراض جانبيه غير مرغوبه  □ □ □ □ □
 الجزء الرابع: علاقة المريض مع الطبيب  
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
 الأسئله
  
 1  طبيبي يقوم بمساعدتي □ □ □ □ □
 2  طبيبي لديه الوقت الكافي لي □ □ □ □ □
 
 
 3  أنا أثق في طبيبي □ □ □ □ □
 4  طبيبي يفهمني □ □ □ □ □
 5  طبيبي يكرس وقته لمساعدتي □ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 
 □
 6  أنا وطبيبي نتفق على طبيعة أعراضي المرضيه لضغط الدم
 
 □
 
 □
 
 □
 
 □
 
 □
 7  أنا أستطيع التحدث إلى طبيبي
 
 □
 
 □
 
 □
 
 □
 
 □
 8  أنا أشعر بالرضا من معاملة طبيبي
 
 □
 
 □
 
 □
 
 □
 
 □
 9  أنا أستطيع أن أتواصل مع طبيبي بسهوله
 الجزء الخامس: الدعم الصحي  
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
   الأسئله
  
 □ □ □ □ □
 1  الطاقم الطبي مساند لمرضى ارتفاع ضغط الدم
 2  الخدمات الطبيه في السمشتفى مسانده لمرضى ارتفاع ضغط الدم □ □ □ □ □
دعم الرعايه الصحيه للمرضى بدورات تعليميه عن كيفيه التعامل مع مرض  □ □ □ □ □
 ارتفاع ضغط الدم
 3 
دعم الرعايه الصحيه في السعوديه للمرضى بالمنشورات والمراجع عن  □ □ □ □ □
 مرض ارتفاع ضغط الدم
 4 
سهولة الحصول على اعادة تعبئه ادوية ارتفاع ضغط الدم من الصيدليه في  □ □ □ □ □
 كل مره
 5 
 
 □
 
 □
 
 □
 
 □
 
 □
 6  الإضطرارية للجوء للصيدليات الخاصه لشراء أدوية إرتفاع ضغط الدم
 الجزء السادس: الإلتزام الدوائي  
 كل الوقت
 
  )4(
 غالبا
 
 )3(
 أحيانا
 
 )2(
 أبدا
 
 
 )1(
  woH
   الأسئله
  
 □ □ □ □
 1  كم مرة تنسى أن تتناول دواء ارتفاع ضغط الدم ؟
 2  كم مرة تقرر أن لا تتناول دواء ارتفاع ضغط الدم ؟ □ □ □ □
 3  كم مرة تنسى فيها الحصول على وصفة طبية من طبيبك المعالج لضغط الدم ؟ □ □ □  □
 4  كم مرة تنفذ منك حبوب ارتفاع ضغط الدم ؟ □ □ □ □
 5  كم مرة تتخطى أخذ الجرعه الدوائيه قبل زيارة الطبيب؟ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 6  كم مرة تتجاهل اخذ الجرعه الدوائيه حينما تشعر بتحسن؟
 7  كم مرة تتجاهل اخذ الجرعه الدوائيه حينما تكون مريضا؟ □ □ □ □
 8  كم مره تاخذ من أدوية شخص اخر؟ □ □ □ □
 
 
 
2- Main study  
English Questionnaire 
 
 
 
Please complete the following information about yourself. 
 
1 Gender  
 Male 
 Female 
 
2 Age  
 
 18-30 
 More than 30 years or less than 45 
 More than 45 years  
 
3 What is the highest level of 
education you have completed? 
 
 
 No formal schooling 
 Less than primary  school 
 Primary school completed 
 Secondary school completed 
 High school completed 
 College/University completed 
 Post graduate degree 
 
4 
 
What is your marital status?  Single 
 Married 
 Divorced 
 Widowed 
5 Which of the following best 
describes your main work status 
over the past 12 months? 
 
 
 
 Government employee 
 Non-government employee 
 Self-employed 
 Non-paid employed 
 Student 
 Housewife 
 Retired 
 Unable to work 
□ □ □ □ ؟لامهلإل ةجيتن كئاود ذخا ىسنت ةرم مك  9 
□ □ □ □  دعوم ديدحت ىلع صرحت ةرم مك؟هدايعلا كترداغم لبق مداقلا هرايزلا  10 
□ □ □ □ ؟كدعومل روضحلا ىسنت ةرم مك  11 
Part 1: Sociodemographic, health and health behaviour data 
 
 
6 If you don’t know the amount, can 
you give an estimate of the annual 
household income if I read some 
options to you? Is it  
 
 Equal or less than 5000 SR                             
 Between 5000 SR and 10000SR              
 Equal or more than10000                               
7 When you did first diagnosed with 
hypertension? 
 
 More than 6 months to one year 
 More than one year to three years 
 More than three years 
 
 
Part 2: Knowledge  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 I have good knowledge about my 
high blood pressure condition   
□ □ □ □ □ 
2 I know the target level of normal 
blood pressure 
□ □ □ □ □ 
3 I know the symptoms of having high 
blood pressure  
 
□ □ □ □ □ 
4 I know the complications of untreated 
high blood pressure  
 
□ □ □ □ □ 
5 I know how to deal with my high 
blood pressure symptoms 
 
□ □ □ □ □ 
6 I know the benefit of high blood 
pressure medications  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
7 I know the side effects of the 
medications I use 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
Part 3: Beliefs about Medication  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 Without my medications I would be 
very sick  
□ □ □ □ □ 
2 My life would be impossible without 
my medicines 
□ □ □ □ □ 
3 My health at the present depends on 
my medicines  
□ □ □ □ □ 
4 My health in the future will depend on 
my medicines  
□ □ □ □ □ 
5 My medicines protect me from 
becoming worse  
□ □ □ □ □ 
6 I sometimes worry about becoming 
too dependent on my medicines  
 
□ 
 
□ 
 
□ 
 
□ 
 
 
 
□ 
7 My medicines disrupt my life  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
8 My medicines are a mystery to me  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
9 Having to take medicines worries me  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
10 I sometimes worry about long-term 
effects of my medicines 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
11 These medicines give me unpleasant 
side effects 
□ □ □ □ □ 
Part 4: Patient-Doctor Relationship  
 
 How  
Items  
Not at all 
appropriate 
(1)  
Somewhat 
appropriate 
(2) 
Appropriate 
 
(3) 
Mostly 
Appropriate 
(4) 
Totally 
appropriate 
 
(5) 
1 My physician helps me   □ □ □ □ □ 
2 My physician has enough time for me □ □ □ □ □ 
3 I trust my physician □ □ □ □ □ 
4 My physician understands  me □ □ □ □ □ 
5 My physician is devote time for me  □ □ □ □ □ 
6 Me and my physician agree about my 
medical symptoms  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
7 I can talk to my physician  
□ 
 
□ 
 
□ 
 
□ 
 
□ 
8 I feel content with my physician’s 
treatment 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
9 I can reach my physician easily 
 
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
Part 5: Health Care Support  
 
 How  
Items  
Strongly 
disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
Strongly 
agree 
 
(5) 
1 I find the healthcare providers 
supportive for patients with high 
blood pressure  
□ □ □ □ □ 
2 I find the hospital services supportive 
for patients with high blood pressure 
□ □ □ □ □ 
3 I am supported with patients 
education session 
□ □ □ □ □ 
4 I am supported with education 
resources/ materials about high blood 
pressure 
□ □ □ □ □ 
 
 
5 It is easy to refill my drugs from the 
hospital pharmacy every time 
□ □ □ □ □ 
6 I  require to buy my medication from 
local pharmacy  
 
□ 
 
□ 
 
□ 
 
□ 
 
□ 
Part 6: Medication Adherence 
 
 How  
Items  
Strongly disagree 
(1)  
Disagree 
 
(2) 
Uncertain  
 
(3) 
Agree 
 
(4) 
1 How often do you forget to take your 
hypertension medicine? 
 
□ □ □ □ 
2 How often do you decide not to take 
your hypertension medicine? 
 
□ □ □ □ 
3 How often do you forget to get 
prescriptions filled? 
 
□ □ □ □ 
4 How often do you run out of 
hypertension pills? 
 
□ □ □ □ 
5 How often do you skip your 
hypertension medicine before you go 
to the doctor? 
 
□ □ □ □ 
6 How often do you miss taking your 
hypertension pills when you feel 
better? 
 
 
□ 
 
□ 
 
□ 
 
□ 
7 How often do you miss taking your 
hypertension pills when you feel 
sick? 
 
□ □ □ □ 
8 How often do you take someone 
else’s hypertension pills? 
 
□ □ □ □ 
9 How often do you miss taking your 
hypertension pills when you are 
careless? 
□ □ □ □ 
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 القسم الأول: المعلومات الشخصية  
  باستكمال البيانات التالية:الرجاء قم 
 البيانات الشخصيه 
  الجنس 1
  ذكر      
  أنثى      
 
  ما هو عمرك؟ 2
 
  لا يوجد تعليم رسمي      ما هو أعلى مستوى تعليمي أكملته ؟ 3
  أقل من الابتدائي      
  أكملت الشهادة الابتدائية      
  التعليم المتوسط     
  أكملت الشهادة الثانوية      
  أكملت البكالريوس     
  شهادة عليا (ماجستير/دكتوراه)     
  لاأرغب في الإجابه      
 
  أعزب      ما هو وضعك الاجتماعي ؟ 4
  متزوج     
  مطلق     
  أرمل     
  لا أرغب في الإجابه    
خلال السنه أي مما يلي هو الوصف المناسب لعملك الأساسي  5
 الماضيه؟
  موظف حكومة     
  موظف غير حكومي    
  عمل خاص    
  طالب     
  ربة منزل     
  متقاعد     
  غير موظف ( قادر على العمل)    
  غير موظف (لأني غير قادر على العمل)    
  لاأرغب في الإجابه    
 6
 
 هل يمكنك إعطائي تخمين للدخل الشهري للأسرة؟ 
  هوهل 
 
  ريال سعودي 0005 أقل من
  ريال سعودي 00001-0005مابين 
  ريال سعودي 00001أكثر من 
 
  سنه أقل من متى تم تشخيصك للمره الاولى بحالة ارتفاع ضغط الدم 7
  مابين سنه الى سنتين    
 أكثر من سنتين الى ثلاث   
  أكثر من اربع سنوات    
 
 الجزء الأول : المعلومات الشخصية والصحية للمريض
 
 
  الدوائيهالثقافه : الثاني الجزء 
أوافق 
 بشده
  )5(
 أوافق
 
  )4(
 لااعلم
 
  )3(
 أعارض
 
  )2(
اعارض 
 بشده
 
  )1(
   الأسئله
 1 اا  دي معرفه جيده عن حالة ارتفاع ضغط الدمل  □ □ □ □ □
 2  اعرف المعدل الطبيعي لضغط الدم □ □ □ □ □
 3  اعرف الأعراض المصاحبه لارتفاع ضغط الدم □ □ □ □ □
 4   ماهي المضاعفات المترتبه عن عدم معالجة ارتفاع ضغط الدماعرف  □ □ □ □ □
 5  لدي معرفه بالتعامل مع اعراض ارتفاع ضغط الدم □ □ □ □ □
 6  اعرف فائدة ادوية ارتفاع ضغط الدم □ □ □ □ □
 7  لدي معرفه بالاعراض الجانبيه لارتفاع ضغط الدم □ □ □ □ □
              الدوائيالجزء الثالث: الإعتقاد    ال
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
 الأسئله
  
 1   ن غير الادويه أصبح مريضام □ □ □ □ □
 2  حياتي ستصبح مستحيله منغير وجود الدواء □ □ □ □ □
 3  حالتي الصحيه الحاليه تعتمد على الادويه □ □ □ □ □
 4  حالتي الصحيه المستقبليه تعتمد على الأدويه  □ □ □ □ □
 5  أدويتي تحمي حالتي الصحيه من التدهور □ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 
 □
 6  بعض الاحيان أقلق بأن اصبح معتمدا على الأدويه
 
 □
 
 □
 
 □
 
 □
 
 □
 7  الأدويه التي استعملها تشكل عائق في حياتي 
 
 □
 
 □
 
 □
 
 □
 
 □
 8   استعملها شيء غامض بالنسبه ليالأدويه التي 
 
 □
 
 □
 
 □
 
 □
 
 □
 9  وجوب أخذ الادويه يقلقني
 
 □
 
 □
 
 □
 
 □
 
 □
أقلق بعض الأحيان من ظهور أعراض جانبيه في المدى البعيد نتيجه للأدويه 
 التي اتناولها 
 01 
 11  الأدويه التي استعملها أصابتني بأعراض جانبيه غير مرغوبه  □ □ □ □ □
 الجزء الرابع: علاقة المريض مع الطبيب  
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
 الأسئله
  
 1  طبيبي يقوم بمساعدتي □ □ □ □ □
 2  طبيبي لديه الوقت الكافي لي □ □ □ □ □
 3  أنا أثق في طبيبي □ □ □ □ □
 4  طبيبي يفهمني □ □ □ □ □
 5  طبيبي يكرس وقته لمساعدتي □ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 
 □
 6  أنا وطبيبي نتفق على طبيعة أعراضي المرضيه لضغط الدم
 
 □
 
 □
 
 □
 
 □
 7  أنا أستطيع التحدث إلى طبيبي 
 
 
  
 □
 
 □
 
 □
 
 □
 
 □
 
 □
 8  أنا أشعر بالرضا من معاملة طبيبي
 
 □
 
 □
 
 □
 
 □
 
 □
 9  أنا أستطيع أن أتواصل مع طبيبي بسهوله
 الجزء الخامس: الدعم الصحي  
أوافق 
 بشده
  )5(
 أوافق
 
 )4(
  لاأعلم
 
 )3(
 أعارض
 
 )2(
أعارض 
 بشده
 
 )1(
  woH
   الأسئله
  
 □ □ □ □ □
 1  الطاقم الطبي مساند لمرضى ارتفاع ضغط الدم
 2  الخدمات الطبيه في السمشتفى مسانده لمرضى ارتفاع ضغط الدم □ □ □ □ □
دعم الرعايه الصحيه للمرضى بدورات تعليميه عن كيفيه التعامل مع مرض  □ □ □ □ □
 ارتفاع ضغط الدم
 3 
دعم الرعايه الصحيه في السعوديه للمرضى بالمنشورات والمراجع عن  □ □ □ □ □
 مرض ارتفاع ضغط الدم
 4 
سهولة الحصول على اعادة تعبئه ادوية ارتفاع ضغط الدم من الصيدليه في  □ □ □ □ □
 كل مره
 5 
 
 □
 
 □
 
 □
 
 □
 
 □
 6  الإضطرارية للجوء للصيدليات الخاصه لشراء أدوية إرتفاع ضغط الدم
 الجزء السادس: الإلتزام الدوائي  
 كل الوقت
 
  )4(
 غالبا
 
 )3(
 أحيانا
 
 )2(
 أبدا
 
 
 )1(
  woH
   الأسئله
  
 □ □ □ □
 1  كم مرة تنسى أن تتناول دواء ارتفاع ضغط الدم ؟
 2  كم مرة تقرر أن لا تتناول دواء ارتفاع ضغط الدم ؟ □ □ □ □
كم مرة تنسى فيها الحصول على وصفة طبية من طبيبك المعالج  □ □ □  □
 لضغط الدم ؟
 3 
 4  كم مرة تنفذ منك حبوب ارتفاع ضغط الدم ؟ □ □ □ □
 5  كم مرة تتخطى أخذ الجرعه الدوائيه قبل زيارة الطبيب؟ □ □ □ □
 
 □
 
 □
 
 □
 
 □
 6  كم مرة تتجاهل اخذ الجرعه الدوائيه حينما تشعر بتحسن؟
 7  كم مرة تتجاهل اخذ الجرعه الدوائيه حينما تكون مريضا؟ □ □ □ □
 8  كم مره تاخذ من أدوية شخص اخر؟ □ □ □ □
 9  كم مرة تنسى اخذ دوائك نتيجة للإهمال؟ □ □ □ □
 
 
 
 
Appendix C: Permission to use copyright protected tool 
 
From: EsmihanAlmontaser [mailto:almontaseresmihan@gmail.com]  
Sent: Tuesday, 17 June 2014 3:21 AM 
To: Fatmah Jabr A Al Solami 
Subject: Medication Adherence Scale 
  
Dear Dr.Alsolami,  
I hope all is well with you. My name is EsmihanAlmontaser and pursuing my PhD with a concentration in Nursing 
Education at Adelphi University in New York.  
I am in my second year gathering my variables and validated instruments to use for my dissertation. My research 
topic is on discrimination, Arabs and health outcomes. I have read your article on medication adherence among 
Arabs which is very relevant to my topic.   
I am writing to you to request permission to use your Hill Bone Medication Adherence Scale  (Arabic and English) 
as well as your scoring methods. Having your translated instrument would be so helpful as it would offset the cost 
for a student like me. What was the Cronbach alpha after translation? 
I would appreciate your permission and assistance on this matter, as well as any professional advice and 
recommendations moving forward.  
                                                                                    Best, 
                                                                                    EsmihanAlmontaser, RN, MA, CPAN 
 
 
 
  
From: hendyaabunabaa@yahoo.com [mailto:hendyaabunabaa@yahoo.com]  
Sent: Wednesday, 28 May 2014 2:35 AM 
To: Ignacio Correa-Velez 
Subject: Message regarding " An Arabic instrument to measure medication adherence in Saudi 
hypertensive patients " 
  
hendyaabunabaa@yahoo.com has sent you the following message via QUT ePrints: 
همجرتم هلءسا نع ثحباو انيدل طغضلاو يركسلا ىضرم دنع جلاعلل مازتللاا يف ثحبا هينيطسلف هثحاب مكتليمز انا الله همحرو مكيلع ملاسلا  ابسانمو
حب يف همدختسملا هلئسلاا هعومجم يل ثعبت نا نكمملا نم لهف اهسيقتمارتحلاا لك عم مكث  
Alsolami, Fatmah Jabr, Hou, Xiang-Yu, Correa-Velez, Ignacio, & Bahlas, Sami M. (2013) An Arabic instrument to 
measure medication adherence in Saudi hypertensive patients. Middle Eastern Journal of Family Medicine, 11(7), 
pp. 17-23. 
 
QUT ePrints 
http://eprints.qut.edu.au/ 
eprints@qut.edu.au 
 
 
 
Appendix D: SPSS Outcome 
 
1- Pilot study: Internal Reliability test for Hill-Bone Scale  
2- Item Mean SD Item 
total correlation 
Cronbach's 
Alpha if Item Deleted 
1- How often do you forget 
to take your HBP medicine? 
1.4953 .60460 .306 .608 
2- How often do you decide 
not to take your HBP medicine? 
1.3925 .54525 .291 .612 
3- How often do you make 
the next appointment before you leave 
the doctor’s office? 
2.6262 .97636 -.278 .756 
4- How often do you miss 
scheduled appointments? 
1.8318 .66568 .237 .620 
5- How often do you forget 
to get prescription filled? 
1.5981 .75059 .446 .575 
6- How often do you run out 
of HBP pills? 
1.9252 .88702 .285 .615 
7- How often do you skip 
your HBP medicine before you go to 
the doctor? 
1.4766 .63463 .460 .578 
8- How often do you miss 
taking your HBP pills when you feel 
better? 
1.5234 .69154 .428 .582 
9- How often do you miss 
taking your HBP pills when you feel 
sick? 
1.4486 .63296 .512 .568 
10- How often do you take 
someone else’s HBP pills? 
1.1963 .44381 .549 .581 
11- How often do you miss 
taking your HBP pills when you are 
careless? 
1.3178 .55962 .506 .575 
 
 
2-Main Study: Measure of Reliability and Validity  
 
Principal Axis Factoring 
 
 
 
KMO and Bartlett's Test 
Kaiser-Meyer-Olkin Measure of Sampling Adequacy. .809 
Bartlett's Test of Sphericity 
Approx. Chi-Square 7741.018 
df 861 
Sig. .000 
 
 
Total Variance Explained 
Factor Initial Eigenvalues Extraction Sums of Squared 
Loadings 
Rotation Sums of Squared 
Loadingsa 
Total % of 
Variance 
Cumulative 
% 
Total % of 
Variance 
Cumulative 
% 
Total 
1 7.137 16.993 16.993 6.696 15.943 15.943 5.407 
2 4.948 11.780 28.773 4.540 10.809 26.751 3.843 
3 3.989 9.498 38.271 3.543 8.436 35.187 4.589 
4 3.421 8.146 46.417 2.925 6.963 42.151 3.324 
5 2.275 5.416 51.833 1.879 4.473 46.624 3.534 
6 1.946 4.634 56.467 1.582 3.766 50.389 3.409 
7 1.464 3.485 59.952     
8 1.202 2.863 62.815     
9 1.173 2.792 65.607     
10 1.075 2.561 68.168     
11 1.030 2.453 70.620     
12 .840 1.999 72.619     
13 .803 1.912 74.531     
14 .758 1.806 76.336     
15 .682 1.624 77.960     
16 .672 1.600 79.560     
17 .638 1.518 81.078     
18 .614 1.462 82.539     
19 .585 1.393 83.932     
20 .530 1.261 85.193     
21 .523 1.246 86.439     
22 .482 1.149 87.588     
23 .465 1.107 88.695     
24 .442 1.051 89.746     
25 .398 .949 90.695     
26 .394 .938 91.632     
27 .362 .863 92.495     
28 .349 .831 93.326     
29 .334 .796 94.122     
30 .304 .723 94.845     
31 .289 .687 95.532     
32 .254 .604 96.136     
33 .243 .579 96.715     
34 .240 .571 97.286     
35 .206 .489 97.776     
36 .202 .480 98.256     
37 .194 .462 98.718     
38 .168 .399 99.118     
39 .143 .342 99.459     
40 .113 .268 99.728     
41 .088 .210 99.938     
 
 
42 .026 .062 100.000     
Extraction Method: Principal Axis Factoring. 
a. When factors are correlated, sums of squared loadings cannot be added to obtain a total variance. 
 
 
 
 
  
 
 
 
Pattern Matrixa 
 Factor 
1 2 3 4 5 6 
K1   -.694   -.131 
K2   -.790    
K3   -.791   .199 
K4   -.770    
K5 .132  -.814    
K6   -.702   -.235 
K7   -.660   -.164 
A1  .105  .537 -.130  
A2  .132  .557 -.228 .133 
A3    .551 -.119  
A4 .145   .504  .128 
A5 .142   .658   
A6 -.158   .714  -.121 
A7  -.143  .710  -.128 
A8    .308   
A9    .617  -.121 
B1     .792  
B2    -.108 .472  
B3     .759 .178 
B4     .735  
B5     .669  
B6  .131   .346  
B7  .852     
B8  .514     
B9  .555    -.133 
B10  .960     
B11  .939     
P1 .702      
P2 .535 .139    -.318 
P3 .762      
P4 .857    -.101  
P5 .560     -.294 
P6 .733 -.102    .120 
P7 .770     .170 
P8 .778      
P9 .361  -.161   -.407 
H1 .423    .275 -.248 
H2 .413    .306 -.211 
H3      -.843 
H4      -.842 
H5 .379    .153 -.134 
H6   -.141  -.119  
Extraction Method: Principal Axis Factoring.  
 Rotation Method: Oblimin with Kaiser Normalization.a 
a. Rotation converged in 9 iterations. 
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